0001628280-18-010708.txt : 20180807 0001628280-18-010708.hdr.sgml : 20180807 20180807165657 ACCESSION NUMBER: 0001628280-18-010708 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180807 DATE AS OF CHANGE: 20180807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc CENTRAL INDEX KEY: 0000727207 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 841072256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31822 FILM NUMBER: 18998842 BUSINESS ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 BUSINESS PHONE: 303-863-8088 MAIL ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 FORMER COMPANY: FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: HYDRO SEEK INC DATE OF NAME CHANGE: 19880802 10-Q 1 axdx-063018x10q.htm 10-Q Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018

o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-31822
ACCELERATE DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
84-1072256
(State or other jurisdiction
(I.R.S. Employer Identification No.)
of incorporation or organization)
 
 
 
3950 South Country Club, Suite 470
 
Tucson, Arizona
85714
(Address of principal executive offices)
(Zip Code)

(520) 365-3100
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þ  Yes o  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). þ  Yes o  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
 
þ
Accelerated filer
 
o
Non-accelerated file
 
o (Do not check if a smaller reporting company)
Smaller reporting company
 
o
Emerging growth company
 
o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o  Yes  þ  No

As of August 3, 2018 there were 54,127,990 shares of the registrant’s common stock outstanding.

1


TABLE OF CONTENTS


2
PART I - FINANCIAL INFORMATION


Item 1. Financial Statements

ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
BALANCE SHEET
(in thousands)
 
June 30,
December 31,
 
2018
2017
 
Unaudited
 
ASSETS
Current assets:
 
 
Cash and cash equivalents
$
66,810

$
28,513

Investments
130,594

80,648

Trade accounts receivable
1,823

1,946

Inventory
11,317

8,063

Prepaid expenses
1,421

850

Other current assets
643

468

Total current assets
212,608

120,488

Property and equipment, net
5,443

4,890

Intellectual property, net
124

134

Other non-current assets
78

—

Total assets
$
218,253

$
125,512

 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
Accounts payable
$
2,355

$
2,080

Accrued liabilities
5,302

3,636

Deferred revenue and income
185

1,071

Total current liabilities
7,842

6,787

Other long term liabilities
26

21

Convertible notes
115,499

—

Total liabilities
$
123,367

$
6,808

 
 
 
Commitments and contingencies




 
 
 
Stockholders’ equity:
 
 
Preferred shares, $0.001 par value;
 
 
5,000,000 preferred shares authorized and none outstanding as of June 30, 2018 and December 31, 2017
—

—

Common stock, $0.001 par value;
 
 
75,000,000 common shares authorized with 54,090,575 shares issued and outstanding on June 30, 2018 and 75,000,000 authorized with 55,673,810 shares issued and outstanding on December 31, 2017
54

56

Contributed capital
426,091

360,620

Treasury Stock
(45,067
)
—

Accumulated deficit
(286,058
)
(241,972
)
Accumulated other comprehensive loss
(134
)
—

Total stockholders’ equity
94,886

118,704

Total liabilities and stockholders’ equity
$
218,253

$
125,512

See accompanying notes to consolidated financial statements.

3


ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
Unaudited
(in thousands, except per share data)
 
Three Months Ended
 
Six Months Ended
 
June 30,
June 30,
 
June 30,
June 30,
 
2018
2017
 
2018
2017
Net sales
$
1,692

$
699

 
$
2,493

$
1,230

 
 
 
 
 
 
Cost of sales
717

135

 
1,210

161

Gross profit
975

564

 
1,283

1,069

 
 
 
 
 
 
Costs and expenses:
 
 
 
 
 
Research and development
6,060

5,527

 
12,842

9,815

Sales, general and administrative
15,330

11,460

 
29,682

21,988

Total costs and expenses
21,390

16,987

 
42,524

31,803

 
 
 
 
 
 
Loss from operations
(20,415
)
(16,423
)
 
(41,241
)
(30,734
)
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
Interest expense
(3,205
)
—

 
(3,363
)
—

Foreign currency exchange (loss)
(253
)
(7
)
 
(198
)
(33
)
Interest income
774

153

 
1,075

290

Other expense, net
(25
)
(5
)
 
(25
)
(5
)
Total other income (expense), net
(2,709
)
141

 
(2,511
)
252

 
 
 
 
 
 
Net loss before income taxes
(23,124
)
(16,282
)
 
(43,752
)
(30,482
)
Provision for income taxes
(101
)
(175
)
 
(285
)
(175
)
Net loss
$
(23,225
)
$
(16,457
)
 
$
(44,037
)
$
(30,657
)
 
 
 
 
 
 
Basic and diluted net loss per share
$
(0.43
)
$
(0.31
)
 
$
(0.80
)
$
(0.58
)
Weighted average shares outstanding
54,003

53,568

 
54,821

52,732

 
 
 
 
 
 
Other comprehensive loss:
 
 
 
 
 
Net loss
$
(23,225
)
$
(16,457
)
 
$
(44,037
)
$
(30,657
)
Net unrealized (loss) gain on available-for-sale investments
(2
)
3

 
(55
)
3

Foreign currency translation adjustment
(191
)
204

 
(79
)
204

Comprehensive loss
$
(23,418
)
$
(16,250
)
 
$
(44,171
)
$
(30,450
)

See accompanying notes to consolidated financial statements.

4


ACCELERATE DIAGNOSTICS, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS
Unaudited
(in thousands)
 
Six Months Ended
 
June 30,
June 30,
 
2018
2017
Cash flows from operating activities:
 
 
Net loss
$
(44,037
)
$
(30,657
)
Adjustments to reconcile net loss to net cash used in operating activities:




Depreciation
1,072

1,045

Amortization of intangible assets
10

6

Amortization of investment discount
(146
)
219

Equity-based compensation
9,011

7,450

Amortization of debt discount and issuance costs
2,273

—

Loss on disposal of property and equipment
266

5

(Increase) decrease in assets:




Accounts receivable
123

(648
)
Inventory
(4,334
)
(5,537
)
Prepaid expense and other
(444
)
(624
)
Other current assets
(175
)
(313
)
Other non-current assets
(78
)
—

Increase (decrease) in liabilities:




Accounts payable
206

528

Accrued liabilities
661

392

Accrued interest
1,105

—

Deferred revenue and income
(935
)
43

Deferred compensation
5

—

Net cash used in operating activities
(35,417
)
(28,091
)
Cash flows from investing activities:
 
 
Purchases of equipment
(702
)
(1,643
)
Purchases of available-for-sale securities
(91,272
)
(39,342
)
Sales of available-for-sale securities
3,000

6,522

Maturity of available-for-sale securities
38,272

18,449

Net cash used in investing activities
(50,702
)
(16,014
)
Cash flows from financing activities:
 
 
Issuance of common stock net of issuance costs
276

83,854

Exercise of options and warrants
2,757

3,418

Proceeds from issuance of convertible note
171,499

—

Prepayment of forward stock repurchase transaction
(45,069
)
—

Payment of debt issuance costs
(4,991
)
—

Net cash provided by financing activities
124,472

87,272

Effect of exchange rate on cash:
(56
)
198

Increase in cash and cash equivalents
38,297

43,365

Cash and cash equivalents, beginning of period
28,513

19,244

Cash and cash equivalents, end of period
$
66,810

$
62,609

Non-cash investing activities:
 
 
Transfer of instruments from inventory to property and equipment 
$
1,196

$
—


See accompanying notes to consolidated financial statements.

5


ACCELERATE DIAGNOSTICS, INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited

NOTE 1. ORGANIZATION AND NATURE OF BUSINESS; BASIS OF PRESENTATION; PRINCIPLES OF CONSOLIDATION; SIGNIFICANT ACCOUNTING POLICIES

Accelerate Diagnostics, Inc. (“we” or “us” or “our” or “Accelerate” or “the Company”) is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, as filed with the SEC on March 1, 2018.

The condensed consolidated balance sheet as of December 31, 2017 included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.

The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending December 31, 2018, or any future period.

All amounts are rounded to the nearest thousand dollars unless otherwise indicated.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.

Use of Estimates

The Company’s consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of the Company’s consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventories, property and equipment, intangible assets, accruals, warranty liabilities, tax valuation accounts and stock-based compensation. Actual results could differ materially from those estimates.

Estimated Fair Value of Financial Instruments

The Company follows ASC Topic 820, Fair Value Measurements and Disclosures which has defined fair value and requires the Company to establish a framework for measuring fair value and disclose fair value measurements. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:

•
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;


6


•
Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

•
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, accounts payable, accrued liabilities, and other liabilities approximate the related fair values due to the short-term maturities of these instruments.

Cash and Cash Equivalents

All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe however, that the market risk arising from holding these financial instruments is minimal.

Investments

The Company invests excess funds in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificate of deposits, debt securities in U.S. government and agency securities, commercial paper, asset-backed securities and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive income (loss), a component of stockholders’ equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.

The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment’s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive income (loss).

Inventory

The Company writes down its inventory for estimated obsolescence or in an amount equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, market conditions and, where applicable, product expiration.

Accounts Receivable

Accounts receivable consist of amounts due to the Company for sales to customers and are recorded net of an allowance for doubtful accounts. Allowances on accounts receivable are recorded when circumstances indicate collection is doubtful for a particular accounts receivable. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis.

The Company has not included an allowance for doubtful accounts as of June 30, 2018 and December 31, 2017, due to no circumstances arising that would indicate collection of any particular or grouping of customer accounts receivable is doubtful.


7


Property and Equipment

Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from one to seven years. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less. Property and equipment includes diagnostic instruments used for sales demonstrations and instruments under rental agreements. The Company retains title to the instruments under these arrangements.

Long-lived Assets

Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.

Warranty Reserve

Instruments are typically sold with a one year limited warranty, while kits and accessories are typically sold with a 60 days limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.

Warranty reserve activity for the three and six months ended June 30, 2018 and 2017 is as follows (in thousands):
 
Three Months Ended
Six Months Ended
 
June 30,
June 30,
June 30,
June 30,
 
2018
2017
2018
2017
Beginning balance
$
176

$
31

$
192

$
1

Provisions
145

50

266

80

Warranty expenses incurred
(122
)
(20
)
(259
)
(20
)
Ending balance
$
199

$
61

$
199

$
61


Convertible Notes

The Company issued convertible notes that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.

Revenue Recognition

Effective January 1, 2018, the Company adopted the requirements of ASC 606, Revenue from Contracts with Customers, ("Topic 606") and recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.

We determine revenue recognition through the following steps:

•
Identification of the contract with a customer

•
Identification of the performance obligations in the contract

8



•
Determination of the transaction price

•
Allocation of the transaction price to the performance obligations

•
Recognition of revenue as we satisfy a performance obligation

Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized.

Service revenue is derived from the sale of extended service agreements which are generally non-cancelable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.

Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the price charged to customers for each individual performance obligation.

We also provide instruments to customers under bundled rental agreements. Under these agreements, we install the instrument in the customer’s facility and provide service. The customer agrees to purchase consumable products at a stated price over the term of the agreement, which is typically five years or less. Contracts sometimes have renewal clauses but such clauses do not provide for a bargain renewal option or penalize the customer if they do not renew. The instrument remains the Company’s property throughout the term of the agreement and there is no transfer of title upon expiration.

Our payment terms vary by the type and location of our customers and the product or services offered and typically range between 30 and 60 days.

Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the quarter ended June 30, 2018.

The Company adopted Topic 606 using the modified retrospective method applied to those contracts that were not fully performed by the Company as of January 1, 2018. We recorded a decrease to opening retained earnings and an increase in deferred revenue of $49,000 as of January 1, 2018 due to the cumulative impact of adopting Topic 606. The impact to revenues for the three and six months ended June 30, 2018 was not material as a result of applying Topic 606.  The reported results for 2017 and prior were prepared and are presented under the guidance of ASC 605, Revenue Recognition.

Cost of Sales

Cost of sales consists of raw materials, depreciation, direct labor and stock-based compensation expense, manufacturing overhead, facility costs and warranty costs.

Shipping and Handling

Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the consolidated statements of operations and comprehensive loss.

Leases

The Company accounts for leases in accordance with ASC 840, Leases, which requires leases to be classified as either operating or capital leases. In general, the Company classifies leases as capital leases when there is either a transfer of ownership at the end of the lease term, the lease contains a bargain purchase option, the lease term is

9


seventy-five percent or more of the estimated economic life of the leased property or the minimum lease payments are ninety percent or more of the fair value of the leased property at lease inception. Other leases are classified as operating leases.

Operating lease rent is recorded as an operating expense on a monthly basis. For capital leases, both an asset and liability are recorded at the inception of the lease based on the present value of lease payments. The asset is included with property and equipment on the condensed consolidated balance sheet and amortization is recorded on a straight-line basis over the term of the lease with the amortization expense included with depreciation on the statements of operations and comprehensive loss. For the liability, the amount due within the next year is recorded as a current liability and the amount due in more than a year is recorded as a long-term liability on the condensed consolidated balance sheet. Interest expense is recorded based on the implicit or explicit interest rate used in the lease and is included as non-operating interest expense on the statements of operations and comprehensive loss. As of June 30, 2018 and December 31, 2017, the Company did not carry any capital leases.

Equity-Based Compensation

The Company awards stock options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method). We account for forfeitures as they occur rather than on an estimated basis.

The Company estimates the fair value of stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.

The Company records the fair value of restricted stock units or stock grants based on published closing market price on the day before the grant date.

Income Taxes and Deferred Tax Assets

Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying condensed consolidated balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.

The Company follows the provisions of ASC 740, Income Taxes, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit the taxpayer must determine it is more likely than not certain that its tax position will be sustained, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.

Foreign Currency Translation and Foreign Currency Transactions

The Company follows ASC 830 Foreign Currency Matters, which provides guidance on foreign currency transactions and translation of financial statements. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in the consolidated statements of stockholders’ equity.

The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.


10


Earnings Per Share

Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share are computed similarly to basic earnings (loss) per share except the denominator includes additional common shares that would have been outstanding if notes convertible at the balance sheet date were converted and share-based payments had been issued. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.

NOTE 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-07, Compensation-Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to Accounting Standards Codification (“ASC”) 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We do not anticipate this update will have an effect on our condensed consolidated financial statements because all share-based awards granted to nonemployees are fully vested.
In March 2018, issued ASU 2018-05, Amendments Pursuant to SEC Staff Accounting Bulletin (“SAB”) No. 118 (SEC Update), Income Taxes (Topic 740). ASU 2018-05 provides guidance regarding the recording of tax impacts where uncertainty exists, in the period of adoption of the 2017 U.S. Tax Cuts and Jobs Act (the “Tax Act”). In accordance with this guidance, the Company’s financial results reflect provisional amounts for those specific income tax effects of the Tax Act for which the accounting under ASC Topic 740 is incomplete but a reasonable estimate could be determined. During the six months ended June 30, 2018, the Company did not recognize any changes to the provisional amounts recorded in its 2017 Annual Report on Form 10-K in connection with the Tax Act, as the Company continues to collect the information necessary to complete those calculations. The accounting for the tax effects of the Tax Act will be completed in the second half of 2018.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220) Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI), which allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act that the FASB refers to as having been stranded in AOCI. This ASU is effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2018, with early adoption permitted. The Company is evaluating the impact of the adoption of ASU 2018-02 on our condensed consolidated financial statements, though its effects are not expected to be material.

In March 2017, the FASB issued ASU 2017-08, Receivable-Nonrefundable Fees and Other Costs (Topic 310-20) Premium Amortization on Purchased Callable Debt Securities. This amendment shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. This ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. If an entity early adopts in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently assessing the impact this will have on our condensed consolidated financial statements.


11


In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740) Intra-Entity Transfers of Assets Other Than Inventory. This ASU is effective for periods after December 15, 2017 and eliminates the requirement that the Company recognize the income tax consequences of an intra-entity transfer of an asset upon transfer other than inventory, eliminating the current recognition requirement. This ASU is effective for the 2018 annual reporting period including the interim periods ended March 31, 2018 and June 30, 2018. In adopting this ASU, the Company recorded no cumulative-effect adjustment to retained earnings at January 1, 2018. As the U.S. and the consolidated group are in a net operating loss position, no prepaid tax has been recorded.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments, which amends the guidance on measuring credit losses on financial assets (including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an “incurred loss” methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this guidance will have a significant impact on our condensed consolidated financial statements and plan to adopt on the effective date.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This replaces the existing standards relating to leases for both lessees and lessors. For lessees, the new standard requires most leases to be recorded on the condensed consolidated balance sheet with expenses recognized much like the existing standard. For lessors, the new standard modifies the classification criteria and accounting for sales-type and direct financing leases and eliminates leveraged leases. For both lessees and lessors, the standard eliminates real estate-specific provisions, changes some of the presentation and disclosure requirements, and changes sale and leaseback criteria. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We are currently assessing the impact this will have on our condensed consolidated financial statements.

In January, 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Topic 825). This standard requires equity investments, with some exceptions, be measured at fair value with valuation changes recognized in net income, simplifies the impairment assessment of some equity investments, eliminates the requirement to disclose the methods and significant assumptions used to estimate the fair value for financial instruments measured at amortized cost, requires the use of the exit price notion when measuring the fair value of financial instruments, requires separate presentation of some changes in other comprehensive income, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial assets, and clarifies the need for a valuation allowance on some deferred tax assets. The Company adopted this ASU on January 1, 2018, and the adoption did not have a material impact on the Company’s consolidated financial statements.

NOTE 3. FDA CLEARANCE

On February 23, 2017, the U.S. Food and Drug Administration (“FDA”) granted Accelerate’s de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples.

Due to various factors, the Company manufactured inventory in advance of regulatory approval (“pre-launch inventory”). On January 1, 2017, the regulatory review process had progressed to a point that objective and persuasive evidence of approval was sufficiently probable, and a future economic benefit existed. On January 1, 2017, the Company started capitalizing pre-launch inventory.


12


NOTE 4. FAIR VALUE OF FINANCIAL INSTRUMENTS

The following tables represent the financial instruments measured at fair value on a recurring basis on the financial statements of the Company and the valuation approach applied to each class of financial instruments at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
37,824

$
—

$
—

$
37,824

Commercial paper
—

5,982

—

5,982

Corporate notes and bonds
—

9,087

—

9,087

Total cash and cash equivalents
$
37,824

$
15,069

$
—

$
52,893

Investments:
 
 
 
 
Certificates of deposit
—

13,682

—

13,682

U.S. Treasury securities
31,744

—

—

31,744

U.S. Agency securities
—

6,944

—

6,944

Commercial paper
—

35,917

—

35,917

Asset-backed securities
—

8,993

—

8,993

Corporate notes and bonds
—

33,314

—

33,314

Total investments
31,744

98,850

—

130,594

Total assets measured at fair value
$
69,568

$
113,919

$
—

$
183,487


 
December 31, 2017
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
7,832

$
—

$
—

$
7,832

Investments:
 
 
 
 
Certificates of deposit
—

13,441

—

13,441

U.S. Treasury securities
14,716

—

—

14,716

U.S. Agency securities
—

8,459

—

8,459

Commercial paper
—

9,171

—

9,171

Asset-backed securities
—

3,025

—

3,025

Corporate notes and bonds
—

31,836

—

31,836

Total investments
14,716

65,932

—

80,648

Total assets measured at fair value
$
22,548

$
65,932

$
—

$
88,480


Highly liquid investments with an original maturity of three months or less at time of purchase are are included in cash and cash equivalents on the condensed consolidated balance sheet.

Level 1 assets are priced using quoted prices in active markets for identical assets which include money market funds and U.S. Treasury securities as these specific assets are liquid.


13


Level 2 available-for-sale securities are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. The Company uses inputs such as actual trade data, benchmark yields, broker/dealer quotes, and other similar data, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets and liabilities. The Company uses such pricing data as the primary input to make its assessments and determinations as to the ultimate valuation of its investment portfolio and has not made, during the periods presented, any material adjustments to such inputs. There were no transfers between levels during the six months ended June 30, 2018.

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Convertible Notes due 2023 (“Notes”). The arrangement provided for a 15% $22.5 million overallotment option to purchase additional Notes 13 days following the execution of the purchase agreement. On April 6, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million, as described in Note 11, Convertible Notes. The calculated fair value of the Notes, of $159.0 million, is highly correlated to the Company’s stock price and as a result, significant changes to the Company’s stock price will have a significant impact on the calculated fair value of the Notes. The fair value of the Notes are classified as Level 2 within the fair value hierarchy.
NOTE 5. CONCENTRATION OF CREDIT RISK

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable, including receivables from major customers.

The Company has financial institutions for banking operations that hold 10% or more of the of the Company’s cash and cash equivalents. As of June 30, 2018, two of the Company's financial institutions held 58% and 28% of the Company’s cash and cash equivalents, respectively. As of December 31, 2017, two of the Company's financial institutions held 82% and 12% of the Company’s cash and cash equivalents, respectively.

The Company grants credit to domestic and international clients in various industries. Exposure to losses on accounts receivable is principally dependent on each client's financial position. The Company has customers who represented 10% or more of the Company’s net accounts receivable balance as of June 30, 2018 and December 31, 2017. The Company had two customers that accounted for 11% and 10% of the Company’s net accounts receivable balance as of June 30, 2018, and one Customer that accounted for 24% of the Company's net accounts receivable balance as of December 31, 2017.

Customers who represented 10% or more of the Company’s total revenue for the three and six months ended June 30, 2018 and 2017 were as follows:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2018
2017
 
2018
2017
Company A
13%
*
 
*
*
Company B
12%
*
 
*
*
Company C
11%
*
 
*
*
Company D
*
22%
 
*
13%
Company E
*
21%
 
*
12%
Company F
*
19%
 
*
11%
Company G
*
15%
 
*
*
Company H
*
*
 
*
31%
Company I
*
*
 
*
15%

* Less than 10% for the period indicated


14


NOTE 6. INVESTMENTS

The following tables summarize the Company’s available-for-sale investments at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
13,682

$
—

$
—

$
13,682

U.S. Treasury securities
31,850

1

(107
)
31,744

U.S. Agency securities
7,013

—

(69
)
6,944

Commercial paper
35,917

—

—

35,917

Asset-backed securities
8,992

2

(1
)
8,993

Corporate notes and bonds
33,388

1

(75
)
33,314

Total
$
130,842

$
4

$
(252
)
$
130,594


 
December 31, 2017
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
13,441

$
—

$
—

$
13,441

U.S. Treasury securities
14,787

—

(71
)
14,716

U.S. Agency securities
8,510

—

(51
)
8,459

Commercial paper
9,171

—

—

9,171

Asset-backed securities
3,026

—

(1
)
3,025

Corporate notes and bonds
31,906

—

(70
)
31,836

Total
$
80,841

$
—

$
(193
)
$
80,648


The following table summarizes the maturities of the Company’s available-for-sale securities at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
December 31, 2017
 
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due in less than 1 year
$
95,448

$
95,312

$
55,801

$
55,735

Due in 1-5 years
35,394

35,282

25,040

24,913

Total
$
130,842

$
130,594

$
80,841

$
80,648


Proceeds from sales of marketable securities (including principal paydowns), for the three months ended June 30, 2018 and 2017 were $0 and $6.5 million, respectively, and for the six months ended June 30, 2018 and 2017 were $3.0 million and $6.5 million, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were no realized gains from sales of marketable securities for the three and six months June 30, 2018 and 2017. No balances were reclassified out of accumulated other comprehensive income (loss) for the three and six months June 30, 2018 and 2017.

No other-than-temporary impairments are recorded as no material investments had a fair value that remained less than its cost for more than twelve months as of those dates. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.


15


NOTE 7. INVENTORY

Inventories consisted of the following at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30,
December 31,
 
2018
2017
Raw materials
$
5,101

$
4,220

Work in process
842

377

Finished goods
5,374

3,466

Inventory, net
$
11,317

$
8,063


NOTE 8. PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30,
December 31,
 
2018
2017
Computer equipment
$
2,801

$
2,756

Technical equipment
3,550

3,348

Facilities
3,620

3,621

Instruments
2,283

1,400

Capital projects in progress
720

349

Total property and equipment
$
12,974

$
11,474

Accumulated depreciation
(7,531
)
(6,584
)
Property and equipment, net
$
5,443

$
4,890


Depreciation expense for the three months ended June 30, 2018 and 2017 was $533,000 and $540,000, respectively, and for the six months ended June 30, 2018 and 2017 was $1.1 million and $1.0 million, respectively.
NOTE 9. LICENSE AGREEMENTS AND GRANTS

National Institute of Health Grant

In February 2015, the National Institute of Health awarded Denver Health and the Company a five-year, $5.0 million grant to develop a fast and reliable identification and categorical susceptibility test for carbepenem-resistant Enterobacteriaceae directly from whole blood. The cumulative amount awarded to date under these subawards is $1.1 million. The amounts invoiced for the three months ended June 30, 2018 and 2017 were $38,000 and $0, respectively, and for the six months ended June 30, 2018 and 2017 were $98,000 and $3,000, respectively.

Arizona Commerce Authority

In August 2012, the Company entered into a Grant Agreement (the “Grant Agreement”) with the Arizona Commerce Authority, an agency of the State of Arizona (the “Authority”), pursuant to which the Authority provided certain state and county sponsored incentives for the Company relocating its corporate headquarters to, and expanding its business within, the State of Arizona (the “Project”). Pursuant to the Grant Agreement, the Authority provided a total grant in the amount of $1.0 million (the “Grant”). The Grant was paid in four installments, upon the achievement of the following milestones:

•
Milestone 1 – Relocation of Company’s operations and corporate headquarters to Arizona and creation of 15 Qualified Jobs (as defined below).

•
Milestone 2 – Creation of 30 Qualified Jobs (including Qualified Jobs under Milestone 1).

•
Milestone 3 – Creation of 40 Qualified Jobs (including Qualified Jobs under Milestones 1 and 2).

16



•
Milestone 4 – Creation of 65 Qualified Jobs (including Qualified Jobs under Milestones 1, 2 and 3) and capital investment of at least $4.5 million.

For purposes of the Grant Agreement, a “Qualified Job” was a job which was permanent, full-time, new to Arizona and for which the Company paid an average annual wage of at least $63,000 and included health insurance benefits, for which the Company paid at least 65% of the premiums. The Grant Agreement also contained other customary provisions, including representations, warranties and covenants of both parties. As of December 31, 2017, the full amount was collected and recorded in current deferred revenue and income.

In January 2018, the full amount was recognized due to the economic development provisions of the grant being satisfied in full, and the “claw-back” provisions expiring. The $1.0 million was recognized as an offset to expense. Further details are included in Note 10, Deferred Revenue, Income and Remaining Performance Obligations.

NOTE 10. DEFERRED REVENUE, INCOME AND REMAINING PERFORMANCE OBLIGATIONS

Deferred revenue consists of amounts received for products or services not yet delivered or earned. Deferred income consists of amounts received for commitments not yet fulfilled. If we anticipate that the revenue or income will not be earned within the following twelve months, the amount is reported as long-term deferred income. A summary of the balances as of June 30, 2018 and December 31, 2017 follows (in thousands):
 
June 30,
December 31,
 
2018
2017
Products and services not yet delivered
$
185

$
71

Arizona Commerce Authority grant
—

1,000

Deferred revenue and income
$
185

$
1,071


We recognized $14,000 and $35,000 of revenues that were included in the contract liabilities balances during the the three and six months ended June 30, 2018, respectively. No material amount of revenue recognized during the period was from performance obligations satisfied in prior periods.
Transaction Price Allocated to Remaining Performance Obligations
As of June 30, 2018, $1.0 million of revenue is expected to be recognized from remaining performance obligations. This balance primarily relates to executed, service contracts that begin as warranty periods expire. These contracts typically provide for four-year terms and revenue is recognized on a straight-line basis over the contract term.
The Company elects not to disclose the value of unsatisfied performance obligations for (i) contracts with an expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

17


NOTE 11. CONVERTIBLE NOTES

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Convertible Notes due 2023. The arrangement provided for a 15% $22.5 million overallotment option to purchase additional Notes 13 days following the execution of the purchase agreement. On April 6, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million. The Notes are the Company's senior unsecured obligations and mature on March 15, 2023 (the “Maturity Date”), unless earlier repurchased or converted into shares of common stock under certain circumstances described below. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of 32.343 shares of common stock per $1,000 principal amount of the Notes, which is equivalent to an initial conversion price of approximately $30.92 per share of common stock, subject to adjustment. The Company will pay interest on the Notes semi-annually in arrears on March 15 and September 15 of each year.

The $171.5 million of proceeds received from the issuance of the Notes were allocated between long-term debt (the “liability component”) of $116.6 million and contributed capital (the “equity component”) of $54.9 million. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature. The carrying amount of the equity component, representing the conversion option, was determined by deducting the fair value of the liability component from the aggregate face value of the Notes. The liability component will be accreted up to the face value of the Notes of $171.5 million, which will result in additional non-cash interest expense being recognized through the Maturity Date. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.

The Company incurred approximately $5.0 million of issuance costs related to the issuance of the Notes, of which $3.4 million and $1.6 million were recorded to long-term debt and contributed capital, respectively. The $3.4 million of issuance costs recorded as long-term debt on the condensed consolidated balance sheet are being amortized over the five-year contractual term of the Notes using the effective interest method. The effective interest rate on the Notes, including accretion of the Notes to par and debt issuance cost amortization, is 11.52%.

The Notes include customary terms and covenants, including certain events of default upon which the Notes may be due and payable immediately. Holders have the option to convert the Notes in multiples of $1,000 principal amount at any time prior to December 15, 2022, but only in the following circumstances:

•
if the Company’s stock price exceeds 130% of the conversion price for 20 of the last 30 trading days of any calendar quarter after June 30, 2018;

•
during the 5 business day period after any 5 consecutive trading day period in which the Notes’ trading price is less than 98% of the product of the common stock price times the conversion rate; or

•
the occurrence of certain corporate events, such as a change of control, merger or liquidation.

At any time on or after December 15, 2022, a holder may convert its Notes in multiples of $1,000 principal amount. Holders of the Notes who convert their Notes in connection with a make-whole fundamental change (as defined in the Indenture pursuant to which the Notes were issued) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change or event of default prior to the Maturity Date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date.

As of June 30, 2018, the outstanding principal amount on the Notes was $171.5 million, the unamortized debt discount was $52.7 million, the unamortized debt issuance cost was $3.3 million and the net carrying amount of the liability component was $115.5 million, which was recorded as convertible notes within the condensed consolidated balance sheet. The Company recorded interest expense of $1.1 million for contractual coupon interest for the six months ended months ended June 30, 2018, which is also recorded as accrued interest expense as of June 30, 2018. The Company also recorded $126,000 and $132,000 for amortization of debt issuance costs for the three and six months ended June 30, 2018, respectively, and $2.0 million and $2.1 million for amortization of the debt discount for the three and six months ended June 30, 2018, respectively. As of June 30, 2018, no Notes were convertible pursuant to their terms.

18



In connection with the debt issuance, the Company entered into a prepaid forward stock repurchase transaction (“Prepaid Forward”) with a financial institution (“Forward Counterparty”). Pursuant to the Prepaid Forward, the Company used approximately $45.1 million of the net proceeds from its issuance of the Notes to fund the Prepaid Forward. The aggregate number of shares of the Company’s common stock underlying the Prepaid Forward was approximately 1,858,500. The expiration date for the Prepaid Forward is March 15, 2023, although it may be settled earlier in whole or in part. Upon settlement of the Prepaid Forward, at expiration or upon any early settlement, the Forward Counterparty will deliver to the Company the number of shares of common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company. The Company’s Prepaid Forward hedge transaction exposes the Company to credit risk to the extent that its counterparty may be unable to meet the terms of the transaction. The Company mitigates this risk by limiting its counterparty to a major financial institution.

NOTE 12. EARNINGS PER SHARE

Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share are the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive due to the Company’s losses.
The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses at June 30, 2018 and December 31, 2017 (in thousands):
 
June 30,
December 31,
 
2018
2017
Shares issuable upon the release of restricted stock awards
16

24

Shares issuable upon exercise of stock options
8,093

7,328

 
8,109

7,352


NOTE 13. EMPLOYEE EQUITY-BASED COMPENSATION

The following table summarizes option activity under all plans during the six-month period ended June 30, 2018:

 
Number of Shares
Weighted Average Exercise Price per Share
Options Outstanding January 1, 2018
7,328,131

$
10.16

Granted
1,115,371

25.45

Forfeited
(91,043
)
20.97

Exercised
(253,621
)
10.87

Expired
(5,495
)
23.43

Options Outstanding June 30, 2018
8,093,343

12.11


The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:


19


 
Three Months Ended
 
June 30,
June 30,
 
2018
2017
Expected term (in years)
6.06

6.12

Volatility
64
%
75
%
Expected dividends
—

—

Risk free interest rates
2.82
%
2.02
%
Weighted average fair value
$
13.53

$
16.80


The following table shows summary information for outstanding options and options that are exercisable (vested) as of June 30, 2018:

 
Options
Outstanding
Options
Exercisable
Number of options
8,093,343

5,689,985

Weighted average remaining contractual term (in years)
6.18

5.13

Weighted average exercise price
$
12.11

$
8.00

Weighted average fair value
$
8.52

$
5.68

Aggregate intrinsic value (in thousands)
$
88,348

$
83,067


The following table summarizes restricted stock unit and restricted stock award activity during the six-month period ending June 30, 2018:

 
Number of Shares
Weighted Average Grant Date Fair Value per Share
Outstanding January 1, 2018
24,150

$
26.45

Granted
—

—

Forfeited
—

—

Vested/released
(8,050
)
26.45

Outstanding June 30, 2018
16,100

26.45


Equity-based compensation is summarized below (in thousands):

 
Three Months Ended
Six Months Ended
 
June 30,
June 30,
June 30,
June 30,
 
2018
2017
2018
2017
Cost of sales
$
58

$
22

$
104

$
22

Research and development
838

1,166

2,450

1,892

Sales, general and administrative
2,513

3,047

6,457

5,536

Equity-based compensation expense
$
3,409

$
4,235

$
9,011

$
7,450


As of June 30, 2018 and 2017, $420,000 and $183,000 of equity-based compensation expense was included as a component of capitalized inventory, respectively. As of June 30, 2018 and 2017, $77,000 and $27,000 of equity-based compensation expense was included as a component of capitalized property and equipment, respectively.


20


As of June 30, 2018, unrecognized equity-based compensation expense related to unvested stock options and unvested restricted stock units was $22.8 million and $111,000, respectively. This is expected to be recognized over the years 2018 through 2023.

NOTE 14. INCOME TAXES

For the three and six months ended June 30, 2018, the Company recorded a provision for income taxes of approximately $101,000 and $285,000, respectively, which primarily relates to profitable foreign jurisdictions without any net operating loss carryforwards. The Company’s tax expense for the three and six months ended June 30, 2018 differs from the tax expense computed by applying the U.S. statutory tax rate to its year-to-date pre-tax loss of $23.1 million and $43.8 million, respectively, as no tax benefits were recorded for tax losses generated in the U.S. and other foreign jurisdictions. At June 30, 2018, the Company had deferred tax assets primarily related to U.S. federal and state tax loss carryforwards. The Company provided a full valuation allowance against its deferred tax assets as future realization of such assets is not more likely than not to occur.

We account for uncertain tax positions pursuant to the recognition and measurement criteria under ASC 740, Income Taxes. For the three and six months ended June 30, 2018, we did not note any significant changes to our uncertain tax positions. We do not anticipate significant changes to uncertain tax position within the next 12 months.

Tax Cuts and Jobs Act

On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act. The Tax Act reduced the corporate tax rate from the maximum federal statutory rate of 35% to 21%. The Tax Act states that the 21% corporate tax rate is effective for tax years beginning on or after January 1, 2018. The Company revalued its net deferred tax assets for U.S. federal purposes to 21% as of December 31, 2017, with a corresponding adjustment to the valuation allowance. Therefore, the reduction in the U.S. corporate tax rate had no impact on the Company's earnings.

In conjunction with the Tax Act, the SEC staff issued SAB 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. The Company has recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in its consolidated financial statements for the year ended December 31, 2017. The ultimate impact may differ from these provisional amounts, possibly materially, due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the Tax Act. Any subsequent determinations and adjustments will be recorded during the remainder of the year ended December 31, 2018, as they are identified. 

The Tax Act subjects a U.S. shareholder to tax on global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. The FASB Staff Q&A, Topic 740, No. 5, Accounting for GILTI, states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. Given the complexity of the GILTI provisions, we are still evaluating the effects of the GILTI provisions and have not yet determined our accounting policy. At June 30, 2018, because we are still evaluating the GILTI provisions and our analysis of future taxable income subject to GILTI, we have included GILTI related to current-year operations only in our estimated annual effective tax rate, with a corresponding adjustment to the valuation allowance, and have not provided additional GILTI on deferred items.

At June 30, 2018, the Company has not completed its accounting for all of the tax effects of the Tax Act and has not made any adjustments to the provisional amounts recorded at December 31, 2017. The Company will continue to make and refine its calculations as additional analysis is completed. The Company’s estimates may also be affected as additional guidance is issued with regards to the Tax Act. These changes are not expected to be material to the Company’s financial statements since the effective tax rate impact will be offset by the corresponding adjustment in the valuation allowance.


21


NOTE 15. COMMITMENTS

Leases

The Company has entered into lease agreements, lease amendments, and lease extensions (“Lease Agreements”) for office, laboratory and manufacturing space located in Tucson, Arizona and Europe, the last of which expires in 2022. Total rent expense, including common area charges was $346,000 and $309,000 for the three months ended June 30, 2018 and 2017, respectively, and for the six months ended June 30, 2018 and 2017 was $688,000 and $625,000, respectively. Future minimum lease payments under these agreements are as follows (in thousands):

Year ending December 31:
 
2018
$
557

2019
206

2020
85

2021
44

2022
4

Thereafter
—

 
$
896


Clinical Trial Agreements

The Company has entered into master agreements with clinical trial sites in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the clinical trial sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation. The expense incurred as part of the clinical trial is included in research and development on the Company's condensed consolidated statements of operations and comprehensive loss.

Marketing Study and Contracted Research

The Company has entered into marketing study agreements and contracted research agreements with research institutions and hospitals in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation.

NOTE 16. INDUSTRY, GEOGRAPHIC AND REVENUE DISAGGREGATION

The Company operates as one operating segment. Sales to customers outside the U.S. represented 28% and 22% for the three months ended June 30, 2018 and 2017, respectively, and 27% and 14% for the six months ended June 30, 2018 and 2017, respectively.

As of June 30, 2018 and December 31, 2017, balances due from foreign customers, in U.S. dollars, were $864,000 and $1.0 million, respectively.


22


 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
 
2018
2017
Primary Geographic Markets:
 
 
 
 
 
Domestic
$
1,220

$
544

 
$
1,815

$
1,063

Foreign
472

155

 
678

167

Net sales
$
1,692

$
699

 
$
2,493

$
1,230

 
 
 
 
 
 
Line of Business:
 
 
 
 
 
Accelerate Pheno™ revenue
$
1,665

$
675

 
$
2,435

$
1,180

Other revenue
27

24

 
58

50

Net sales
$
1,692

$
699

 
$
2,493

$
1,230

 
 
 
 
 
 
Products and Services:
 
 
 
 
 
Products
$
1,671

$
695

 
$
2,467

$
1,224

Services
21

4

 
26

6

Net sales
$
1,692

$
699

 
$
2,493

$
1,230


Lease income included in net sales for the three months ended June 30, 2018 and 2017 was $172,000 and $11,000, respectively, and $181,000 and $12,000 for the six months ended June 30, 2018 and 2017, respectively, which does not represent revenues recognized from contracts with customers.

The following presents long-lived assets (excluding intangible assets) by geographic territory (in thousands):
 
June 30,
December 31,
 
2018
2017
Domestic
$
4,210

$
3,779

Foreign
1,233

1,111

Property and equipment, net
$
5,443

$
4,890


NOTE 17. RELATED PARTY TRANSACTIONS

As part of the transaction discussed in Note 11, Convertible Notes, an affiliate of one member of the Company's board of directors purchased an aggregate of $30 million of the Notes. The affiliated entity is a Qualified Institutional Buyer which purchased and holds the Notes at June 30, 2018.


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introductory Note

Except as otherwise indicated by the context, references in this Quarterly Report on Form 10-Q (this “Form 10-Q”) to the “Company,” “Accelerate,” “we," “us” or “our” are references to the combined business of Accelerate Diagnostics, Inc.

Forward-Looking Statements

This Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities

23


Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Company intends that such forward-looking statements be subject to the safe harbors created thereby. These forward-looking statements, which can be identified by the use of words such as “may,” “will,” “expect,” “anticipate,” “estimate,” or “continue,” or variations thereon or comparable terminology, include the plans and objectives of management for future operations, including plans and objectives relating to the products and future economic performance of the Company. In addition, all statements other than statements of historical facts that address activities, events, or developments the Company expects, believes, or anticipates will or may occur in the future, and other such matters, are forward-looking statements.

The forward-looking statements included herein are based on current expectations that involve a number of risks and uncertainties. These forward-looking statements are based on assumptions that the Company will retain key management personnel, the Company will be successful in the commercialization of the Accelerate Pheno™ system, the Company will obtain sufficient capital to commercialize the Accelerate Pheno™ system and continue development of complementary products, the Company will be able to protect its intellectual property, the Company’s ability to respond to technological change, the Company will accurately anticipate market demand for the Company’s products and there will be no material adverse change in the Company’s operations or business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the results contemplated in forward-looking statements will be realized. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) summarizes the significant factors affecting our results of operations, liquidity, capital resources and contractual obligations. The following discussion and analysis should be read in conjunction with the Company’s unaudited condensed consolidated financial statements and related notes included elsewhere herein. Certain information contained in the discussion and analysis set forth below and elsewhere in this report, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. The Company’s future operating results may be affected by various trends and factors which are beyond the Company’s control. These include, among other factors, general public perception of issues and solutions, and other uncertain business conditions that may affect the Company’s business. The Company cautions the reader that a number of important factors discussed herein, and in other reports filed with the SEC including but not limited to the risks in the section entitled “Risk Factors” in its Annual Report on Form 10-K for the period ended December 31, 2017, could affect the Company’s actual results and cause actual results to differ materially from those discussed in forward-looking statements.

Our MD&A is composed of the following sections: Overview, Changes in Results of Operations, Capital Resources and Liquidity and Off-Balance Sheet Arrangements. All amounts have been rounded to the nearest thousand unless otherwise indicated.

Overview

Accelerate Diagnostics, Inc. (“Accelerate”) is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Microbiology laboratories are in need of new tools to address what the U.S. Centers for Disease Control and Prevention calls one of the most serious healthcare threats of our time, antibiotic resistance. A significant contributing factor to the rise of resistance is the overuse and misuse of antibiotics, which is exacerbated by a lack of timely diagnostic results. The delay of identification and antibiotic susceptibility results is often due to the reliance by microbiology laboratories on traditional culture-based tests that often take two to three days to complete. Our technology platform is built to address these challenges by delivering significantly faster and more accurate testing of infectious pathogens in various patient sample types.

Since 2004, we have focused our efforts on the research, development, and commercialization of an innovative rapid diagnostic platform, the Accelerate Pheno™ system. The Accelerate Pheno™ system utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing, (AST) which determines whether live bacterial and fungal cells are resistant or susceptible to a particular antibiotic. The Accelerate PhenoTest™ BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia,

24


both life-threatening conditions with high morbidity and mortality risk. The Accelerate PhenoTest™ BC Kit is a highly multiplexed panel targeting over 80% of the routine and significant pathogens causing blood stream infections and over 90% of the antibiotics useful in treating those pathogens.

On June 30, 2015, we declared our conformity to the European In Vitro Diagnostic Directive 98/79 EC and applied a CE Mark to the Accelerate Pheno™ system and the Accelerate PhenoTest™ BC Kit for in vitro diagnostic use. On February 23, 2017, the U.S. Food and Drug Administration (“FDA”) granted our de novo request to market our Accelerate Pheno™ system and Accelerate PhenoTest™ BC Kit.

In 2017, we began selling the Accelerate Pheno™ system in hospitals in the United States, Europe, and the Middle East. Consistent with the Company's business model revenues were generated from the sale of the instrument and the sale of single use consumable test kits.

Changes in Results of Operations: Three and six months ended June 30, 2018 compared to three and six months ended June 30, 2017

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
$ Change
% Change
 
2018
2017
$ Change
% Change
Net sales
$
1,692

$
699

$
993

142
%
 
$
2,493

$
1,230

$
1,263

103
%

For the three and six months ended June 30, 2018, total revenues increased due to sales of Accelerate Pheno™ systems and Accelerate PhenoTest™ BC kits.

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
$ Change
% Change
 
2018
2017
$ Change
% Change
Cost of sales
$
717

$
135

$
582

431
%
 
$
1,210

$
161

$
1,049

652
%
Gross profit
$
975

$
564

$
411

73
%
 
$
1,283

$
1,069

$
214

20
%

For the three and six months ended June 30, 2018, cost of sales and gross profit increased as a result of of higher sales for the three and six months ended June 30, 2018. Inventory without a cost basis was sold to customers for the three and six months ended June 30, 2018 and 2017. Sales for the three and six months ended June 30, 2018 included proportionately fewer sales of inventory expensed in a previous period; this decrease contributed to an increase in cost of sales and less gross profit. Pre-launch inventory previously not capitalized and expensed in a previous period for the three months ended June 30, 2018 and 2017, was $122,000 and $187,000, respectively, and $244,000 and $367,000 for the six months ended June 30, 2018 and 2017, respectively.

Cost of sales included non-cash equity-based compensation of $58,000 and $22,000 for the three months ended June 30, 2018 and 2017, respectively, and $104,000 and $22,000 for the six months ended June 30, 2018 and 2017, respectively.

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
$ Change
% Change
 
2018
2017
$ Change
% Change
Research and development
$
6,060

$
5,527

$
533

10
%
 
$
12,842

$
9,815

$
3,027

31
%

Research and development expenses for the three months ended June 30, 2018 increased as compared to the three months ended ended June 30, 2017. The increase was primarily the result of increasing employee salaries, in preparation of upcoming clinical trials and studies, as well as, an increase in purchases of engineering supplies to

25


support research and development. Research and development expenses for the six months ended June 30, 2018 increased as compared to the six months ended ended June 30, 2017. The increase was primarily the result of increasing employee salaries, non-cash equity-based compensation and increases in purchases of engineering supplies to support research and development.

Pre-launch inventory not capitalized in accordance with U.S. GAAP, which included instruments and consumables charged to research and development, were $0 and $76,000 for the three months ended June 30, 2018 and 2017, respectively, and $25,000 and $151,000 for the six months ended June 30, 2018 and 2017, respectively.

Research and development expenses included non-cash equity-based compensation of $838,000 and $1.2 million for the three months ended June 30, 2018 and 2017, respectively, and $2.5 million and $1.9 million for the six months ended June 30, 2018 and 2017, respectively. In March of 2018, the Company granted immediately vested stock options as a part of its annual bonus program, which increased expenses relative to the same periods in 2017.

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
$ Change
% Change
 
2018
2017
$ Change
% Change
Sales, general and administrative
$
15,330

$
11,460

$
3,870

34
%
 
$
29,682

$
21,988

$
7,694

35
%

Sales, general and administrative expenses for the three months ended June 30, 2018 increased as compared to the three months ended ended June 30, 2017. The increase was primarily the result of an increase in salaries and related expenses as we continued to ramp up our sales and marketing operations globally. Sales, general and administrative expenses for the six months ended June 30, 2018 increased as compared to the six months ended ended June 30, 2017. The increase was primarily the result of an increase an increase in salaries, non-cash equity-based compensation and related expenses as we continued to ramp up our sales and marketing operations globally.

Pre-launch inventory not capitalized in accordance with U.S. GAAP, which included instruments and consumables charged to sales, general and administrative expenses, were $0 and $12,000 for the three months ended June 30, 2018 and 2017, respectively, and $0 and $29,000 for the six months ended June 30, 2018 and 2017, respectively.

Sales, general and administrative expenses included non-cash equity-based compensation of $2.5 million and $3.0 million for the three months ended June 30, 2018 and 2017, respectively, and $6.5 million and $5.5 million for the six months ended June 30, 2018 and 2017, respectively. In March of 2018, the Company granted immediately vested stock options as a part of its annual bonus program, which increased expenses relative to the same periods in 2017.

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
$ Change
% Change
 
2018
2017
$ Change
% Change
Loss from operations
$
(20,415
)
$
(16,423
)
$
(3,992
)
24
%
 
$
(41,241
)
$
(30,734
)
$
(10,507
)
34
%

For the three and six months ended June 30, 2018, our loss from operations increased. The increase was the result of our continued investments in research and development, sales and marketing, and increased employee headcount, along with other factors.

Loss from operations included non-cash equity-based compensation of $3.4 million and $4.2 million for the three months ended June 30, 2018 and 2017, respectively, and $9.0 million and $7.5 million for the six months ended June 30, 2018 and 2017, respectively. This loss and further losses are anticipated and was the result of our continued investments in sales and marketing, key research and development personnel, related costs associated with product development, and commercialization of the Company’s products.


26


 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
$ Change
% Change
 
2018
2017
$ Change
% Change
Total other income (expense), net
$
(2,709
)
$
141

$
(2,850
)
(2,021
)%
 
$
(2,511
)
$
252

$
(2,763
)
(1,096
)%

Other expense for the three and six months ended June 30, 2018 increased compared to the three and six months ended June 30, 2017, primarily due to an increase in interest expense associated with our convertible notes, offset in part by other expenses.

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
$ Change
% Change
 
2018
2017
$ Change
% Change
Provision for income taxes
$
(101
)
$
(175
)
$
74

(42
)%
 
$
(285
)
$
(175
)
$
(110
)
63
%

Due to net losses incurred, we have only recorded tax provisions related to tax liabilities generated by our foreign subsidiaries for international income taxes.


Capital Resources and Liquidity

Our primary source of liquidity has been from sales of shares of common stock and issuances of convertible notes. As of June 30, 2018, the Company had $197.4 million in cash and cash equivalents and available-for-sale securities, an increase of $88.2 million from $109.2 million at December 31, 2017. The primary reason for the change in these assets was a convertible note offering that occurred during the six months ended June 30, 2018.

The Company is subject to lease agreements. The future minimum lease payments under these lease agreements is included in Item 1, Note 15, Commitments.

As of June 30, 2018, management believes that current cash balances will be more than sufficient to fund our capital and liquidity needs for the next twelve months.

The following summarizes selected items in the Company’s consolidated statements of cash flows for the six months ended June 30, 2018 and 2017:

Cash Flow Summary
(in thousands)
 
Six Months Ended
 
 
June 30,
June 30,
Increase (Decrease)
 
2018
2017
Net cash used in operating activities
$
(35,417
)
$
(28,091
)
$
(7,326
)
Net cash used in investing activities
(50,702
)
(16,014
)
(34,688
)
Net cash provided by financing activities
124,472

87,272

37,200


The net cash used in operating activities was $35.4 million and $28.1 million for the six months ended June 30, 2018 and 2017, respectively. These losses are the result of our continued investments in research and development, sales and marketing, and increased employee headcount, along with other factors.

The net cash used in investing activities was $50.7 million for the six months ended June 30, 2018 and $16.0 million for the six months ended June 30, 2017. The net cash used is comprised of the purchases of available-for-sale securities, offset by maturities of available-for-sale securities for both periods.


27


The net cash provided by financing activities was $124.5 million for the six months ended June 30, 2018, and is primarily comprised of proceeds from our convertible note offering, offset by the prepayment of a forward stock repurchase. The net cash provided by financing activities was $87.3 million for the six months ended June 30, 2017, and was primarily comprised of the sale of common stock.

Our primary use of capital has been for the commercialization and development of the Accelerate Pheno™ system. We believe our capital requirements will continue to be met with our existing cash balance and those provided under revenue, grants, exercises of stock options and/or additional issuance of equity or debt securities. However, if capital requirements vary materially from those currently planned, we may require additional capital sooner than expected. There can be no assurance that such capital will be available in sufficient amounts or on terms acceptable to us, if at all. Additional issuances of equity or convertible debt securities will result in dilution to our current common stockholders.

Convertible Notes

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Notes. The arrangement provided for a 15% $22.5 million overallotment option to purchase additional Notes 13 days following the execution of the purchase agreement. On April 6, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million. The Notes mature on March 15, 2023, unless earlier repurchased or converted into shares of common stock subject to certain conditions. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of 32.343 shares of common stock per $1,000 principal amount of the Notes, which is equivalent to an initial conversion price of approximately $30.92 per share of common stock, subject to adjustment. We will pay interest on the Notes semi-annually in arrears on March 15 and September 15 of each year with interest payments beginning on September 15, 2018. Proceeds received from the issuance of the Notes was allocated between long-term debt (the “liability component”) and contributed capital (the “equity component”), within the condensed consolidated balance sheet. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature.

In connection with the offering, we entered into a prepaid forward stock repurchase transaction (the “Prepaid Forward”) with a financial institution. Pursuant to the Prepaid Forward, we used approximately $45.1 million of the proceeds from the offering of the Notes to pay the prepayment amount. The aggregate number of our common stock underlying the Prepaid Forward is approximately 1.9 million shares (based on the sale price of $24.25). The expiration date for the Prepaid Forward is March 15, 2023, although it may be settled earlier in whole or in part. Upon settlement of the Prepaid Forward, at expiration or upon any early settlement, the Forward Counterparty will deliver to us the number of shares of common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward were treated as treasury stock on the condensed consolidated balance sheet (and not outstanding for purposes of the calculation of basic and diluted earnings per share), but remain outstanding for corporate law purposes, including for purposes of any future stockholders' votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to us. We intend to use the remaining net proceeds less issuance cost from the offering of approximately $121.4 million for general corporate purposes.

Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of June 30, 2018.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make certain estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We evaluate our estimates on an ongoing basis, including those related to accounts receivable, inventories, property and equipment, intangible assets, accruals, warranty liabilities, tax valuation accounts and stock-based compensation. We base our estimates on historical experience and on various other assumptions we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities is not readily apparent from other sources. Actual results may differ from these estimates. Our critical accounting policies and estimates are discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017. Additional critical accounting policies

28


added to Note 1, Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies include the the adoption of ASC 606, Revenue from Contracts with Customers, and the Company's accounting policy on convertible notes during the six months ended June 30, 2018.


Item 3. Quantitative and Qualitative Disclosures

Interest Rate Risk

Our investment portfolio is exposed to market risk from changes in interest rates. The fair market value of fixed rate securities may be adversely impacted by fluctuations in interest rates while income earned on floating rate securities may decline as a result of decreases in interest rates. We have historically maintained a relatively short average maturity for our investment portfolio, and we believe a hypothetical 100 basis point adverse move in interest rates along the entire interest rate yield curve would change the fair value of our interest sensitive financial instruments by approximately $907,000 as of June 30, 2018 and $555,000 as of December 31, 2017.

Under our current policies, we do not use interest rate derivative instruments to manage exposure to interest rate changes. We attempt to ensure the safety and preservation of our invested principal funds by limiting default risk, market risk and reinvestment risk. The goals of our investment policy are preservation of capital, fulfillment of liquidity needs and fiduciary control of cash and investments. We also seek to maximize income from our investments without assuming significant risk. To achieve our goals, we maintain a portfolio of cash equivalents and investments in a variety of securities that management believes to be of high credit quality. Further information regarding our investments is included in Item 1, Note 6, Investments.

Foreign Currency Risk

We operate primarily in the United States and a majority of our cost, expense and capital purchasing activities for the six months ended June 30, 2018 were transacted in United States dollars. As a corporation with international and domestic operations, we are exposed to changes in foreign exchange rates. Our international revenue is predominantly in Europe and the Middle East and is denominated in Euros and United States dollars. In our international operations, we pay payroll and other expenses in local currencies. Our exposures to foreign currency risks may change over time and could have a material adverse impact on our financial results.


Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on an evaluation under the supervision and with the participation of the Company’s management, the Company’s Principal Executive Officer and Principal Financial Officer have concluded that the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act were effective as of June 30, 2018, to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to the Company’s management, including its Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There was no change in the Company’s internal control over financial reporting during the period ended June 30, 2018 that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.


29


PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We are from time to time subject to various claims and legal actions in the ordinary course of our business. We believe that there are currently no claims or legal actions that would reasonably be expected to have a material adverse effect on our results of operations or financial condition.


Item 1A. Risk Factors

Except as described below, there have been no material changes to the risk factors that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017.

Risks related to our convertible senior notes

We have indebtedness in the form of convertible senior notes.

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Notes. The arrangement provided for a 15% $22.5 million overallotment option to purchase additional Notes 13 days following the execution of the purchase agreement. On April 6, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million. Holders of the Notes will have the right to require us to repurchase their Notes upon the occurrence of a fundamental change at a purchase price equal to 100% of the principal amount of the Notes to be purchased, plus accrued and unpaid interest, if any. In addition, the indenture for the Notes provides that we are required to repay amounts due under the indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to maturity date for the Notes. There can be no assurance that we will be able to repay this indebtedness when due, or that we will be able to refinance this indebtedness on acceptable terms or at all. In addition, this indebtedness could, among other things:

•
heighten our vulnerability to adverse general economic conditions and competitive pressures;

•
require us to dedicate a larger portion of our cash flow from operations to interest payments, limiting the availability of cash for other purposes;

•
limit our flexibility in planning for, or reacting to, changes in our business and industry; and

•
impair our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes.

Our failure to repurchase Notes at a time when the repurchase is required by the indenture (whether upon a fundamental change or otherwise under the indenture) or pay cash payable on future conversions of the Notes as required by the indenture would constitute a default under the indenture. A default under the indenture or the fundamental change itself could also lead to a default under agreements governing our existing or future indebtedness. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness, repurchase the Notes or make cash payments upon conversions thereof.

The prepaid forward may affect the value of the Notes and our common stock and may result in unexpected market activity in the Notes and/or our common stock.

In connection with the issuance of the Notes, we entered into a prepaid forward with a forward counterparty. The prepaid forward is intended to facilitate privately negotiated derivative transactions by which investors in the Notes will be able to hedge their investment. In connection with establishing its initial hedge of the prepaid forward, the forward counterparty (or its affiliate) was to purchase shares of our common stock from, and/or enter into one or more derivative transactions with respect to our common stock, with purchasers of the Notes concurrently with or after the offering of the Notes. The prepaid forward is intended to reduce the dilution to our stockholders from the issuance of our common stock (if any) upon conversion of the Notes and to allow certain investors to establish short positions that generally correspond to initial hedges of their investment in the Notes. Neither we nor the forward counterparty control how such investors may use such derivative transactions. In addition, such investors may enter into other transactions in connection with such derivative transactions, including the purchase or sale of our common stock, at any time. As a result, the existence of the prepaid forward, such derivative transactions, and any related market activity could cause

30


more sales of our common stock over the term of the prepaid forward than there would have otherwise been had we not entered into the prepaid forward. Such sales could potentially impact the market price of our common stock and/or the Notes.

We are subject to counterparty risk with respect to the prepaid forward.

We will be subject to the risk that the forward counterparty might default under the prepaid forward. Our exposure to the credit risk of the forward counterparty will not be secured by any collateral. Global economic conditions have in the recent past resulted in, and may again result in, the actual or perceived failure or financial difficulties of many financial institutions. If the forward counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings, with a claim equal to our exposure at that time under our transactions with the forward counterparty. Our exposure will depend on many factors, but, generally, an increase in our exposure will be correlated to an increase in the market price of our common stock. In addition, upon a default by the forward counterparty, we may suffer more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the forward counterparty to the prepaid forward.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.


Item 3. Defaults Upon Senior Securities

Not applicable.


Item 4. Mine Safety Disclosures

Not applicable.


Item 5. Other Information

None.


31



Item 6. Exhibits

Exhibit No.
Description
Filing Information
Incorporated by reference to Appendix B to the Registrant’s Definitive Proxy Statement on Schedule 14A filed on November 13, 2012
Incorporated by reference to Exhibit A to the Registrant’s Definitive Information Statement on Schedule 14C filed on July 12, 2013
Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on March 15, 2016
Incorporated by reference to Exhibit 3.2 filed with the Registrant’s Annual Report on Form 10-K for the fiscal year ended July 31, 2012
Incorporated by reference to Exhibit 3.1 filed with the Registrant’s Current Report on Form 8-K filed on November 16, 2017
Incorporated by reference to Exhibit 4.1 filed with the Registrant’s Current Report on Form 8-K filed on March 28, 2018
Incorporated by reference to Exhibit 4.2 filed with the Registrant’s Current Report on Form 8-K filed on March 28, 2018
Incorporated by reference to Exhibit 10.1 filed with the Registrant’s Current Report on Form 8-K filed on March 28, 2018
Incorporated by reference to Exhibit 10.2 filed with the Registrant’s Current Report on Form 8-K filed on March 28, 2018
Filed herewith
Filed herewith
Filed herewith
101**
XBRL Instance Document
 
101**
XBRL Taxonomy Extension Schema Document
 
101**
XBRL Taxonomy Calculation Linkbase Document
 
101**
XBRL Taxonomy Extension Definition Linkbase Document
 
101**
XBRL Taxonomy Label Linkbase Document
 
101**
XBRL Taxonomy Presentation Linkbase Document
 

** Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised that, pursuant to Rule 406T, these interactive data files are deemed not filed and otherwise are not subject to liability.


32


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

ACCELERATE DIAGNOSTICS, INC.
August 7, 2018
/s/ Lawrence Mehren
 
Lawrence Mehren
President and Chief Executive Officer
 
(Principal Executive Officer)
 
 
August 7, 2018
/s/ Steve Reichling
 
Steve Reichling
Chief Financial Officer
 
(Principal Financial and Accounting Officer)


33
 EX-31.1 2 a06302018-exh311.htm EXHIBIT 31.1 Exhibit


EXHIBIT 31.1
CERTIFICATION PURSUANT TO
RULE 13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lawrence Mehren, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Accelerate Diagnostics, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
August 7, 2018
/s/ Lawrence Mehren
 
Lawrence Mehren
President and Chief Executive Officer
 
(Principal Executive Officer)


 EX-31.2 3 a06302018-exh312.htm EXHIBIT 31.2 Exhibit


EXHIBIT 31.2
CERTIFICATION PURSUANT TO
RULE 13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steve Reichling, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Accelerate Diagnostics, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
August 7, 2018
/s/ Steve Reichling
 
Steve Reichling
Chief Financial Officer
 
(Principal Financial and Accounting Officer)


 EX-32 4 a06302018-exh32.htm EXHIBIT 32 Exhibit


Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned officers of Accelerate Diagnostics, Inc. (the “Company”) hereby certifies that, to his knowledge, the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2018 to which this certification is attached (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 7, 2018
/s/ Lawrence Mehren
 
Lawrence Mehren
President and Chief Executive Officer
 
(Principal Executive Officer)
 
 
August 7, 2018
/s/ Steve Reichling
 
Steve Reichling
Chief Financial Officer
 
(Principal Financial and Accounting Officer)


 EX-101.INS 5 axdx-20180710.xml XBRL INSTANCE DOCUMENT 0000727207 2018-01-01 2018-06-30 0000727207 2018-08-03 0000727207 2018-06-30 0000727207 2017-12-31 0000727207 2017-01-01 2017-06-30 0000727207 2018-04-01 2018-06-30 0000727207 2017-04-01 2017-06-30 0000727207 2016-12-31 0000727207 2017-06-30 0000727207 us-gaap:MinimumMember 2018-01-01 2018-06-30 0000727207 us-gaap:MaximumMember 2018-01-01 2018-06-30 0000727207 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 0000727207 2018-03-31 0000727207 2017-03-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2017-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2017-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2017-12-31 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2017-12-31 0000727207 2018-03-27 2018-03-27 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-03-27 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-06 2018-04-06 0000727207 2018-04-06 2018-04-06 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-06-30 0000727207 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-06-30 0000727207 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-06-30 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-06-30 0000727207 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-06-30 0000727207 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-06-30 0000727207 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember axdx:FinancialInstitutionBMember 2017-01-01 2017-12-31 0000727207 us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember axdx:FinancialInstitutionAMember 2018-01-01 2018-06-30 0000727207 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerCMember 2017-01-01 2017-12-31 0000727207 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerBMember 2018-01-01 2018-06-30 0000727207 us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember axdx:FinancialInstitutionAMember 2017-01-01 2017-12-31 0000727207 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerAMember 2018-01-01 2018-06-30 0000727207 us-gaap:CashAndCashEquivalentsMember us-gaap:CreditConcentrationRiskMember axdx:FinancialInstitutionBMember 2018-01-01 2018-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerHMember 2017-01-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerAMember 2018-04-01 2018-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerEMember 2017-01-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerIMember 2017-01-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerFMember 2017-01-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerCMember 2018-04-01 2018-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerEMember 2017-04-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerDMember 2017-01-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerGMember 2017-04-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerBMember 2018-04-01 2018-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerDMember 2017-04-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axdx:CustomerFMember 2017-04-01 2017-06-30 0000727207 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2017-12-31 0000727207 us-gaap:AssetBackedSecuritiesMember 2017-12-31 0000727207 us-gaap:CorporateDebtSecuritiesMember 2017-12-31 0000727207 us-gaap:CertificatesOfDepositMember 2017-12-31 0000727207 us-gaap:USTreasuryAndGovernmentMember 2017-12-31 0000727207 us-gaap:USTreasuryAndGovernmentMember 2018-06-30 0000727207 us-gaap:CorporateDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:AssetBackedSecuritiesMember 2018-06-30 0000727207 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-06-30 0000727207 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-06-30 0000727207 us-gaap:CertificatesOfDepositMember 2018-06-30 0000727207 axdx:InstrumentsMember 2017-12-31 0000727207 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2017-12-31 0000727207 us-gaap:ConstructionInProgressMember 2017-12-31 0000727207 us-gaap:TechnologyEquipmentMember 2018-06-30 0000727207 us-gaap:ConstructionInProgressMember 2018-06-30 0000727207 us-gaap:ComputerEquipmentMember 2017-12-31 0000727207 axdx:InstrumentsMember 2018-06-30 0000727207 us-gaap:ComputerEquipmentMember 2018-06-30 0000727207 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2018-06-30 0000727207 us-gaap:TechnologyEquipmentMember 2017-12-31 0000727207 2018-01-01 2018-01-31 0000727207 us-gaap:MinimumMember 2012-08-01 2012-08-31 0000727207 axdx:NationalInstituteofHealthGrantMember 2015-02-01 2015-02-28 0000727207 2012-08-01 2012-08-31 0000727207 axdx:NationalInstituteofHealthGrantMember 2015-02-01 2018-06-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2018-01-01 2018-06-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2017-01-01 2017-06-30 0000727207 2012-08-31 0000727207 axdx:NationalInstituteofHealthGrantMember 2017-04-01 2017-06-30 0000727207 axdx:NationalInstituteofHealthGrantMember 2018-04-01 2018-06-30 0000727207 2018-04-06 0000727207 us-gaap:AdditionalPaidInCapitalMember axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-06 0000727207 axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-06 0000727207 us-gaap:LongTermDebtMember axdx:TwoPointFiveZeroConvertibleNotesdue2023Member us-gaap:UnsecuredDebtMember 2018-04-06 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-06-30 0000727207 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-12-31 0000727207 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0000727207 2017-01-01 2017-12-31 0000727207 us-gaap:InventoriesMember 2018-01-01 2018-06-30 0000727207 us-gaap:InventoriesMember 2017-01-01 2017-06-30 0000727207 us-gaap:RestrictedStockUnitsRSUMember 2018-06-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2018-01-01 2018-06-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember 2017-01-01 2017-06-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-04-01 2018-06-30 0000727207 us-gaap:CostOfSalesMember 2017-04-01 2017-06-30 0000727207 us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0000727207 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-04-01 2017-06-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2017-04-01 2017-06-30 0000727207 us-gaap:ResearchAndDevelopmentExpenseMember 2018-04-01 2018-06-30 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2018-01-01 2018-06-30 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2018-06-30 0000727207 axdx:RestrictedStockUnitsAndRestrictedStockAwardsMember 2017-12-31 0000727207 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-04-01 2018-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2017-04-01 2017-06-30 0000727207 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2017-12-31 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2017-01-01 2017-06-30 0000727207 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-01-01 2018-06-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionDomesticMember 2017-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2017-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember 2018-06-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionForeignMember 2018-06-30 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember 2017-12-31 0000727207 us-gaap:PropertyPlantAndEquipmentMember us-gaap:GeographicConcentrationRiskMember us-gaap:GeographicDistributionDomesticMember 2018-06-30 0000727207 axdx:OtherRevenueMember 2017-01-01 2017-06-30 0000727207 us-gaap:GeographicDistributionForeignMember 2017-04-01 2017-06-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2017-04-01 2017-06-30 0000727207 axdx:OtherRevenueMember 2017-04-01 2017-06-30 0000727207 us-gaap:GeographicDistributionForeignMember 2018-01-01 2018-06-30 0000727207 us-gaap:GeographicDistributionForeignMember 2018-04-01 2018-06-30 0000727207 axdx:AcceleratePhenoMember 2017-04-01 2017-06-30 0000727207 axdx:OtherRevenueMember 2018-01-01 2018-06-30 0000727207 axdx:AcceleratePhenoMember 2017-01-01 2017-06-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2018-01-01 2018-06-30 0000727207 us-gaap:GeographicDistributionForeignMember 2017-01-01 2017-06-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2017-01-01 2017-06-30 0000727207 axdx:OtherRevenueMember 2018-04-01 2018-06-30 0000727207 us-gaap:GeographicDistributionDomesticMember 2018-04-01 2018-06-30 0000727207 axdx:AcceleratePhenoMember 2018-04-01 2018-06-30 0000727207 axdx:AcceleratePhenoMember 2018-01-01 2018-06-30 0000727207 axdx:ConvertibleNoteHolderMember us-gaap:DirectorMember 2018-06-30 axdx:day xbrli:pure axdx:segment axdx:job iso4217:USD xbrli:shares axdx:milestone xbrli:shares iso4217:USD 1000 0.98 1 45100000 0 1196000 22500000 0.15 P60D P30D 21500000 3418000 2757000 1100000 P5Y 63000 4500000.0 65 15 40 30 4 0.65 5.68 8.52 P1Y P60D false --12-31 Q2 2018 2018-06-30 10-Q 0000727207 54127990 Large Accelerated Filer Accelerate Diagnostics, Inc. 3636000 5302000 2080000 2355000 0 2273000 6584000 7531000 0 -134000 360620000 426091000 54900000 4235000 22000 1166000 3047000 183000 27000 3409000 58000 838000 2513000 420000 77000 2000000 2100000 126000 132000 6000 10000 7352000 7328000 24000 8109000 8093000 16000 125512000 218253000 120488000 212608000 22548000 65932000 0 88480000 69568000 113919000 0 183487000 80841000 130842000 80648000 14716000 0 0 0 0 0 14716000 65932000 3025000 13441000 9171000 31836000 8459000 0 0 0 0 0 0 0 0 80648000 3025000 13441000 9171000 31836000 8459000 14716000 3025000 13441000 9171000 31836000 8459000 14716000 130594000 31744000 0 0 0 0 0 31744000 98850000 8993000 13682000 35917000 33314000 6944000 0 0 0 0 0 0 0 0 130594000 8993000 13682000 35917000 33314000 6944000 31744000 8993000 13682000 35917000 33314000 6944000 31744000 0 0 0 0 0 0 0 4000 2000 0 0 1000 0 1000 193000 1000 0 0 70000 51000 71000 252000 1000 0 0 75000 69000 107000 80841000 3026000 13441000 9171000 31906000 8510000 14787000 130842000 8992000 13682000 35917000 33388000 7013000 31850000 25040000 35394000 24913000 35282000 55801000 95448000 55735000 95312000 80648000 130594000 19244000 62609000 28513000 66810000 7832000 0 0 7832000 0 5982000 0 5982000 0 9087000 0 9087000 37824000 0 0 37824000 37824000 15069000 0 52893000 43365000 38297000 0.001 0.001 75000000 75000000 55673810 54090575 55673810 54090575 56000 54000 -16250000 -30450000 -23418000 -44171000 0.22 0.21 0.19 0.15 0.22 0.13 0.12 0.11 0.31 0.15 0.14 0.24 0.82 0.12 0.13 0.12 0.11 0.28 0.11 0.10 0.58 0.28 0.27 14000 35000 0 115499000 135000 161000 717000 1210000 16987000 31803000 21390000 42524000 171500000 116600000 30.92 0.032343 20 1.3 30 30000000 150000000 171500000.0 171500000 0.1152 0.025 P5Y 52700000 1000000.0 1000000 0 1600000 3400000 5000000 3300000 1071000 185000 71000 185000 1000000 1045000 1072000 540000 1000000 533000 1100000 -0.31 -0.58 -0.43 -0.80 198000 -56000 111000 22800000 16.80 13.53 134000 124000 -7000 -33000 -253000 -198000 -5000 -266000 11460000 21988000 15330000 29682000 564000 1069000 975000 1283000 -16282000 -30482000 -23124000 -23100000 -43800000 -43752000 175000 175000 101000 285000 528000 206000 648000 -123000 392000 661000 0 5000 43000 -935000 0 1105000 5537000 4334000 313000 175000 0 78000 624000 444000 0 0 3205000 3363000 1100000 1100000 1100000 3466000 5374000 8063000 11317000 4220000 5101000 377000 842000 153000 290000 774000 1075000 -219000 146000 80648000 130594000 309000 625000 346000 688000 11000 12000 172000 181000 6808000 123367000 125512000 218253000 6787000 7842000 115500000 159000000 0 0 0 0 87272000 124472000 -16014000 -50702000 -28091000 -35417000 -16457000 -30657000 -23225000 -44037000 1 -16423000 -30734000 -20415000 -41241000 896000 4000 44000 85000 206000 0 557000 468000 643000 0 78000 3000 3000 -2000 -55000 204000 204000 -191000 -79000 21000 26000 5000 5000 25000 25000 141000 252000 -2709000 -2511000 0 45069000 0 4991000 39342000 91272000 1643000 702000 0.001 0.001 5000000 5000000 0 0 0 0 850000 1421000 0 171499000 83854000 276000 171500000 6500000 6522000 0 3000000 18449000 38272000 11474000 1400000 2756000 349000 3621000 3348000 12974000 2283000 2801000 720000 3620000 3550000 4890000 4890000 3779000 1111000 5443000 5443000 4210000 1233000 P7Y P1Y 1946000 1000000 1823000 864000 5000000 0 3000 38000 98000 5527000 9815000 6060000 12842000 -241972000 -286058000 -49000 699000 544000 155000 675000 24000 1230000 1063000 167000 1180000 50000 1692000 1220000 472000 1665000 27000 2493000 1815000 678000 2435000 58000 1000000 P4Y 695000 1224000 1671000 2467000 699000 1230000 1692000 2493000 4000 6000 21000 26000 7450000 9011000 0 0.00 0 0.00 26.45 26.45 8050 26.45 0 0 0.75 0.64 0.0202 0.0282 7328000 24000 8093000 16000 5689985 8.00 5495 91043 1115371 88348000 8093343 10.16 12.11 10.87 23.43 20.97 25.45 P6Y1M13D P6Y0M22D 83067000 P5Y1M17D P6Y2M5D 1000 31000 61000 192000 176000 199000 20000 20000 122000 259000 50000 80000 145000 266000 253621 118704000 94886000 1858500 0 45067000 53568000 52732000 54003000 54821000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 3. FDA CLEARANCE</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On February 23, 2017, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) granted Accelerate&#8217;s de novo request to market the Accelerate Pheno&#8482; system and Accelerate PhenoTest&#8482; BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Due to various factors, the Company manufactured inventory in advance of regulatory approval (&#8220;pre-launch inventory&#8221;). On January 1, 2017, the regulatory review process had progressed to a point that objective and persuasive evidence of approval was sufficiently probable, and a future economic benefit existed. On January 1, 2017, the Company started capitalizing pre-launch inventory.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 9. LICENSE AGREEMENTS AND GRANTS</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">National Institute of Health Grant</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In February 2015, the National Institute of Health awarded Denver Health and the Company a </font><font style="font-family:Arial;font-size:10pt;">five</font><font style="font-family:Arial;font-size:10pt;">-year, </font><font style="font-family:Arial;font-size:10pt;">$5.0 million</font><font style="font-family:Arial;font-size:10pt;"> grant to develop a fast and reliable identification and categorical susceptibility test for carbepenem-resistant Enterobacteriaceae directly from whole blood. The cumulative amount awarded to date under these subawards is </font><font style="font-family:Arial;font-size:10pt;">$1.1 million</font><font style="font-family:Arial;font-size:10pt;">. The amounts invoiced for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> were </font><font style="font-family:Arial;font-size:10pt;">$38,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$0</font><font style="font-family:Arial;font-size:10pt;">, respectively, and for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> were </font><font style="font-family:Arial;font-size:10pt;">$98,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$3,000</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Arizona Commerce Authority</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In August 2012, the Company entered into a Grant Agreement (the &#8220;Grant Agreement&#8221;) with the Arizona Commerce Authority, an agency of the State of Arizona (the &#8220;Authority&#8221;), pursuant to which the Authority provided certain state and county sponsored incentives for the Company relocating its corporate headquarters to, and expanding its business within, the State of Arizona (the &#8220;Project&#8221;). Pursuant to the Grant Agreement, the Authority provided a total grant in the amount of </font><font style="font-family:Arial;font-size:10pt;">$1.0 million</font><font style="font-family:Arial;font-size:10pt;"> (the &#8220;Grant&#8221;). The Grant was paid in </font><font style="font-family:Arial;font-size:10pt;">four</font><font style="font-family:Arial;font-size:10pt;"> installments, upon the achievement of the following milestones:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Milestone 1 &#8211; Relocation of Company&#8217;s operations and corporate headquarters to Arizona and creation of </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;"> Qualified Jobs (as defined below).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Milestone 2 &#8211; Creation of </font><font style="font-family:Arial;font-size:10pt;">30</font><font style="font-family:Arial;font-size:10pt;"> Qualified Jobs (including Qualified Jobs under Milestone 1).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Milestone 3 &#8211; Creation of </font><font style="font-family:Arial;font-size:10pt;">40</font><font style="font-family:Arial;font-size:10pt;"> Qualified Jobs (including Qualified Jobs under Milestones 1 and 2).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Milestone 4 &#8211; Creation of </font><font style="font-family:Arial;font-size:10pt;">65</font><font style="font-family:Arial;font-size:10pt;"> Qualified Jobs (including Qualified Jobs under Milestones 1, 2 and 3) and capital investment of at least </font><font style="font-family:Arial;font-size:10pt;">$4.5 million</font><font style="font-family:Arial;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">For purposes of the Grant Agreement, a &#8220;Qualified Job&#8221; was a job which was permanent, full-time, new to Arizona and for which the Company paid an average annual wage of at least </font><font style="font-family:Arial;font-size:10pt;">$63,000</font><font style="font-family:Arial;font-size:10pt;"> and included health insurance benefits, for which the Company paid at least </font><font style="font-family:Arial;font-size:10pt;">65%</font><font style="font-family:Arial;font-size:10pt;"> of the premiums. The Grant Agreement also contained other customary provisions, including representations, warranties and covenants of both parties. As of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, the full amount was collected and recorded in current deferred revenue and income.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In January 2018, the full amount was recognized due to the economic development provisions of the grant being satisfied in full, and the &#8220;claw-back&#8221; provisions expiring. The </font><font style="font-family:Arial;font-size:10pt;">$1.0 million</font><font style="font-family:Arial;font-size:10pt;"> was recognized as an offset to expense. Further details are included in </font><font style="font-family:Arial;font-size:10pt;">Note 10, Deferred Revenue, Income and Remaining Performance Obligations</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes the maturities of the Company&#8217;s available-for-sale securities at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Due in less than 1 year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,448</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,312</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">55,801</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">55,735</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Due in 1-5 years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,394</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,282</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">25,040</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">24,913</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,842</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,594</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,841</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, as filed with the SEC on March 1, 2018.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The condensed consolidated balance sheet as of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending </font><font style="font-family:Arial;font-size:10pt;">December 31, 2018</font><font style="font-family:Arial;font-size:10pt;">, or any future period.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All amounts are rounded to the nearest thousand dollars unless otherwise indicated.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 1. ORGANIZATION AND NATURE OF BUSINESS; BASIS OF PRESENTATION; PRINCIPLES OF CONSOLIDATION; SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Accelerate Diagnostics, Inc. (&#8220;we&#8221; or &#8220;us&#8221; or &#8220;our&#8221; or &#8220;Accelerate&#8221; or &#8220;the Company&#8221;) is an </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">in vitro</font><font style="font-family:Arial;font-size:10pt;"> diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, as filed with the SEC on March 1, 2018.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The condensed consolidated balance sheet as of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending </font><font style="font-family:Arial;font-size:10pt;">December 31, 2018</font><font style="font-family:Arial;font-size:10pt;">, or any future period.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All amounts are rounded to the nearest thousand dollars unless otherwise indicated.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Principles of Consolidation</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company&#8217;s consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). The preparation of the Company&#8217;s consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventories, property and equipment, intangible assets, accruals, warranty liabilities, tax valuation accounts and stock-based compensation. Actual results could differ materially from those estimates.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Estimated Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company follows </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">ASC Topic 820, Fair Value Measurements and Disclosures</font><font style="font-family:Arial;font-size:10pt;"> which has defined fair value and requires the Company to establish a framework for measuring fair value and disclose fair value measurements. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, accounts payable, accrued liabilities, and other liabilities approximate the related fair values due to the short-term maturities of these instruments.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe however, that the market risk arising from holding these financial instruments is minimal.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Investments</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company invests excess funds in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificate of deposits, debt securities in U.S. government and agency securities, commercial paper, asset-backed securities and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive income (loss), a component of stockholders&#8217; equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment&#8217;s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive income (loss)</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Inventory</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company writes down its inventory for estimated obsolescence or in an amount equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, market conditions and, where applicable, product expiration.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Accounts Receivable</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Accounts receivable consist of amounts due to the Company for sales to customers and are recorded net of an allowance for doubtful accounts. Allowances on accounts receivable are recorded when circumstances indicate collection is doubtful for a particular accounts receivable. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis. </font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company has not included&#160;an allowance for doubtful accounts as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, due to no circumstances arising that would indicate collection of any particular or grouping of customer accounts receivable is doubtful.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Property and Equipment</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from </font><font style="font-family:Arial;font-size:10pt;">one</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">seven years</font><font style="font-family:Arial;font-size:10pt;">. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less. Property and equipment includes diagnostic instruments used for sales demonstrations and instruments under rental agreements. The Company retains title to the instruments under these arrangements.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Long-lived Assets</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Warranty Reserve</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Instruments are typically sold with a </font><font style="font-family:Arial;font-size:10pt;">one year</font><font style="font-family:Arial;font-size:10pt;"> limited warranty, while kits and accessories are typically sold with a </font><font style="font-family:Arial;font-size:10pt;">60 days</font><font style="font-family:Arial;font-size:10pt;"> limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Warranty reserve activity for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Provisions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Warranty expenses incurred</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(122</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(259</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Convertible Notes</font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company issued convertible notes that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Revenue Recognition</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Effective January 1, 2018, the Company adopted the requirements of ASC 606, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:Arial;font-size:10pt;">, ("Topic 606") and recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We determine revenue recognition through the following steps:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Identification of the contract with a customer</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Identification of the performance obligations in the contract</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Determination of the transaction price</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Allocation of the transaction price to the performance obligations</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Recognition of revenue as we satisfy a performance obligation</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Service revenue is derived from the sale of extended service agreements which are generally non-cancelable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the price charged to customers for each individual performance obligation.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also provide instruments to customers under bundled rental agreements. Under these agreements, we install the instrument in the customer&#8217;s facility and provide service. The customer agrees to purchase consumable products at a stated price over the term of the agreement, which is typically five years or less. Contracts sometimes have renewal clauses but such clauses do not provide for a bargain renewal option or penalize the customer if they do not renew. The instrument remains the Company&#8217;s property throughout the term of the agreement and there is no transfer of title upon expiration.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our payment terms vary by the type and location of our customers and the product or services offered and typically range between </font><font style="font-family:Arial;font-size:10pt;">30</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">60 days</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the quarter ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company adopted Topic 606 using the modified retrospective method applied to those contracts that were not fully performed by the Company as of January 1, 2018. We recorded a decrease to opening retained earnings and an increase in deferred revenue of </font><font style="font-family:Arial;font-size:10pt;">$49,000</font><font style="font-family:Arial;font-size:10pt;"> as of January 1, 2018 due to the cumulative impact of adopting Topic 606. The impact to revenues for the three and six months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> was not material as a result of applying Topic 606. &#160;The reported results for 2017 and prior were prepared and are presented under the guidance of ASC 605,&#160;</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Revenue Recognition</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Cost of Sales</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cost of sales consists of raw materials, depreciation, direct labor and stock-based compensation expense, manufacturing overhead, facility costs and warranty costs.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Shipping and Handling</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the consolidated statements of operations and comprehensive loss.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Leases</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company accounts for leases in accordance with ASC 840, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Leases,</font><font style="font-family:Arial;font-size:10pt;"> which requires leases to be classified as either operating or capital leases. In general, the Company classifies leases as capital leases when there is either a transfer of ownership at the end of the lease term, the lease contains a bargain purchase option, the lease term is seventy-five percent or more of the estimated economic life of the leased property or the minimum lease payments are ninety percent or more of the fair value of the leased property at lease inception. Other leases are classified as operating leases.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Operating lease rent is recorded as an operating expense on a monthly basis. For capital leases, both an asset and liability are recorded at the inception of the lease based on the present value of lease payments. The asset is included with property and equipment on the condensed consolidated balance sheet and amortization is recorded on a straight-line basis over the term of the lease with the amortization expense included with depreciation on the statements of operations and comprehensive loss. For the liability, the amount due within the next year is recorded as a current liability and the amount due in more than a year is recorded as a long-term liability on the condensed consolidated balance sheet. Interest expense is recorded based on the implicit or explicit interest rate used in the lease and is included as non-operating interest expense on the statements of operations and comprehensive loss. As of&#160;</font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, the Company did not carry any capital leases.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Equity-Based Compensation</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company awards stock options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method). We account for forfeitures as they occur rather than on an estimated basis.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company estimates the fair value of stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company records the fair value of restricted stock units or stock grants based on published closing market price on the day before the grant date.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Income Taxes and Deferred Tax Assets</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying condensed consolidated balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company follows the provisions of ASC 740, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:Arial;font-size:10pt;">, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit the taxpayer must determine it is more likely than not certain that its tax position will be sustained, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Foreign Currency Translation and Foreign Currency Transactions</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company follows ASC 830 </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Foreign Currency Matters</font><font style="font-family:Arial;font-size:10pt;">, which provides guidance on foreign currency transactions and translation of financial statements. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in the consolidated statements of stockholders&#8217; equity.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share are computed similarly to basic earnings (loss) per share except the denominator includes additional common shares that would have been outstanding if notes convertible at the balance sheet date were converted and share-based payments had been issued. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe however, that the market risk arising from holding these financial instruments is minimal.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 15. COMMITMENTS</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Leases</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company has entered into lease agreements, lease amendments, and lease extensions (&#8220;Lease Agreements&#8221;) for office, laboratory and manufacturing space located in Tucson, Arizona and Europe, the last of which expires in 2022. Total rent expense, including common area charges was </font><font style="font-family:Arial;font-size:10pt;">$346,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$309,000</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, respectively, and for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> was </font><font style="font-family:Arial;font-size:10pt;">$688,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$625,000</font><font style="font-family:Arial;font-size:10pt;">, respectively. Future minimum lease payments under these agreements are as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Year ending December 31:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">896</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Clinical Trial Agreements</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company has entered into master agreements with clinical trial sites in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the clinical trial sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation. The expense incurred as part of the clinical trial is included in research and development on the Company's condensed consolidated statements of operations and comprehensive loss.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Marketing Study and Contracted Research</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company has entered into marketing study agreements and contracted research agreements with research institutions and hospitals in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 5. CONCENTRATION OF CREDIT RISK</font><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable, including receivables from major customers.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company has financial institutions for banking operations that hold 10% or more of the of the Company&#8217;s cash and cash equivalents. As of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, two of the Company's financial institutions held </font><font style="font-family:Arial;font-size:10pt;">58%</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">28%</font><font style="font-family:Arial;font-size:10pt;"> of the Company&#8217;s cash and cash equivalents, respectively. As of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, two of the Company's financial institutions held </font><font style="font-family:Arial;font-size:10pt;">82%</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">12%</font><font style="font-family:Arial;font-size:10pt;"> of the Company&#8217;s cash and cash equivalents, respectively.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company grants credit to domestic and international clients in various industries. Exposure to losses on accounts receivable is principally dependent on each client's financial position. The Company has customers who represented 10%&#160;or more of the Company&#8217;s net accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. The Company had two customers that accounted for </font><font style="font-family:Arial;font-size:10pt;">11%</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">10%</font><font style="font-family:Arial;font-size:10pt;"> of the Company&#8217;s net accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, and one Customer that accounted for </font><font style="font-family:Arial;font-size:10pt;">24%</font><font style="font-family:Arial;font-size:10pt;"> of the Company's net accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Customers who represented 10% or more of the Company&#8217;s total revenue for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company C</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company D</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">22%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company E</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">21%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company F</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">19%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company G</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">15%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company H</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company I</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">15%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">* Less than 10% for the period indicated</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Principles of Consolidation</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Cost of Sales</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cost of sales consists of raw materials, depreciation, direct labor and stock-based compensation expense, manufacturing overhead, facility costs and warranty costs.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 11. CONVERTIBLE NOTES</font><font style="font-family:Arial;font-size:10pt;"> </font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">March&#160;27, 2018</font><font style="font-family:Arial;font-size:10pt;">, the Company issued </font><font style="font-family:Arial;font-size:10pt;">$150.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">2.50%</font><font style="font-family:Arial;font-size:10pt;"> Convertible Notes due 2023. The arrangement provided for a </font><font style="font-family:Arial;font-size:10pt;">15%</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">$22.5 million</font><font style="font-family:Arial;font-size:10pt;"> overallotment option to purchase additional Notes 13 days following the execution of the purchase agreement. On </font><font style="font-family:Arial;font-size:10pt;">April&#160;6, 2018</font><font style="font-family:Arial;font-size:10pt;"> the option was partially exercised, which resulted in </font><font style="font-family:Arial;font-size:10pt;">$21.5 million</font><font style="font-family:Arial;font-size:10pt;"> of additional proceeds, for total proceeds of </font><font style="font-family:Arial;font-size:10pt;">$171.5 million</font><font style="font-family:Arial;font-size:10pt;">. The Notes are the Company's senior unsecured obligations and mature on </font><font style="font-family:Arial;font-size:10pt;">March&#160;15, 2023</font><font style="font-family:Arial;font-size:10pt;"> (the &#8220;Maturity Date&#8221;), unless earlier repurchased or converted into shares of common stock under certain circumstances described below. The Notes are convertible into shares of the Company&#8217;s common stock, can be repurchased for cash, or a combination thereof, at the Company&#8217;s election, at an initial conversion rate of </font><font style="font-family:Arial;font-size:10pt;">32.343</font><font style="font-family:Arial;font-size:10pt;"> shares of common stock per </font><font style="font-family:Arial;font-size:10pt;">$1,000</font><font style="font-family:Arial;font-size:10pt;"> principal amount of the Notes, which is equivalent to an initial conversion price of approximately </font><font style="font-family:Arial;font-size:10pt;">$30.92</font><font style="font-family:Arial;font-size:10pt;"> per share of common stock, subject to adjustment. The Company will pay interest on the Notes semi-annually in arrears on March 15 and September 15 of each year.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The </font><font style="font-family:Arial;font-size:10pt;">$171.5 million</font><font style="font-family:Arial;font-size:10pt;"> of proceeds received from the issuance of the Notes were allocated between long-term debt (the &#8220;liability component&#8221;) of </font><font style="font-family:Arial;font-size:10pt;">$116.6 million</font><font style="font-family:Arial;font-size:10pt;"> and contributed capital (the &#8220;equity component&#8221;) of </font><font style="font-family:Arial;font-size:10pt;">$54.9 million</font><font style="font-family:Arial;font-size:10pt;">. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature. The carrying amount of the equity component, representing the conversion option, was determined by deducting the fair value of the liability component from the aggregate face value of the Notes. The liability component will be accreted up to the face value of the Notes of </font><font style="font-family:Arial;font-size:10pt;">$171.5 million</font><font style="font-family:Arial;font-size:10pt;">, which will result in additional non-cash interest expense being recognized through the Maturity Date. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company incurred approximately </font><font style="font-family:Arial;font-size:10pt;">$5.0 million</font><font style="font-family:Arial;font-size:10pt;"> of issuance costs related to the issuance of the Notes, of which </font><font style="font-family:Arial;font-size:10pt;">$3.4 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$1.6 million</font><font style="font-family:Arial;font-size:10pt;"> were recorded to long-term debt and contributed capital, respectively. The </font><font style="font-family:Arial;font-size:10pt;">$3.4 million</font><font style="font-family:Arial;font-size:10pt;"> of issuance costs recorded as long-term debt on the condensed consolidated balance sheet are being amortized over the </font><font style="font-family:Arial;font-size:10pt;">five</font><font style="font-family:Arial;font-size:10pt;">-year contractual term of the Notes using the effective interest method. The effective interest rate on the Notes, including accretion of the Notes to par and debt issuance cost amortization, is </font><font style="font-family:Arial;font-size:10pt;">11.52%</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Notes include customary terms and covenants, including certain events of default upon which the Notes may be due and payable immediately. Holders have the option to convert the Notes in multiples of </font><font style="font-family:Arial;font-size:10pt;">$1,000</font><font style="font-family:Arial;font-size:10pt;"> principal amount at any time prior to December 15, 2022, but only in the following circumstances:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">if the Company&#8217;s stock price exceeds </font><font style="font-family:Arial;font-size:10pt;">130%</font><font style="font-family:Arial;font-size:10pt;"> of the conversion price for </font><font style="font-family:Arial;font-size:10pt;">20</font><font style="font-family:Arial;font-size:10pt;"> of the last </font><font style="font-family:Arial;font-size:10pt;">30</font><font style="font-family:Arial;font-size:10pt;"> trading days of any calendar quarter after June 30, 2018;</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">during the 5 business day period after any 5 consecutive trading day period in which the Notes&#8217; trading price is less than </font><font style="font-family:Arial;font-size:10pt;">98%</font><font style="font-family:Arial;font-size:10pt;"> of the product of the common stock price times the conversion rate; or</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the occurrence of certain corporate events, such as a change of control, merger or liquidation.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">At any time on or after December 15, 2022, a holder may convert its Notes in multiples of </font><font style="font-family:Arial;font-size:10pt;">$1,000</font><font style="font-family:Arial;font-size:10pt;"> principal amount. Holders of the Notes who convert their Notes in connection with a make-whole fundamental change (as defined in the Indenture pursuant to which the Notes were issued) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change or event of default prior to the Maturity Date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the Notes at a repurchase price equal to </font><font style="font-family:Arial;font-size:10pt;">100%</font><font style="font-family:Arial;font-size:10pt;"> of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, the outstanding principal amount on the Notes was </font><font style="font-family:Arial;font-size:10pt;">$171.5 million</font><font style="font-family:Arial;font-size:10pt;">, the unamortized debt discount was </font><font style="font-family:Arial;font-size:10pt;">$52.7 million</font><font style="font-family:Arial;font-size:10pt;">, the unamortized debt issuance cost was </font><font style="font-family:Arial;font-size:10pt;">$3.3 million</font><font style="font-family:Arial;font-size:10pt;"> and the net carrying amount of the liability component was </font><font style="font-family:Arial;font-size:10pt;">$115.5 million</font><font style="font-family:Arial;font-size:10pt;">, which was recorded as convertible notes within the condensed consolidated balance sheet. The Company recorded interest expense of </font><font style="font-family:Arial;font-size:10pt;">$1.1 million</font><font style="font-family:Arial;font-size:10pt;"> for contractual coupon interest for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, which is also recorded as accrued interest expense as of </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">. The Company also recorded </font><font style="font-family:Arial;font-size:10pt;">$126,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$132,000</font><font style="font-family:Arial;font-size:10pt;"> for amortization of debt issuance costs for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, respectively, and </font><font style="font-family:Arial;font-size:10pt;">$2.0 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$2.1 million</font><font style="font-family:Arial;font-size:10pt;"> for amortization of the debt discount for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, respectively. As of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, no Notes were convertible pursuant to their terms.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In connection with the debt issuance, the Company entered into a prepaid forward stock repurchase transaction (&#8220;Prepaid Forward&#8221;) with a financial institution (&#8220;Forward Counterparty&#8221;). Pursuant to the Prepaid Forward, the Company used approximately </font><font style="font-family:Arial;font-size:10pt;">$45.1 million</font><font style="font-family:Arial;font-size:10pt;"> of the net proceeds from its issuance of the Notes to fund the Prepaid Forward. The aggregate number of shares of the Company&#8217;s common stock underlying the Prepaid Forward was approximately </font><font style="font-family:Arial;font-size:10pt;">1,858,500</font><font style="font-family:Arial;font-size:10pt;">. The expiration date for the Prepaid Forward is March 15, 2023, although it may be settled earlier in whole or in part. Upon settlement of the Prepaid Forward, at expiration or upon any early settlement, the Forward Counterparty will deliver to the Company the number of shares of common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders&#8217; votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company. The Company&#8217;s Prepaid Forward hedge transaction exposes the Company to credit risk to the extent that its counterparty may be unable to meet the terms of the transaction. The Company mitigates this risk by limiting its counterparty to a major financial institution.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Convertible Notes</font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company issued convertible notes that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A summary of the balances as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products and services not yet delivered</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Arizona Commerce Authority grant</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred revenue and income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Primary Geographic Markets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,220</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">544</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,815</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,063</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">472</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">155</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">678</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,692</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Line of Business:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Accelerate Pheno&#8482; revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,665</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">675</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,692</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products and Services:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">695</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,692</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 13. EMPLOYEE EQUITY-BASED COMPENSATION</font></div><div style="line-height:120%;padding-bottom:0px;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes option activity under all plans during the </font><font style="font-family:Arial;font-size:10pt;">six</font><font style="font-family:Arial;font-size:10pt;">-month period ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Number of&#160;Shares</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price per Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Options Outstanding January 1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">7,328,131</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">10.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,115,371</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">25.45</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(91,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">20.97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(253,621</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">10.87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(5,495</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">23.43</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Options Outstanding June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">8,093,343</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">12.11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Expected term (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Expected dividends</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Risk free interest rates</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2.82</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2.02</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Weighted average fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13.53</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">16.80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table shows summary information for outstanding options and options that are exercisable (vested) as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Options</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Options</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Number of options</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,093,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,689,985</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Weighted average remaining contractual term (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6.18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Weighted average fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Aggregate intrinsic value (in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">88,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">83,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes restricted stock unit and restricted stock award activity during the </font><font style="font-family:Arial;font-size:10pt;">six</font><font style="font-family:Arial;font-size:10pt;">-month period ending </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Number of&#160;Shares</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Weighted Average Grant Date Fair Value per Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding January 1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">24,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">26.45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Vested/released</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(8,050</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">26.45</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding June 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">16,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">26.45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Equity-based compensation is summarized below (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,166</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,450</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,892</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Sales, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,513</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,047</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,457</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,536</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Equity-based compensation expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,409</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,235</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,011</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,450</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;">$420,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$183,000</font><font style="font-family:Arial;font-size:10pt;"> of equity-based compensation expense was included as a component of capitalized inventory, respectively. As of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;">$77,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$27,000</font><font style="font-family:Arial;font-size:10pt;"> of equity-based compensation expense was included as a component of capitalized property and equipment, respectively.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, unrecognized equity-based compensation expense related to unvested stock options and unvested restricted stock units was </font><font style="font-family:Arial;font-size:10pt;">$22.8 million</font><font style="font-family:Arial;font-size:10pt;"> and $</font><font style="font-family:Arial;font-size:10pt;">111,000</font><font style="font-family:Arial;font-size:10pt;">, respectively. This is expected to be recognized over the years </font><font style="font-family:Arial;font-size:10pt;">2018</font><font style="font-family:Arial;font-size:10pt;"> through </font><font style="font-family:Arial;font-size:10pt;">2023</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Equity-based compensation is summarized below (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,166</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,450</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,892</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Sales, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,513</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,047</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,457</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,536</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Equity-based compensation expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,409</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,235</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,011</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,450</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share are computed similarly to basic earnings (loss) per share except the denominator includes additional common shares that would have been outstanding if notes convertible at the balance sheet date were converted and share-based payments had been issued. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 12. EARNINGS PER SHARE</font></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share are the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive due to the Company&#8217;s losses.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shares issuable upon the release of restricted stock awards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shares issuable upon exercise of stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,093</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,328</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,109</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,352</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following tables represent the financial instruments measured at fair value on a recurring basis on the financial statements of the Company and the valuation approach applied to each class of financial instruments at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Quoted Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets<br clear="none"/>(Level 1)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Other<br clear="none"/>Observable Inputs<br clear="none"/>(Level 2)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cash and cash equivalents:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">37,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">37,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,982</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,982</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,087</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total cash and cash equivalents</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">37,824</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">15,069</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">52,893</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Investments:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certificates of deposit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,682</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,682</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,744</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,744</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Agency securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,944</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,944</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">33,314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">33,314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,744</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">98,850</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,594</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Total assets measured at fair value</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">69,568</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">113,919</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">183,487</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Quoted Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets<br clear="none"/>(Level 1)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Other<br clear="none"/>Observable Inputs<br clear="none"/>(Level 2)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cash and cash equivalents:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,832</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,832</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Investments:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certificates of deposit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,441</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,441</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Agency securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,836</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,716</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">65,932</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,648</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Total assets measured at fair value</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">22,548</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">65,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">88,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 4. FAIR VALUE OF FINANCIAL INSTRUMENTS</font></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following tables represent the financial instruments measured at fair value on a recurring basis on the financial statements of the Company and the valuation approach applied to each class of financial instruments at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Quoted Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets<br clear="none"/>(Level 1)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Other<br clear="none"/>Observable Inputs<br clear="none"/>(Level 2)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cash and cash equivalents:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">37,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">37,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,982</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,982</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,087</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total cash and cash equivalents</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">37,824</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">15,069</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">52,893</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Investments:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certificates of deposit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,682</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,682</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,744</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,744</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Agency securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,944</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,944</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">33,314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">33,314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,744</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">98,850</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,594</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Total assets measured at fair value</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">69,568</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">113,919</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">183,487</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Quoted Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets<br clear="none"/>(Level 1)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Other<br clear="none"/>Observable Inputs<br clear="none"/>(Level 2)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cash and cash equivalents:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,832</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,832</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Investments:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certificates of deposit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,441</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,441</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Agency securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,836</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,716</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">65,932</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,648</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Total assets measured at fair value</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">22,548</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">65,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">88,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Highly liquid investments with an original maturity of three months or less at time of purchase are are included in cash and cash equivalents on the condensed consolidated balance sheet.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Level 1 assets are priced using quoted prices in active markets for identical assets which include money market funds and U.S. Treasury securities as these specific assets are liquid.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Level 2 available-for-sale securities are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. The Company uses inputs such as actual trade data, benchmark yields, broker/dealer quotes, and other similar data, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets and liabilities. The Company uses such pricing data as the primary input to make its assessments and determinations as to the ultimate valuation of its investment portfolio and has not made, during the periods presented, any material adjustments to such inputs. There were no transfers between levels during the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">March&#160;27, 2018</font><font style="font-family:Arial;font-size:10pt;">, the Company issued </font><font style="font-family:Arial;font-size:10pt;">$150.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">2.50%</font><font style="font-family:Arial;font-size:10pt;"> Convertible Notes due 2023 (&#8220;Notes&#8221;). The arrangement provided for a </font><font style="font-family:Arial;font-size:10pt;">15%</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">$22.5 million</font><font style="font-family:Arial;font-size:10pt;"> overallotment option to purchase additional Notes 13 days following the execution of the purchase agreement. On </font><font style="font-family:Arial;font-size:10pt;">April&#160;6, 2018</font><font style="font-family:Arial;font-size:10pt;"> the option was partially exercised, which resulted in </font><font style="font-family:Arial;font-size:10pt;">$21.5 million</font><font style="font-family:Arial;font-size:10pt;"> of additional proceeds, for total proceeds of </font><font style="font-family:Arial;font-size:10pt;">$171.5 million</font><font style="font-family:Arial;font-size:10pt;">, as described in </font><font style="font-family:Arial;font-size:10pt;color:#000000;">Note 11, Convertible Notes</font><font style="font-family:Arial;font-size:10pt;">. The calculated fair value of the Notes, of </font><font style="font-family:Arial;font-size:10pt;">$159.0 million</font><font style="font-family:Arial;font-size:10pt;">, is highly correlated to the Company&#8217;s stock price and as a result, significant changes to the Company&#8217;s stock price will have a significant impact on the calculated fair value of the Notes. The fair value of the Notes are classified as Level 2 within the fair value hierarchy.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Estimated Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company follows </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">ASC Topic 820, Fair Value Measurements and Disclosures</font><font style="font-family:Arial;font-size:10pt;"> which has defined fair value and requires the Company to establish a framework for measuring fair value and disclose fair value measurements. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, accounts payable, accrued liabilities, and other liabilities approximate the related fair values due to the short-term maturities of these instruments.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Foreign Currency Translation and Foreign Currency Transactions</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company follows ASC 830 </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Foreign Currency Matters</font><font style="font-family:Arial;font-size:10pt;">, which provides guidance on foreign currency transactions and translation of financial statements. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in the consolidated statements of stockholders&#8217; equity.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Long-lived Assets</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 14. INCOME TAXES</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">For the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, the Company recorded a provision for income taxes of approximately </font><font style="font-family:Arial;font-size:10pt;">$101,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$285,000</font><font style="font-family:Arial;font-size:10pt;">, respectively, which primarily relates to profitable foreign jurisdictions without any net operating loss carryforwards. The Company&#8217;s tax expense for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> differs from the tax expense computed by applying the U.S. statutory tax rate to its year-to-date pre-tax loss of </font><font style="font-family:Arial;font-size:10pt;">$23.1 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$43.8 million</font><font style="font-family:Arial;font-size:10pt;">, respectively, as no tax benefits were recorded for tax losses generated in the U.S. and other foreign jurisdictions. At </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, the Company had deferred tax assets primarily related to U.S. federal and state tax loss carryforwards. The Company provided a full valuation allowance against its deferred tax assets as future realization of such assets is not more likely than not to occur.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We account for uncertain tax positions pursuant to the recognition and measurement criteria under ASC 740, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:Arial;font-size:10pt;">. For the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, we did not note any significant changes to our uncertain tax positions. We do not anticipate significant changes to uncertain tax position within the next 12 months.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Tax Cuts and Jobs Act</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December&#160;22, 2017</font><font style="font-family:Arial;font-size:10pt;">, President Trump signed into law the Tax Cuts and Jobs Act. The Tax Act reduced the corporate tax rate from the maximum federal statutory rate of 35% to 21%. The Tax Act states that the 21% corporate tax rate is effective for tax years beginning on or after </font><font style="font-family:Arial;font-size:10pt;">January&#160;1, 2018</font><font style="font-family:Arial;font-size:10pt;">. The Company revalued its net deferred tax assets for U.S. federal purposes to 21% as of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, with a corresponding adjustment to the valuation allowance. Therefore, the reduction in the U.S. corporate tax rate had no impact on the Company's earnings.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In conjunction with the Tax Act, the SEC staff issued SAB 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. The Company has recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in its consolidated financial statements for the year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. The ultimate impact may differ from these provisional amounts, possibly materially, due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the Tax Act. Any subsequent determinations and adjustments will be recorded during the remainder of the year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:Arial;font-size:10pt;">, as they are identified.&#160; </font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Tax Act subjects a U.S. shareholder to tax on global intangible low-taxed income (&#8220;GILTI&#8221;) earned by certain foreign subsidiaries. The FASB Staff Q&amp;A, Topic 740, No. 5, Accounting for GILTI, states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. Given the complexity of the GILTI provisions, we are still evaluating the effects of the GILTI provisions and have not yet determined our accounting policy. At </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, because we are still evaluating the GILTI provisions and our analysis of future taxable income subject to GILTI, we have included GILTI related to current-year operations only in our estimated annual effective tax rate, with a corresponding adjustment to the valuation allowance, and have not provided additional GILTI on deferred items.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">At </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, the Company has not completed its accounting for all of the tax effects of the Tax Act and has not made any adjustments to the provisional amounts recorded at </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. The Company will continue to make and refine its calculations as additional analysis is completed. The Company&#8217;s estimates may also be affected as additional guidance is issued with regards to the Tax Act. These changes are not expected to be material to the Company&#8217;s financial statements since the effective tax rate impact will be offset by the corresponding adjustment in the valuation allowance.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Income Taxes and Deferred Tax Assets</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying condensed consolidated balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company follows the provisions of ASC 740, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:Arial;font-size:10pt;">, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit the taxpayer must determine it is more likely than not certain that its tax position will be sustained, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 7. INVENTORY</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Inventories consisted of the following at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,220</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">842</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Inventory, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,063</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Inventory</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company writes down its inventory for estimated obsolescence or in an amount equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, market conditions and, where applicable, product expiration.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Investments</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company invests excess funds in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificate of deposits, debt securities in U.S. government and agency securities, commercial paper, asset-backed securities and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive income (loss), a component of stockholders&#8217; equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment&#8217;s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive income (loss)</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 6. INVESTMENTS</font></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following tables summarize the Company&#8217;s available-for-sale investments at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Cost</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gains</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Losses</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certificates of deposit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,682</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,682</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(107</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Agency securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,013</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(69</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,944</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,917</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,917</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,993</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">33,388</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">33,314</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,842</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,594</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Gains</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Losses</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certificates of deposit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,441</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,441</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,787</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Agency securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,510</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(51</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,906</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(70</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,841</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(193</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes the maturities of the Company&#8217;s available-for-sale securities at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Due in less than 1 year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,448</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,312</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">55,801</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">55,735</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Due in 1-5 years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,394</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,282</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">25,040</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">24,913</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,842</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,594</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,841</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Proceeds from sales of marketable securities (including principal paydowns), for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> were </font><font style="font-family:Arial;font-size:10pt;">$0</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$6.5 million</font><font style="font-family:Arial;font-size:10pt;">, respectively, and for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> were </font><font style="font-family:Arial;font-size:10pt;">$3.0 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$6.5 million</font><font style="font-family:Arial;font-size:10pt;">, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were </font><font style="font-family:Arial;font-size:10pt;">no</font><font style="font-family:Arial;font-size:10pt;"> realized gains from sales of marketable securities for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">. No balances were reclassified out of accumulated other comprehensive income (loss) for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">No other-than-temporary impairments are recorded as no material investments had a fair value that remained less than its cost for more than twelve months as of those dates. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Leases</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company accounts for leases in accordance with ASC 840, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Leases,</font><font style="font-family:Arial;font-size:10pt;"> which requires leases to be classified as either operating or capital leases. In general, the Company classifies leases as capital leases when there is either a transfer of ownership at the end of the lease term, the lease contains a bargain purchase option, the lease term is seventy-five percent or more of the estimated economic life of the leased property or the minimum lease payments are ninety percent or more of the fair value of the leased property at lease inception. Other leases are classified as operating leases.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Operating lease rent is recorded as an operating expense on a monthly basis. For capital leases, both an asset and liability are recorded at the inception of the lease based on the present value of lease payments. The asset is included with property and equipment on the condensed consolidated balance sheet and amortization is recorded on a straight-line basis over the term of the lease with the amortization expense included with depreciation on the statements of operations and comprehensive loss. For the liability, the amount due within the next year is recorded as a current liability and the amount due in more than a year is recorded as a long-term liability on the condensed consolidated balance sheet. Interest expense is recorded based on the implicit or explicit interest rate used in the lease and is included as non-operating interest expense on the statements of operations and comprehensive loss. As of&#160;</font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, the Company did not carry any capital leases.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following presents long-lived assets (excluding intangible assets) by geographic territory (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,779</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,233</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;padding-bottom:0px;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2018-07, Compensation-Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to Accounting Standards Codification (&#8220;ASC&#8221;) 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We do not anticipate this update will have an effect on our condensed consolidated financial statements because all share-based awards granted to nonemployees are fully vested.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In March 2018, issued ASU 2018-05, Amendments Pursuant to SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) No. 118 (SEC Update), Income Taxes (Topic 740). ASU 2018-05 provides guidance regarding the recording of tax impacts where uncertainty exists, in the period of adoption of the 2017 U.S. Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;). In accordance with this guidance, the Company&#8217;s financial results reflect provisional amounts for those specific income tax effects of the Tax Act for which the accounting under ASC Topic 740 is incomplete but a reasonable estimate could be determined. During the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, the Company did not recognize any changes to the provisional amounts recorded in its 2017 Annual Report on Form 10-K in connection with the Tax Act, as the Company continues to collect the information necessary to complete those calculations. The accounting for the tax effects of the Tax Act will be completed in the second half of 2018.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220) Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI), which allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act that the FASB refers to as having been stranded in AOCI. This ASU is effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2018, with early adoption permitted. The Company is evaluating the impact of the adoption of ASU 2018-02 on our condensed consolidated financial statements, though its effects are not expected to be material.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In March 2017, the FASB issued ASU 2017-08, Receivable-Nonrefundable Fees and Other Costs (Topic 310-20) Premium Amortization on Purchased Callable Debt Securities. This amendment shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. This ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. If an entity early adopts in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently assessing the impact this will have on our condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740) Intra-Entity Transfers of Assets Other Than Inventory. This ASU is effective for periods after December 15, 2017 and eliminates the requirement that the Company recognize the income tax consequences of an intra-entity transfer of an asset upon transfer other than inventory, eliminating the current recognition requirement. This ASU is effective for the 2018 annual reporting period including the interim periods ended March 31, 2018 and June 30, 2018. In adopting this ASU, the Company recorded no cumulative-effect adjustment to retained earnings at January 1, 2018. As the U.S. and the consolidated group are in a net operating loss position, no prepaid tax has been recorded.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments, which amends the guidance on measuring credit losses on financial assets (including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an &#8220;incurred loss&#8221; methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this guidance will have a significant impact on our condensed consolidated financial statements and plan to adopt on the effective date.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This replaces the existing standards relating to leases for both lessees and lessors. For lessees, the new standard requires most leases to be recorded on the condensed consolidated balance sheet with expenses recognized much like the existing standard. For lessors, the new standard modifies the classification criteria and accounting for sales-type and direct financing leases and eliminates leveraged leases. For both lessees and lessors, the standard eliminates real estate-specific provisions, changes some of the presentation and disclosure requirements, and changes sale and leaseback criteria. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We are currently assessing the impact this will have on our condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In January, 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Topic 825). This standard requires equity investments, with some exceptions, be measured at fair value with valuation changes recognized in net income, simplifies the impairment assessment of some equity investments, eliminates the requirement to disclose the methods and significant assumptions used to estimate the fair value for financial instruments measured at amortized cost, requires the use of the exit price notion when measuring the fair value of financial instruments, requires separate presentation of some changes in other comprehensive income, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial assets, and clarifies the need for a valuation allowance on some deferred tax assets. The Company adopted this ASU on January 1, 2018, and the adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2018-07, Compensation-Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to Accounting Standards Codification (&#8220;ASC&#8221;) 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We do not anticipate this update will have an effect on our condensed consolidated financial statements because all share-based awards granted to nonemployees are fully vested.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In March 2018, issued ASU 2018-05, Amendments Pursuant to SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) No. 118 (SEC Update), Income Taxes (Topic 740). ASU 2018-05 provides guidance regarding the recording of tax impacts where uncertainty exists, in the period of adoption of the 2017 U.S. Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;). In accordance with this guidance, the Company&#8217;s financial results reflect provisional amounts for those specific income tax effects of the Tax Act for which the accounting under ASC Topic 740 is incomplete but a reasonable estimate could be determined. During the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, the Company did not recognize any changes to the provisional amounts recorded in its 2017 Annual Report on Form 10-K in connection with the Tax Act, as the Company continues to collect the information necessary to complete those calculations. The accounting for the tax effects of the Tax Act will be completed in the second half of 2018.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220) Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI), which allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act that the FASB refers to as having been stranded in AOCI. This ASU is effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2018, with early adoption permitted. The Company is evaluating the impact of the adoption of ASU 2018-02 on our condensed consolidated financial statements, though its effects are not expected to be material.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In March 2017, the FASB issued ASU 2017-08, Receivable-Nonrefundable Fees and Other Costs (Topic 310-20) Premium Amortization on Purchased Callable Debt Securities. This amendment shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. This ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. If an entity early adopts in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently assessing the impact this will have on our condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740) Intra-Entity Transfers of Assets Other Than Inventory. This ASU is effective for periods after December 15, 2017 and eliminates the requirement that the Company recognize the income tax consequences of an intra-entity transfer of an asset upon transfer other than inventory, eliminating the current recognition requirement. This ASU is effective for the 2018 annual reporting period including the interim periods ended March 31, 2018 and June 30, 2018. In adopting this ASU, the Company recorded no cumulative-effect adjustment to retained earnings at January 1, 2018. As the U.S. and the consolidated group are in a net operating loss position, no prepaid tax has been recorded.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments, which amends the guidance on measuring credit losses on financial assets (including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an &#8220;incurred loss&#8221; methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this guidance will have a significant impact on our condensed consolidated financial statements and plan to adopt on the effective date.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This replaces the existing standards relating to leases for both lessees and lessors. For lessees, the new standard requires most leases to be recorded on the condensed consolidated balance sheet with expenses recognized much like the existing standard. For lessors, the new standard modifies the classification criteria and accounting for sales-type and direct financing leases and eliminates leveraged leases. For both lessees and lessors, the standard eliminates real estate-specific provisions, changes some of the presentation and disclosure requirements, and changes sale and leaseback criteria. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We are currently assessing the impact this will have on our condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In January, 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Topic 825). This standard requires equity investments, with some exceptions, be measured at fair value with valuation changes recognized in net income, simplifies the impairment assessment of some equity investments, eliminates the requirement to disclose the methods and significant assumptions used to estimate the fair value for financial instruments measured at amortized cost, requires the use of the exit price notion when measuring the fair value of financial instruments, requires separate presentation of some changes in other comprehensive income, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial assets, and clarifies the need for a valuation allowance on some deferred tax assets. The Company adopted this ASU on January 1, 2018, and the adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes restricted stock unit and restricted stock award activity during the </font><font style="font-family:Arial;font-size:10pt;">six</font><font style="font-family:Arial;font-size:10pt;">-month period ending </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Number of&#160;Shares</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Weighted Average Grant Date Fair Value per Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding January 1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">24,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">26.45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Vested/released</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(8,050</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">26.45</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding June 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">16,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">26.45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Future minimum lease payments under these agreements are as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Year ending December 31:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">896</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 8. PROPERTY AND EQUIPMENT</font></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Property and equipment consisted of the following at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Computer equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,801</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Technical equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,550</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Facilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,620</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,621</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Instruments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,283</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,400</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Capital projects in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12,974</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11,474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Accumulated depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(7,531</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(6,584</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Depreciation expense for the </font><font style="font-family:Arial;font-size:10pt;color:#000000;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial;font-size:10pt;"> was </font><font style="font-family:Arial;font-size:10pt;color:#000000;">$533,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$540,000</font><font style="font-family:Arial;font-size:10pt;">, respectively, and for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> was </font><font style="font-family:Arial;font-size:10pt;">$1.1 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$1.0 million</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Property and Equipment</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from </font><font style="font-family:Arial;font-size:10pt;">one</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">seven years</font><font style="font-family:Arial;font-size:10pt;">. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less. Property and equipment includes diagnostic instruments used for sales demonstrations and instruments under rental agreements. The Company retains title to the instruments under these arrangements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Property and equipment consisted of the following at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Computer equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,801</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Technical equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,550</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Facilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,620</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,621</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Instruments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,283</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,400</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Capital projects in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12,974</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11,474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Accumulated depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(7,531</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(6,584</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 17. RELATED PARTY TRANSACTIONS</font></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As part of the transaction discussed in </font><font style="font-family:Arial;font-size:10pt;">Note 11, Convertible Notes</font><font style="font-family:Arial;font-size:10pt;">, an affiliate of one member of the Company's board of directors purchased an aggregate of </font><font style="font-family:Arial;font-size:10pt;color:#000000;">$30 million</font><font style="font-family:Arial;font-size:10pt;"> of the Notes. The affiliated entity is a Qualified Institutional Buyer which purchased and holds the Notes at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 10. DEFERRED REVENUE, INCOME AND REMAINING PERFORMANCE OBLIGATIONS</font></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred revenue consists of amounts received for products or services not yet delivered or earned. Deferred income consists of amounts received for commitments not yet fulfilled. If we anticipate that the revenue or income will not be earned within the following twelve months, the amount is reported as long-term deferred income. A summary of the balances as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products and services not yet delivered</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Arizona Commerce Authority grant</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred revenue and income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We recognized $</font><font style="font-family:Arial;font-size:10pt;">14,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$35,000</font><font style="font-family:Arial;font-size:10pt;"> of revenues that were included in the contract liabilities balances during the the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, respectively. No material amount of revenue recognized during the period was from performance obligations satisfied in prior periods.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Transaction Price Allocated to Remaining Performance Obligations</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, $</font><font style="font-family:Arial;font-size:10pt;">1.0 million</font><font style="font-family:Arial;font-size:10pt;"> of revenue is expected to be recognized from remaining performance obligations. This balance primarily relates to executed, service contracts that begin as warranty periods expire. These contracts typically provide for </font><font style="font-family:Arial;font-size:10pt;">four</font><font style="font-family:Arial;font-size:10pt;">-year terms and revenue is recognized on a straight-line basis over the contract term.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company elects not to disclose the value of unsatisfied performance obligations for (i) contracts with an expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Revenue Recognition</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Effective January 1, 2018, the Company adopted the requirements of ASC 606, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:Arial;font-size:10pt;">, ("Topic 606") and recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We determine revenue recognition through the following steps:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Identification of the contract with a customer</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Identification of the performance obligations in the contract</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Determination of the transaction price</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Allocation of the transaction price to the performance obligations</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:36px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-36px;"><font style="font-family:Arial;font-size:10pt;">Recognition of revenue as we satisfy a performance obligation</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Service revenue is derived from the sale of extended service agreements which are generally non-cancelable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the price charged to customers for each individual performance obligation.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also provide instruments to customers under bundled rental agreements. Under these agreements, we install the instrument in the customer&#8217;s facility and provide service. The customer agrees to purchase consumable products at a stated price over the term of the agreement, which is typically five years or less. Contracts sometimes have renewal clauses but such clauses do not provide for a bargain renewal option or penalize the customer if they do not renew. The instrument remains the Company&#8217;s property throughout the term of the agreement and there is no transfer of title upon expiration.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our payment terms vary by the type and location of our customers and the product or services offered and typically range between </font><font style="font-family:Arial;font-size:10pt;">30</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">60 days</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the quarter ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company adopted Topic 606 using the modified retrospective method applied to those contracts that were not fully performed by the Company as of January 1, 2018. We recorded a decrease to opening retained earnings and an increase in deferred revenue of </font><font style="font-family:Arial;font-size:10pt;">$49,000</font><font style="font-family:Arial;font-size:10pt;"> as of January 1, 2018 due to the cumulative impact of adopting Topic 606. The impact to revenues for the three and six months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> was not material as a result of applying Topic 606.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shares issuable upon the release of restricted stock awards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shares issuable upon exercise of stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,093</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,328</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,109</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,352</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following tables summarize the Company&#8217;s available-for-sale investments at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Cost</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gains</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Losses</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certificates of deposit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,682</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,682</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(107</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Agency securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7,013</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(69</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,944</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,917</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35,917</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,993</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">33,388</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">33,314</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,842</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">130,594</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Gains</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Losses</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certificates of deposit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,441</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,441</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Treasury securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,787</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">U.S. Agency securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,510</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(51</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,025</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate notes and bonds</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,906</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(70</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31,836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,841</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(193</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Inventories consisted of the following at </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,220</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">842</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Inventory, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,063</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Warranty reserve activity for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Provisions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Warranty expenses incurred</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(122</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(259</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes option activity under all plans during the </font><font style="font-family:Arial;font-size:10pt;">six</font><font style="font-family:Arial;font-size:10pt;">-month period ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Number of&#160;Shares</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price per Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Options Outstanding January 1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">7,328,131</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">10.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,115,371</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">25.45</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(91,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">20.97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(253,621</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">10.87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(5,495</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">23.43</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Options Outstanding June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">8,093,343</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">12.11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table shows summary information for outstanding options and options that are exercisable (vested) as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Options</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Options</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Number of options</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,093,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,689,985</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Weighted average remaining contractual term (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6.18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Weighted average exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Weighted average fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Aggregate intrinsic value (in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">88,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">83,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Expected term (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Expected dividends</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Risk free interest rates</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2.82</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2.02</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Weighted average fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13.53</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">16.80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">ustomers who represented 10%&#160;or more of the Company&#8217;s net accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. The Company had two customers that accounted for </font><font style="font-family:Arial;font-size:10pt;">11%</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">10%</font><font style="font-family:Arial;font-size:10pt;"> of the Company&#8217;s net accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;">, and one Customer that accounted for </font><font style="font-family:Arial;font-size:10pt;">24%</font><font style="font-family:Arial;font-size:10pt;"> of the Company's net accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Customers who represented 10% or more of the Company&#8217;s total revenue for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company C</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company D</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">22%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company E</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">21%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company F</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">19%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company G</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">15%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company H</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">31%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Company I</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">15%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">* Less than 10% for the period indicated</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">NOTE 16. INDUSTRY, GEOGRAPHIC AND REVENUE DISAGGREGATION</font></div><div style="line-height:120%;padding-bottom:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company operates as </font><font style="font-family:Arial;font-size:10pt;">one</font><font style="font-family:Arial;font-size:10pt;"> operating segment. Sales to customers outside the U.S. represented </font><font style="font-family:Arial;font-size:10pt;">28%</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">22%</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;color:#000000;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial;font-size:10pt;">, respectively, and </font><font style="font-family:Arial;font-size:10pt;">27%</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">14%</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As of </font><font style="font-family:Arial;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Arial;font-size:10pt;">, balances due from foreign customers, in U.S. dollars, were </font><font style="font-family:Arial;font-size:10pt;">$864,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$1.0 million</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Primary Geographic Markets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,220</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">544</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,815</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,063</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">472</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">155</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">678</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,692</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Line of Business:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Accelerate Pheno&#8482; revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,665</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">675</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,692</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products and Services:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">695</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,692</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">699</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Lease income included in net sales for the </font><font style="font-family:Arial;font-size:10pt;color:#000000;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial;font-size:10pt;"> was </font><font style="font-family:Arial;font-size:10pt;">$172,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$11,000</font><font style="font-family:Arial;font-size:10pt;">, respectively, and </font><font style="font-family:Arial;font-size:10pt;">$181,000</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$12,000</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, respectively, which does not represent revenues recognized from contracts with customers.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following presents long-lived assets (excluding intangible assets) by geographic territory (in thousands):</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,779</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,233</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Equity-Based Compensation</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company awards stock options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method). We account for forfeitures as they occur rather than on an estimated basis.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company estimates the fair value of stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company records the fair value of restricted stock units or stock grants based on published closing market price on the day before the grant date.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Shipping and Handling</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the consolidated statements of operations and comprehensive loss.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Warranty Reserve</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Instruments are typically sold with a </font><font style="font-family:Arial;font-size:10pt;">one year</font><font style="font-family:Arial;font-size:10pt;"> limited warranty, while kits and accessories are typically sold with a </font><font style="font-family:Arial;font-size:10pt;">60 days</font><font style="font-family:Arial;font-size:10pt;"> limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Accounts Receivable</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Accounts receivable consist of amounts due to the Company for sales to customers and are recorded net of an allowance for doubtful accounts. Allowances on accounts receivable are recorded when circumstances indicate collection is doubtful for a particular accounts receivable. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis. </font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company&#8217;s consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). The preparation of the Company&#8217;s consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventories, property and equipment, intangible assets, accruals, warranty liabilities, tax valuation accounts and stock-based compensation. Actual results could differ materially from those estimates.</font></div></div> EX-101.SCH 6 axdx-20180710.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2116100 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Commitments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Commitments - Operating Lease Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Concentration of Credit Risk link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Concentration of Credit Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Concentration of Credit Risk (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATEDSTATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Convertible Notes link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - Convertible Notes (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Deferred Revenue, Income and Remaining Performance Obligations link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Deferred Revenue, Income and Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Deferred Revenue, Income and Remaining Performance Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Earnings Per Share - (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Employee Equity-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2414406 - Disclosure - Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details) link:presentationLink link:calculationLink link:definitionLink 2414405 - Disclosure - Employee Equity-Based Compensation - Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Employee Equity-Based Compensation - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - Employee Equity-Based Compensation - Stock Option Supplemental Information (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Employee Equity-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Fair Value of Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - FDA Clearance link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2415401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Industry and Geographic Information link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Industry and Geographic Information - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Industry and Geographic Information - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2417404 - Disclosure - Industry and Geographic Information - Long-lived Assets by Geographic Territory (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Industry and Geographic Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Industry and Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Investments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Investments - Schedule of Available-for-Sale Investment Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Investments - Schedule of Available-for-sale Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - License Agreements and Grants link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - License Agreements and Grants - Arizona Commerce Authority and R&D Refundable Tax Credit Program (Details) link:presentationLink link:calculationLink link:definitionLink 2409401 - Disclosure - License Agreements and Grants - National Institute of Health Grant (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Recently Issued Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Related Party Transaction (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 axdx-20180710_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 axdx-20180710_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 axdx-20180710_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Research and Development [Abstract] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Project [Axis] Project [Axis] Project [Domain] Project [Domain] National Institute of Health Grant National Institute of Health Grant [Member] National Institute of Health Grant [Member] Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others, Proposed Period Research and Development Arrangement, Contract to Perform for Others, Proposed Period Research and Development Arrangement, Contract to Perform for Others, Proposed Period Total grant funding Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Cumulative amount awarded Research and Development Arrangement, Contract to Perform for Others, Invoiced Research and Development Arrangement, Contract to Perform for Others, Invoiced Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock Option Activity Share-based Compensation, Stock Options, Activity [Table Text Block] Inputs to Calculate Estimated Fair Value of Options Awarded Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Stock Option Supplemental Information Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity [Table Text Block] Restricted Stock Unit (RSU) Activity Nonvested Restricted Stock Shares Activity [Table Text Block] Equity-Based Compensation Expenses Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Arizona Commerce Authority grant Deferred Credits and Other Liabilities Number of installments Revenue Recognition, Milestone Method, Number Of Milestones Revenue Recognition, Milestone Method, Number Of Milestones Qualified jobs created, milestone 1 Revenue Recognition, Milestone Method, Milestone, Jobs Created, Milestone One Revenue Recognition, Milestone Method, Milestone, Jobs Created, Milestone One Qualified jobs created, milestone 2 Revenue Recognition, Milestone Method, Milestone, Jobs Created, Milestone Two Revenue Recognition, Milestone Method, Milestone, Jobs Created, Milestone Two Qualified jobs created, milestone 3 Revenue Recognition, Milestone Method, Milestone, Jobs Created, Milestone Three Revenue Recognition, Milestone Method, Milestone, Jobs Created, Milestone Three Qualified jobs created, milestone 4 Revenue Recognition, Milestone Method, Milestone, Jobs Created, Milestone Four Revenue Recognition, Milestone Method, Milestone, Jobs Created, Milestone Four Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Capital investment milestone Revenue Recognition, Milestone Method, Milestone, Capital Investment Revenue Recognition, Milestone Method, Milestone, Capital Investment Grant related minimum annual wages Revenue Recognition, Milestone Method, Annual Wages Revenue Recognition, Milestone Method, Annual Wages Percent of company paid premiums Revenue Recognition, Milestone Method, Percent of Company Paid Premiums Revenue Recognition, Milestone Method, Percent of Company Paid Premiums Revenue recognized Deferred Revenue, Revenue Recognized Deferred Revenue Disclosure [Abstract] Deferred Revenue and Income Summary Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Inventory Disclosure [Abstract] Inventory Inventory Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] RSUs and RSAs Restricted Stock Units And Restricted Stock Awards [Member] Restricted Stock Units And Restricted Stock Awards [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Beginning balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Vested/Released (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Ending balance (shares) Weighted Average Grant Date Fair Value per Share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Beginning balance (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Forfeited (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Vested/Released (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Ending balance (dollars per share) Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Computer equipment Computer Equipment [Member] Technical equipment Technology Equipment [Member] Facilities Leaseholds and Leasehold Improvements [Member] Instruments Instruments [Member] Instruments [Member] Capital projects in progress Construction in Progress [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Total property and equipment Property, Plant and Equipment, Gross Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, net Property, Plant and Equipment, Net Depreciation Depreciation, Depletion and Amortization Investments, Debt and Equity Securities [Abstract] Investment [Table] Investment [Table] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Certificates of deposit Certificates of Deposit [Member] U.S. Treasury securities US Treasury and Government [Member] U.S. Agency securities US Government Agencies Debt Securities [Member] Commercial paper Commercial Paper, Not Included with Cash and Cash Equivalents [Member] Asset-backed securities Asset-backed Securities [Member] Corporate notes and bonds Corporate Debt Securities [Member] Investment [Line Items] Investment [Line Items] Amortized Cost Available-for-sale Securities, Amortized Cost Basis Gross Unrealized Gains Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Losses Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Fair Value Available-for-sale Securities Related Party Transactions [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Income Statement [Abstract] Net sales Revenue, Net Cost of sales Cost of Goods Sold Gross profit Gross Profit Costs and expenses: Costs and Expenses [Abstract] Research and development Research and Development Expense Sales, general and administrative General and Administrative Expense Total costs and expenses Costs and Expenses Loss from operations Operating Income (Loss) Other income (expense): Other Nonoperating Income (Expense) [Abstract] Interest expense Interest Expense Foreign currency exchange (loss) Foreign Currency Transaction Gain (Loss), before Tax Interest income Investment Income, Interest and Dividend Other expense, net Other Nonoperating Expense Total other income (expense), net Other Nonoperating Income (Expense) Net loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Provision for income taxes Income Tax Expense (Benefit) Net loss Net Income (Loss) Attributable to Parent Basic and diluted net loss per share (usd per share) Earnings Per Share, Basic and Diluted Weighted average shares outstanding (shares) Weighted Average Number of Shares Outstanding, Basic Other comprehensive loss: Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Net loss Net unrealized (loss) gain on available-for-sale investments Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Earnings Per Share [Abstract] Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Operating Leases Obligations Lessee, Operating Lease, Disclosure [Table Text Block] Income Tax Disclosure [Abstract] Provision for income taxes Pre-tax loss Accounting Policies [Abstract] Schedule of Product Warranty Reserve Activity Schedule of Product Warranty Liability [Table Text Block] Proceeds from sales of marketable securities Proceeds from Sale and Maturity of Available-for-sale Securities Gross realized gains or losses from sales of marketable securities Marketable Securities, Realized Gain (Loss) Property and Equipment Property, Plant and Equipment [Table Text Block] Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Investments Investments Trade accounts receivable Receivables, Net, Current Inventory Inventory, Net Prepaid expenses Prepaid Expense and Other Assets, Current Other current assets Other Assets, Current Total current assets Assets, Current Property and equipment, net Intellectual property, net Finite-Lived Intangible Assets, Net Other non-current assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued liabilities Accounts Payable and Accrued Liabilities, Current Deferred revenue and income Deferred Revenue and Credits Total current liabilities Liabilities, Current Other long term liabilities Other Liabilities, Noncurrent Convertible notes Convertible Debt, Noncurrent Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred shares Preferred Stock, Value, Issued Common stock Common Stock, Value, Outstanding Contributed capital Additional Paid in Capital, Common Stock Treasury Stock Treasury Stock, Value Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total stockholders’ equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders’ equity Liabilities and Equity Risks and Uncertainties [Abstract] Schedule of Customer Concentration Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Components of Inventories Schedule of Inventory, Current [Table Text Block] Earnings Per Share Earnings Per Share [Text Block] Segment Reporting [Abstract] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Long-lived Assets by Geographic Territory Long-lived Assets by Geographic Areas [Table Text Block] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Geographic Distribution [Axis] Geographic Distribution [Axis] Geographic Distribution [Domain] Geographic Distribution [Domain] Domestic Geographic Distribution, Domestic [Member] Foreign Geographic Distribution, Foreign [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Accelerate Pheno™ revenue Accelerate Pheno [Member] Accelerate Pheno [Member] Other revenue Other Revenue [Member] Other Revenue [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Revenue from contracts with customers Revenue from Contract with Customer, Excluding Assessed Tax Products Sales Revenue, Goods, Net Services Sales Revenue, Services, Net Net sales License Agreements and Grants License Agreements and Grants License agreements Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Options Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Number of options (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Weighted average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average exercise price (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average fair value (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Fair Value Aggregate intrinsic value (in thousands) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Options Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] Number of options (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted average exercise price (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted average fair value (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value Aggregate intrinsic value (in thousands) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding, beginning balance (shares) Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Exercised (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Expired (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Outstanding, ending balance (shares) Weighted Average Exercise Price per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price [Abstract] Outstanding, beginning balance (dollars per share) Granted (dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Forfeited (dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Exercised (dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Expired (dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Outstanding, ending balance (dollars per share) Concentration Risk [Table] Concentration Risk [Table] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Financial institution A Financial Institution A [Member] Financial Institution A [Member] Financial institution B Financial Institution B [Member] Financial Institution B [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Cash and cash equivalents Cash and Cash Equivalents [Member] Net accounts receivable Accounts Receivable [Member] Total revenue Sales Revenue, Net [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Concentration of credit risk Credit Concentration Risk [Member] Customer concentration Customer Concentration Risk [Member] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Company A Customer A [Member] Customer A [Member] Company B Customer B [Member] Customer B [Member] Company C Customer C [Member] Customer C [Member] Company D Customer D [Member] Customer D [Member] Company E Customer E [Member] Customer E [Member] Company F Customer F [Member] Customer F [Member] Company G Customer G [Member] Customer G [Member] Company H Customer H [Member] Customer H [Member] Company I Customer I [Member] Customer I [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Risk concentration Concentration Risk, Percentage Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies Business Description and Basis of Presentation [Text Block] Year ending December 31: Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2018 Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2019 Operating Leases, Future Minimum Payments, Due in Two Years 2020 Operating Leases, Future Minimum Payments, Due in Three Years 2021 Operating Leases, Future Minimum Payments, Due in Four Years 2022 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total operating lease obligations Operating Leases, Future Minimum Payments Due Fair Value Disclosures [Abstract] Schedule of Fair Value Measurement Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Property and equipment Property, Plant and Equipment [Member] Geographic concentration Geographic Concentration Risk [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Long-lived assets (excluding intangible assets) Industry and Geographic Information Segment Reporting Disclosure [Text Block] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Title of Individual [Axis] Title of Individual [Axis] Relationship to Entity [Domain] Relationship to Entity [Domain] Director Director [Member] Related Party Transaction [Axis] Related Party Transaction [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Note holder Convertible Note Holder [Member] Convertible Note Holder [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Aggregate principal amount Debt Instrument, Face Amount Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Unsecured obligations Unsecured Debt [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 2.50% Convertible notes due 2023 Two Point Five Zero Convertible Notes due 2023 [Member] Two Point Five Zero Convertible Notes due 2023 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Interest rate Debt Instrument, Interest Rate, Stated Percentage Over-allotment option, percent Over-Allotment Option, Percent Over-Allotment Option, Percent Over-allotment option Over-Allotment Option, Amount Over-Allotment Option, Amount Additional proceeds Proceeds from Over-Allotment Option Proceeds from Over-Allotment Option Proceeds received Proceeds from Issuance of Debt Fair value Long-term Debt, Fair Value Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Beginning balance Standard Product Warranty Accrual Provisions Standard Product Warranty Accrual, Increase for Warranties Issued Warranty expenses incurred Standard Product Warranty Accrual, Decrease for Payments Ending balance Debt Disclosure [Abstract] Convertible Notes Debt Disclosure [Text Block] Concentration of Credit Risk Concentration Risk Disclosure [Text Block] Schedule of Available-for-Sale Investments Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Schedule of Available-For-Sale Investment Maturities Available-for-sale Securities [Table Text Block] Commitments Commitments and Contingencies Disclosure [Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair value on a recurring basis Fair Value, Measurements, Recurring [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Total cash and cash equivalents Money Market Funds [Member] Commercial Paper [Member] Commercial Paper [Member] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash and cash equivalents: Cash and Cash Equivalents, Fair Value Disclosure Investments Total assets measured at fair value Assets, Fair Value Disclosure Deferred Revenue, Income and Remaining Performance Obligations Revenue Recognition, Deferred Revenue [Policy Text Block] Preferred Stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share Preferred Stock, shares authorized (shares) Preferred Stock, Shares Authorized Preferred Stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Common Stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Common Stock, shares authorized (shares) Common Stock, Shares Authorized Common Stock, shares issued (shares) Common Stock, Shares, Issued Common Stock, shares outstanding (shares) Common Stock, Shares, Outstanding Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Maximum Maximum [Member] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Cumulative impact of adopting Topic 606 Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Topic 606 Accounting Standards Update 2014-09 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Estimated useful life of assets Property, Plant and Equipment, Useful Life Instrument warranty term Standard Product Warranty, Instruments, Term Standard Product Warranty, Instruments, Term Kits and accessories warranty term Standard Product Warranty, Kits And Accessories, Term Standard Product Warranty, Kits And Accessories, Term Payment terms Payment Terms Payment Terms Decrease to opening retained earnings Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Long-term debt Long-term Debt [Member] Additional paid-in capital Additional Paid-in Capital [Member] Conversion ratio Debt Instrument, Convertible, Conversion Ratio Conversion multiple Debt Instrument, Convertible, Conversion Principal Multiple Debt Instrument, Convertible, Conversion Principal Multiple Initial conversion price (usd per share) Debt Instrument, Convertible, Conversion Price Long-term debt Long-term Debt, Gross Equity component Adjustments to Additional Paid in Capital, Other Debt issuance costs Debt Issuance Costs, Gross Contractual term Debt Instrument, Term Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Stock price conversion threshold, percentage Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Threshold trading days Debt Instrument, Convertible, Threshold Trading Days Trading price threshold, percentage Debt Instrument, Convertible, Threshold Percentage of Notes Trading Price Trigger Debt Instrument, Convertible, Threshold Percentage of Notes Trading Price Trigger Repurchase principal balance, percent Debt Instrument, Principle Repurchase Percent Debt Instrument, Principle Repurchase Percent Unamortized debt discount Debt Instrument, Unamortized Discount Debt issuance costs, net Debt Issuance Costs, Net Net carrying amount Long-term Debt Interest expense Interest Expense, Debt, Excluding Amortization Accrued interest expense Interest Payable Amortization of debt issuance costs Amortization of Debt Issuance Costs Amortization of the debt discount Amortization of Debt Discount (Premium) Net proceeds from notes to fund Prepaid Forward Debt Proceeds Used to Fund Embedded Derivative Debt Proceeds Used to Fund Embedded Derivative Aggregate number of shares Treasury Stock, Shares, Acquired Employee Equity-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Income Taxes Income Tax Disclosure [Text Block] Amortized Cost Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract] Due in less than 1 year Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis Due in 1-5 years Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis Total Available-for-sale Debt Securities, Amortized Cost Basis Fair Value Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract] Due in less than 1 year Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Due in 1-5 years Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value Total Available-for-sale Securities, Debt Securities Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected dividends Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Risk free interest rates Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Weighted average fair value (dollars per share) Fair Value Inputs, Price Earnings Ratio Multiple Document And Entity Information Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus FDA Clearance Federal Drug Administration Clearance [Text Block] Federal Drug Administration Clearance [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Shares issuable upon the release of restricted stock awards Restricted Stock Units (RSUs) [Member] Shares issuable upon exercise of stock options Employee Stock Option [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive common stock instruments outstanding (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount New Accounting Pronouncements and Changes in Accounting Principles [Abstract] Recently Issued Accounting Pronouncements New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Number of operating segments Number of Operating Segments Lease Income Lease Income Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of sales Cost of Sales [Member] Research and development Research and Development Expense [Member] Sales, general and administrative Selling, General and Administrative Expenses [Member] Capitalized inventory Inventories [Member] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Equity-based compensation expense Allocated Share-based Compensation Expense Unrecognized equity-based compensation cost Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Unrecognized equity-based compensation cost, restricted stock units Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation Depreciation Amortization of intangible assets Amortization of Intangible Assets Amortization of investment discount Investment Income, Net, Amortization of Discount and Premium Equity-based compensation Share-based Compensation Amortization of debt discount and issuance costs Accretion Expense Loss on disposal of property and equipment Gain (Loss) on Disposition of Assets (Increase) decrease in assets: Increase (Decrease) in Operating Assets [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Prepaid expense and other Increase (Decrease) in Prepaid Expense and Other Assets Other current assets Increase (Decrease) in Other Current Assets Other non-current assets Increase (Decrease) in Other Noncurrent Assets Increase (decrease) in liabilities: Increase (Decrease) in Accrued Liabilities [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Interest Payable, Net Increase (Decrease) in Interest Payable, Net Deferred revenue and income Increase (Decrease) in Deferred Revenue Deferred compensation Increase (Decrease) in Deferred Compensation Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of equipment Payments to Acquire Productive Assets Purchases of available-for-sale securities Payments to Acquire Marketable Securities Sales of available-for-sale securities Maturity of available-for-sale securities Proceeds from Sale and Maturity of Marketable Securities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Issuance of common stock net of issuance costs Proceeds from Issuance of Common Stock Exercise of options and warrants Proceeds from Stock Options and Warrants Exercised Proceeds from Stock Options and Warrants Exercised Proceeds from issuance of convertible note Proceeds from Convertible Debt Prepayment of forward stock repurchase transaction Payments for Repurchase of Common Stock Payment of debt issuance costs Payments of Debt Issuance Costs Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate on cash: Effect of Exchange Rate on Cash and Cash Equivalents Increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Non-cash investing activities: Noncash Investing and Financing Items [Abstract] Transfer of instruments from inventory to property and equipment Inventory Transferred to Fixed Assets Inventory Transferred to Fixed Assets Rent expense Operating Leases, Rent Expense Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventory, net Products and services not yet delivered Deferred Revenue, Current Arizona Commerce Authority grant Deferred Credits and Other Liabilities, Current Deferred revenue and income Revenues recognized included in contract liabilities balances Contract with Customer, Liability, Revenue Recognized Revenue expected to be recognized from remaining performance obligations Revenue, Remaining Performance Obligation Contact period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Estimated Fair Value of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Investments Investment, Policy [Policy Text Block] Inventory Inventory, Policy [Policy Text Block] Accounts Receivable Trade and Other Accounts Receivable, Policy [Policy Text Block] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Long-lived Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Warranty Reserve Standard Product Warranty, Policy [Policy Text Block] Convertible Notes Debt, Policy [Policy Text Block] Revenue Revenue Recognition, Policy [Policy Text Block] Cost of Sales Cost of Sales, Policy [Policy Text Block] Shipping and Handling Shipping and Handling Cost, Policy [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Equity-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Income Taxes and Deferred Tax Assets Income Tax, Policy [Policy Text Block] Foreign Currency Translation and Foreign Currency Transactions Foreign Currency Transactions and Translations Policy [Policy Text Block] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] EX-101.PRE 10 axdx-20180710_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2018
Aug. 03, 2018
Document And Entity Information    
Entity Registrant Name Accelerate Diagnostics, Inc.  
Entity Central Index Key 0000727207  
Document Type 10-Q  
Document Period End Date Jun. 30, 2018  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   54,127,990
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2018  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 66,810 $ 28,513
Investments 130,594 80,648
Trade accounts receivable 1,823 1,946
Inventory 11,317 8,063
Prepaid expenses 1,421 850
Other current assets 643 468
Total current assets 212,608 120,488
Property and equipment, net 5,443 4,890
Intellectual property, net 124 134
Other non-current assets 78 0
Total assets 218,253 125,512
Current liabilities:    
Accounts payable 2,355 2,080
Accrued liabilities 5,302 3,636
Deferred revenue and income 185 1,071
Total current liabilities 7,842 6,787
Other long term liabilities 26 21
Convertible notes 115,499 0
Total liabilities 123,367 6,808
Commitments and contingencies
Stockholders’ equity:    
Preferred shares 0 0
Common stock 54 56
Contributed capital 426,091 360,620
Treasury Stock (45,067) 0
Accumulated deficit (286,058) (241,972)
Accumulated other comprehensive loss (134) 0
Total stockholders’ equity 94,886 118,704
Total liabilities and stockholders’ equity $ 218,253 $ 125,512
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) - $ / shares
Jun. 30, 2018
Dec. 31, 2017
Statement of Financial Position [Abstract]    
Preferred Stock, par value (usd per share) $ 0.001 $ 0.001
Preferred Stock, shares authorized (shares) 5,000,000 5,000,000
Preferred Stock, shares outstanding (shares) 0 0
Common Stock, par value (usd per share) $ 0.001 $ 0.001
Common Stock, shares authorized (shares) 75,000,000 75,000,000
Common Stock, shares issued (shares) 54,090,575 55,673,810
Common Stock, shares outstanding (shares) 54,090,575 55,673,810
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATEDSTATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Net sales $ 1,692 $ 699 $ 2,493 $ 1,230
Cost of sales 717 135 1,210 161
Gross profit 975 564 1,283 1,069
Costs and expenses:        
Research and development 6,060 5,527 12,842 9,815
Sales, general and administrative 15,330 11,460 29,682 21,988
Total costs and expenses 21,390 16,987 42,524 31,803
Loss from operations (20,415) (16,423) (41,241) (30,734)
Other income (expense):        
Interest expense (3,205) 0 (3,363) 0
Foreign currency exchange (loss) (253) (7) (198) (33)
Interest income 774 153 1,075 290
Other expense, net (25) (5) (25) (5)
Total other income (expense), net (2,709) 141 (2,511) 252
Net loss before income taxes (23,124) (16,282) (43,752) (30,482)
Provision for income taxes (101) (175) (285) (175)
Net loss $ (23,225) $ (16,457) $ (44,037) $ (30,657)
Basic and diluted net loss per share (usd per share) $ (0.43) $ (0.31) $ (0.80) $ (0.58)
Weighted average shares outstanding (shares) 54,003 53,568 54,821 52,732
Other comprehensive loss:        
Net loss $ (23,225) $ (16,457) $ (44,037) $ (30,657)
Net unrealized (loss) gain on available-for-sale investments (2) 3 (55) 3
Foreign currency translation adjustment (191) 204 (79) 204
Comprehensive loss $ (23,418) $ (16,250) $ (44,171) $ (30,450)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (44,037) $ (30,657)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,072 1,045
Amortization of intangible assets 10 6
Amortization of investment discount (146) 219
Equity-based compensation 9,011 7,450
Amortization of debt discount and issuance costs 2,273 0
Loss on disposal of property and equipment 266 5
(Increase) decrease in assets:    
Accounts receivable 123 (648)
Inventory (4,334) (5,537)
Prepaid expense and other (444) (624)
Other current assets (175) (313)
Other non-current assets (78) 0
Increase (decrease) in liabilities:    
Accounts payable 206 528
Accrued liabilities 661 392
Increase (Decrease) in Interest Payable, Net 1,105 0
Deferred revenue and income (935) 43
Deferred compensation 5 0
Net cash used in operating activities (35,417) (28,091)
Cash flows from investing activities:    
Purchases of equipment (702) (1,643)
Purchases of available-for-sale securities (91,272) (39,342)
Sales of available-for-sale securities 3,000 6,522
Maturity of available-for-sale securities 38,272 18,449
Net cash used in investing activities (50,702) (16,014)
Cash flows from financing activities:    
Issuance of common stock net of issuance costs 276 83,854
Exercise of options and warrants 2,757 3,418
Proceeds from issuance of convertible note 171,499 0
Prepayment of forward stock repurchase transaction (45,069) 0
Payment of debt issuance costs (4,991) 0
Net cash provided by financing activities 124,472 87,272
Effect of exchange rate on cash: (56) 198
Increase in cash and cash equivalents 38,297 43,365
Cash and cash equivalents, beginning of period 28,513 19,244
Cash and cash equivalents, end of period 66,810 62,609
Non-cash investing activities:    
Transfer of instruments from inventory to property and equipment $ 1,196 $ 0
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies
NOTE 1. ORGANIZATION AND NATURE OF BUSINESS; BASIS OF PRESENTATION; PRINCIPLES OF CONSOLIDATION; SIGNIFICANT ACCOUNTING POLICIES

Accelerate Diagnostics, Inc. (“we” or “us” or “our” or “Accelerate” or “the Company”) is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, as filed with the SEC on March 1, 2018.

The condensed consolidated balance sheet as of December 31, 2017 included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.

The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending December 31, 2018, or any future period.

All amounts are rounded to the nearest thousand dollars unless otherwise indicated.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.

Use of Estimates

The Company’s consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of the Company’s consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventories, property and equipment, intangible assets, accruals, warranty liabilities, tax valuation accounts and stock-based compensation. Actual results could differ materially from those estimates.

Estimated Fair Value of Financial Instruments

The Company follows ASC Topic 820, Fair Value Measurements and Disclosures which has defined fair value and requires the Company to establish a framework for measuring fair value and disclose fair value measurements. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:

•
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

•
Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

•
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, accounts payable, accrued liabilities, and other liabilities approximate the related fair values due to the short-term maturities of these instruments.

Cash and Cash Equivalents

All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe however, that the market risk arising from holding these financial instruments is minimal.

Investments

The Company invests excess funds in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificate of deposits, debt securities in U.S. government and agency securities, commercial paper, asset-backed securities and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive income (loss), a component of stockholders’ equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.

The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment’s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive income (loss).

Inventory

The Company writes down its inventory for estimated obsolescence or in an amount equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, market conditions and, where applicable, product expiration.

Accounts Receivable

Accounts receivable consist of amounts due to the Company for sales to customers and are recorded net of an allowance for doubtful accounts. Allowances on accounts receivable are recorded when circumstances indicate collection is doubtful for a particular accounts receivable. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis.

The Company has not included an allowance for doubtful accounts as of June 30, 2018 and December 31, 2017, due to no circumstances arising that would indicate collection of any particular or grouping of customer accounts receivable is doubtful.

Property and Equipment

Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from one to seven years. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less. Property and equipment includes diagnostic instruments used for sales demonstrations and instruments under rental agreements. The Company retains title to the instruments under these arrangements.

Long-lived Assets

Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.

Warranty Reserve

Instruments are typically sold with a one year limited warranty, while kits and accessories are typically sold with a 60 days limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.

Warranty reserve activity for the three and six months ended June 30, 2018 and 2017 is as follows (in thousands):
 
Three Months Ended
Six Months Ended
 
June 30,
June 30,
June 30,
June 30,
 
2018
2017
2018
2017
Beginning balance
$
176

$
31

$
192

$
1

Provisions
145

50

266

80

Warranty expenses incurred
(122
)
(20
)
(259
)
(20
)
Ending balance
$
199

$
61

$
199

$
61



Convertible Notes

The Company issued convertible notes that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.

Revenue Recognition

Effective January 1, 2018, the Company adopted the requirements of ASC 606, Revenue from Contracts with Customers, ("Topic 606") and recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.

We determine revenue recognition through the following steps:

•
Identification of the contract with a customer

•
Identification of the performance obligations in the contract

•
Determination of the transaction price

•
Allocation of the transaction price to the performance obligations

•
Recognition of revenue as we satisfy a performance obligation

Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized.

Service revenue is derived from the sale of extended service agreements which are generally non-cancelable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.

Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the price charged to customers for each individual performance obligation.

We also provide instruments to customers under bundled rental agreements. Under these agreements, we install the instrument in the customer’s facility and provide service. The customer agrees to purchase consumable products at a stated price over the term of the agreement, which is typically five years or less. Contracts sometimes have renewal clauses but such clauses do not provide for a bargain renewal option or penalize the customer if they do not renew. The instrument remains the Company’s property throughout the term of the agreement and there is no transfer of title upon expiration.

Our payment terms vary by the type and location of our customers and the product or services offered and typically range between 30 and 60 days.

Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the quarter ended June 30, 2018.

The Company adopted Topic 606 using the modified retrospective method applied to those contracts that were not fully performed by the Company as of January 1, 2018. We recorded a decrease to opening retained earnings and an increase in deferred revenue of $49,000 as of January 1, 2018 due to the cumulative impact of adopting Topic 606. The impact to revenues for the three and six months ended June 30, 2018 was not material as a result of applying Topic 606.  The reported results for 2017 and prior were prepared and are presented under the guidance of ASC 605, Revenue Recognition.

Cost of Sales

Cost of sales consists of raw materials, depreciation, direct labor and stock-based compensation expense, manufacturing overhead, facility costs and warranty costs.

Shipping and Handling

Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the consolidated statements of operations and comprehensive loss.

Leases

The Company accounts for leases in accordance with ASC 840, Leases, which requires leases to be classified as either operating or capital leases. In general, the Company classifies leases as capital leases when there is either a transfer of ownership at the end of the lease term, the lease contains a bargain purchase option, the lease term is seventy-five percent or more of the estimated economic life of the leased property or the minimum lease payments are ninety percent or more of the fair value of the leased property at lease inception. Other leases are classified as operating leases.

Operating lease rent is recorded as an operating expense on a monthly basis. For capital leases, both an asset and liability are recorded at the inception of the lease based on the present value of lease payments. The asset is included with property and equipment on the condensed consolidated balance sheet and amortization is recorded on a straight-line basis over the term of the lease with the amortization expense included with depreciation on the statements of operations and comprehensive loss. For the liability, the amount due within the next year is recorded as a current liability and the amount due in more than a year is recorded as a long-term liability on the condensed consolidated balance sheet. Interest expense is recorded based on the implicit or explicit interest rate used in the lease and is included as non-operating interest expense on the statements of operations and comprehensive loss. As of June 30, 2018 and December 31, 2017, the Company did not carry any capital leases.

Equity-Based Compensation

The Company awards stock options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method). We account for forfeitures as they occur rather than on an estimated basis.

The Company estimates the fair value of stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.

The Company records the fair value of restricted stock units or stock grants based on published closing market price on the day before the grant date.

Income Taxes and Deferred Tax Assets

Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying condensed consolidated balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.

The Company follows the provisions of ASC 740, Income Taxes, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit the taxpayer must determine it is more likely than not certain that its tax position will be sustained, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.

Foreign Currency Translation and Foreign Currency Transactions

The Company follows ASC 830 Foreign Currency Matters, which provides guidance on foreign currency transactions and translation of financial statements. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in the consolidated statements of stockholders’ equity.

The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.

Earnings Per Share

Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share are computed similarly to basic earnings (loss) per share except the denominator includes additional common shares that would have been outstanding if notes convertible at the balance sheet date were converted and share-based payments had been issued. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Recently Issued Accounting Pronouncements
 6 Months Ended
Jun. 30, 2018
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
Recently Issued Accounting Pronouncements
NOTE 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-07, Compensation-Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to Accounting Standards Codification (“ASC”) 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We do not anticipate this update will have an effect on our condensed consolidated financial statements because all share-based awards granted to nonemployees are fully vested.
In March 2018, issued ASU 2018-05, Amendments Pursuant to SEC Staff Accounting Bulletin (“SAB”) No. 118 (SEC Update), Income Taxes (Topic 740). ASU 2018-05 provides guidance regarding the recording of tax impacts where uncertainty exists, in the period of adoption of the 2017 U.S. Tax Cuts and Jobs Act (the “Tax Act”). In accordance with this guidance, the Company’s financial results reflect provisional amounts for those specific income tax effects of the Tax Act for which the accounting under ASC Topic 740 is incomplete but a reasonable estimate could be determined. During the six months ended June 30, 2018, the Company did not recognize any changes to the provisional amounts recorded in its 2017 Annual Report on Form 10-K in connection with the Tax Act, as the Company continues to collect the information necessary to complete those calculations. The accounting for the tax effects of the Tax Act will be completed in the second half of 2018.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220) Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI), which allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act that the FASB refers to as having been stranded in AOCI. This ASU is effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2018, with early adoption permitted. The Company is evaluating the impact of the adoption of ASU 2018-02 on our condensed consolidated financial statements, though its effects are not expected to be material.

In March 2017, the FASB issued ASU 2017-08, Receivable-Nonrefundable Fees and Other Costs (Topic 310-20) Premium Amortization on Purchased Callable Debt Securities. This amendment shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. This ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. If an entity early adopts in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently assessing the impact this will have on our condensed consolidated financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740) Intra-Entity Transfers of Assets Other Than Inventory. This ASU is effective for periods after December 15, 2017 and eliminates the requirement that the Company recognize the income tax consequences of an intra-entity transfer of an asset upon transfer other than inventory, eliminating the current recognition requirement. This ASU is effective for the 2018 annual reporting period including the interim periods ended March 31, 2018 and June 30, 2018. In adopting this ASU, the Company recorded no cumulative-effect adjustment to retained earnings at January 1, 2018. As the U.S. and the consolidated group are in a net operating loss position, no prepaid tax has been recorded.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments, which amends the guidance on measuring credit losses on financial assets (including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an “incurred loss” methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this guidance will have a significant impact on our condensed consolidated financial statements and plan to adopt on the effective date.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This replaces the existing standards relating to leases for both lessees and lessors. For lessees, the new standard requires most leases to be recorded on the condensed consolidated balance sheet with expenses recognized much like the existing standard. For lessors, the new standard modifies the classification criteria and accounting for sales-type and direct financing leases and eliminates leveraged leases. For both lessees and lessors, the standard eliminates real estate-specific provisions, changes some of the presentation and disclosure requirements, and changes sale and leaseback criteria. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We are currently assessing the impact this will have on our condensed consolidated financial statements.

In January, 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Topic 825). This standard requires equity investments, with some exceptions, be measured at fair value with valuation changes recognized in net income, simplifies the impairment assessment of some equity investments, eliminates the requirement to disclose the methods and significant assumptions used to estimate the fair value for financial instruments measured at amortized cost, requires the use of the exit price notion when measuring the fair value of financial instruments, requires separate presentation of some changes in other comprehensive income, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial assets, and clarifies the need for a valuation allowance on some deferred tax assets. The Company adopted this ASU on January 1, 2018, and the adoption did not have a material impact on the Company’s consolidated financial statements.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
FDA Clearance
 6 Months Ended
Jun. 30, 2018
Research and Development [Abstract]  
FDA Clearance
NOTE 3. FDA CLEARANCE

On February 23, 2017, the U.S. Food and Drug Administration (“FDA”) granted Accelerate’s de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples.

Due to various factors, the Company manufactured inventory in advance of regulatory approval (“pre-launch inventory”). On January 1, 2017, the regulatory review process had progressed to a point that objective and persuasive evidence of approval was sufficiently probable, and a future economic benefit existed. On January 1, 2017, the Company started capitalizing pre-launch inventory.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments
 6 Months Ended
Jun. 30, 2018
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
NOTE 4. FAIR VALUE OF FINANCIAL INSTRUMENTS

The following tables represent the financial instruments measured at fair value on a recurring basis on the financial statements of the Company and the valuation approach applied to each class of financial instruments at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
37,824

$
—

$
—

$
37,824

Commercial paper
—

5,982

—

5,982

Corporate notes and bonds
—

9,087

—

9,087

Total cash and cash equivalents
$
37,824

$
15,069

$
—

$
52,893

Investments:
 
 
 
 
Certificates of deposit
—

13,682

—

13,682

U.S. Treasury securities
31,744

—

—

31,744

U.S. Agency securities
—

6,944

—

6,944

Commercial paper
—

35,917

—

35,917

Asset-backed securities
—

8,993

—

8,993

Corporate notes and bonds
—

33,314

—

33,314

Total investments
31,744

98,850

—

130,594

Total assets measured at fair value
$
69,568

$
113,919

$
—

$
183,487


 
December 31, 2017
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
7,832

$
—

$
—

$
7,832

Investments:
 
 
 
 
Certificates of deposit
—

13,441

—

13,441

U.S. Treasury securities
14,716

—

—

14,716

U.S. Agency securities
—

8,459

—

8,459

Commercial paper
—

9,171

—

9,171

Asset-backed securities
—

3,025

—

3,025

Corporate notes and bonds
—

31,836

—

31,836

Total investments
14,716

65,932

—

80,648

Total assets measured at fair value
$
22,548

$
65,932

$
—

$
88,480



Highly liquid investments with an original maturity of three months or less at time of purchase are are included in cash and cash equivalents on the condensed consolidated balance sheet.

Level 1 assets are priced using quoted prices in active markets for identical assets which include money market funds and U.S. Treasury securities as these specific assets are liquid.

Level 2 available-for-sale securities are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. The Company uses inputs such as actual trade data, benchmark yields, broker/dealer quotes, and other similar data, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets and liabilities. The Company uses such pricing data as the primary input to make its assessments and determinations as to the ultimate valuation of its investment portfolio and has not made, during the periods presented, any material adjustments to such inputs. There were no transfers between levels during the six months ended June 30, 2018.

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Convertible Notes due 2023 (“Notes”). The arrangement provided for a 15% $22.5 million overallotment option to purchase additional Notes 13 days following the execution of the purchase agreement. On April 6, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million, as described in Note 11, Convertible Notes. The calculated fair value of the Notes, of $159.0 million, is highly correlated to the Company’s stock price and as a result, significant changes to the Company’s stock price will have a significant impact on the calculated fair value of the Notes. The fair value of the Notes are classified as Level 2 within the fair value hierarchy.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Concentration of Credit Risk
 6 Months Ended
Jun. 30, 2018
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk
NOTE 5. CONCENTRATION OF CREDIT RISK

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable, including receivables from major customers.

The Company has financial institutions for banking operations that hold 10% or more of the of the Company’s cash and cash equivalents. As of June 30, 2018, two of the Company's financial institutions held 58% and 28% of the Company’s cash and cash equivalents, respectively. As of December 31, 2017, two of the Company's financial institutions held 82% and 12% of the Company’s cash and cash equivalents, respectively.

The Company grants credit to domestic and international clients in various industries. Exposure to losses on accounts receivable is principally dependent on each client's financial position. The Company has customers who represented 10% or more of the Company’s net accounts receivable balance as of June 30, 2018 and December 31, 2017. The Company had two customers that accounted for 11% and 10% of the Company’s net accounts receivable balance as of June 30, 2018, and one Customer that accounted for 24% of the Company's net accounts receivable balance as of December 31, 2017.

Customers who represented 10% or more of the Company’s total revenue for the three and six months ended June 30, 2018 and 2017 were as follows:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2018
2017
 
2018
2017
Company A
13%
*
 
*
*
Company B
12%
*
 
*
*
Company C
11%
*
 
*
*
Company D
*
22%
 
*
13%
Company E
*
21%
 
*
12%
Company F
*
19%
 
*
11%
Company G
*
15%
 
*
*
Company H
*
*
 
*
31%
Company I
*
*
 
*
15%

* Less than 10% for the period indicated
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments
 6 Months Ended
Jun. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Investments
NOTE 6. INVESTMENTS

The following tables summarize the Company’s available-for-sale investments at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
13,682

$
—

$
—

$
13,682

U.S. Treasury securities
31,850

1

(107
)
31,744

U.S. Agency securities
7,013

—

(69
)
6,944

Commercial paper
35,917

—

—

35,917

Asset-backed securities
8,992

2

(1
)
8,993

Corporate notes and bonds
33,388

1

(75
)
33,314

Total
$
130,842

$
4

$
(252
)
$
130,594


 
December 31, 2017
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
13,441

$
—

$
—

$
13,441

U.S. Treasury securities
14,787

—

(71
)
14,716

U.S. Agency securities
8,510

—

(51
)
8,459

Commercial paper
9,171

—

—

9,171

Asset-backed securities
3,026

—

(1
)
3,025

Corporate notes and bonds
31,906

—

(70
)
31,836

Total
$
80,841

$
—

$
(193
)
$
80,648



The following table summarizes the maturities of the Company’s available-for-sale securities at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
December 31, 2017
 
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due in less than 1 year
$
95,448

$
95,312

$
55,801

$
55,735

Due in 1-5 years
35,394

35,282

25,040

24,913

Total
$
130,842

$
130,594

$
80,841

$
80,648



Proceeds from sales of marketable securities (including principal paydowns), for the three months ended June 30, 2018 and 2017 were $0 and $6.5 million, respectively, and for the six months ended June 30, 2018 and 2017 were $3.0 million and $6.5 million, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were no realized gains from sales of marketable securities for the three and six months June 30, 2018 and 2017. No balances were reclassified out of accumulated other comprehensive income (loss) for the three and six months June 30, 2018 and 2017.

No other-than-temporary impairments are recorded as no material investments had a fair value that remained less than its cost for more than twelve months as of those dates. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventory
 6 Months Ended
Jun. 30, 2018
Inventory Disclosure [Abstract]  
Inventory
NOTE 7. INVENTORY

Inventories consisted of the following at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30,
December 31,
 
2018
2017
Raw materials
$
5,101

$
4,220

Work in process
842

377

Finished goods
5,374

3,466

Inventory, net
$
11,317

$
8,063
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment
 6 Months Ended
Jun. 30, 2018
Property, Plant and Equipment [Abstract]  
Property and Equipment
NOTE 8. PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30,
December 31,
 
2018
2017
Computer equipment
$
2,801

$
2,756

Technical equipment
3,550

3,348

Facilities
3,620

3,621

Instruments
2,283

1,400

Capital projects in progress
720

349

Total property and equipment
$
12,974

$
11,474

Accumulated depreciation
(7,531
)
(6,584
)
Property and equipment, net
$
5,443

$
4,890



Depreciation expense for the three months ended June 30, 2018 and 2017 was $533,000 and $540,000, respectively, and for the six months ended June 30, 2018 and 2017 was $1.1 million and $1.0 million, respectively.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
License Agreements and Grants
 6 Months Ended
Jun. 30, 2018
Research and Development [Abstract]  
License Agreements and Grants
NOTE 9. LICENSE AGREEMENTS AND GRANTS

National Institute of Health Grant

In February 2015, the National Institute of Health awarded Denver Health and the Company a five-year, $5.0 million grant to develop a fast and reliable identification and categorical susceptibility test for carbepenem-resistant Enterobacteriaceae directly from whole blood. The cumulative amount awarded to date under these subawards is $1.1 million. The amounts invoiced for the three months ended June 30, 2018 and 2017 were $38,000 and $0, respectively, and for the six months ended June 30, 2018 and 2017 were $98,000 and $3,000, respectively.

Arizona Commerce Authority

In August 2012, the Company entered into a Grant Agreement (the “Grant Agreement”) with the Arizona Commerce Authority, an agency of the State of Arizona (the “Authority”), pursuant to which the Authority provided certain state and county sponsored incentives for the Company relocating its corporate headquarters to, and expanding its business within, the State of Arizona (the “Project”). Pursuant to the Grant Agreement, the Authority provided a total grant in the amount of $1.0 million (the “Grant”). The Grant was paid in four installments, upon the achievement of the following milestones:

•
Milestone 1 – Relocation of Company’s operations and corporate headquarters to Arizona and creation of 15 Qualified Jobs (as defined below).

•
Milestone 2 – Creation of 30 Qualified Jobs (including Qualified Jobs under Milestone 1).

•
Milestone 3 – Creation of 40 Qualified Jobs (including Qualified Jobs under Milestones 1 and 2).

•
Milestone 4 – Creation of 65 Qualified Jobs (including Qualified Jobs under Milestones 1, 2 and 3) and capital investment of at least $4.5 million.

For purposes of the Grant Agreement, a “Qualified Job” was a job which was permanent, full-time, new to Arizona and for which the Company paid an average annual wage of at least $63,000 and included health insurance benefits, for which the Company paid at least 65% of the premiums. The Grant Agreement also contained other customary provisions, including representations, warranties and covenants of both parties. As of December 31, 2017, the full amount was collected and recorded in current deferred revenue and income.

In January 2018, the full amount was recognized due to the economic development provisions of the grant being satisfied in full, and the “claw-back” provisions expiring. The $1.0 million was recognized as an offset to expense. Further details are included in Note 10, Deferred Revenue, Income and Remaining Performance Obligations.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Deferred Revenue, Income and Remaining Performance Obligations
 6 Months Ended
Jun. 30, 2018
Deferred Revenue Disclosure [Abstract]  
Deferred Revenue, Income and Remaining Performance Obligations
NOTE 10. DEFERRED REVENUE, INCOME AND REMAINING PERFORMANCE OBLIGATIONS

Deferred revenue consists of amounts received for products or services not yet delivered or earned. Deferred income consists of amounts received for commitments not yet fulfilled. If we anticipate that the revenue or income will not be earned within the following twelve months, the amount is reported as long-term deferred income. A summary of the balances as of June 30, 2018 and December 31, 2017 follows (in thousands):
 
June 30,
December 31,
 
2018
2017
Products and services not yet delivered
$
185

$
71

Arizona Commerce Authority grant
—

1,000

Deferred revenue and income
$
185

$
1,071



We recognized $14,000 and $35,000 of revenues that were included in the contract liabilities balances during the the three and six months ended June 30, 2018, respectively. No material amount of revenue recognized during the period was from performance obligations satisfied in prior periods.
Transaction Price Allocated to Remaining Performance Obligations
As of June 30, 2018, $1.0 million of revenue is expected to be recognized from remaining performance obligations. This balance primarily relates to executed, service contracts that begin as warranty periods expire. These contracts typically provide for four-year terms and revenue is recognized on a straight-line basis over the contract term.
The Company elects not to disclose the value of unsatisfied performance obligations for (i) contracts with an expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Convertible Notes
 6 Months Ended
Jun. 30, 2018
Debt Disclosure [Abstract]  
Convertible Notes
NOTE 11. CONVERTIBLE NOTES

On March 27, 2018, the Company issued $150.0 million aggregate principal amount of 2.50% Convertible Notes due 2023. The arrangement provided for a 15% $22.5 million overallotment option to purchase additional Notes 13 days following the execution of the purchase agreement. On April 6, 2018 the option was partially exercised, which resulted in $21.5 million of additional proceeds, for total proceeds of $171.5 million. The Notes are the Company's senior unsecured obligations and mature on March 15, 2023 (the “Maturity Date”), unless earlier repurchased or converted into shares of common stock under certain circumstances described below. The Notes are convertible into shares of the Company’s common stock, can be repurchased for cash, or a combination thereof, at the Company’s election, at an initial conversion rate of 32.343 shares of common stock per $1,000 principal amount of the Notes, which is equivalent to an initial conversion price of approximately $30.92 per share of common stock, subject to adjustment. The Company will pay interest on the Notes semi-annually in arrears on March 15 and September 15 of each year.

The $171.5 million of proceeds received from the issuance of the Notes were allocated between long-term debt (the “liability component”) of $116.6 million and contributed capital (the “equity component”) of $54.9 million. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature. The carrying amount of the equity component, representing the conversion option, was determined by deducting the fair value of the liability component from the aggregate face value of the Notes. The liability component will be accreted up to the face value of the Notes of $171.5 million, which will result in additional non-cash interest expense being recognized through the Maturity Date. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.

The Company incurred approximately $5.0 million of issuance costs related to the issuance of the Notes, of which $3.4 million and $1.6 million were recorded to long-term debt and contributed capital, respectively. The $3.4 million of issuance costs recorded as long-term debt on the condensed consolidated balance sheet are being amortized over the five-year contractual term of the Notes using the effective interest method. The effective interest rate on the Notes, including accretion of the Notes to par and debt issuance cost amortization, is 11.52%.

The Notes include customary terms and covenants, including certain events of default upon which the Notes may be due and payable immediately. Holders have the option to convert the Notes in multiples of $1,000 principal amount at any time prior to December 15, 2022, but only in the following circumstances:

•
if the Company’s stock price exceeds 130% of the conversion price for 20 of the last 30 trading days of any calendar quarter after June 30, 2018;

•
during the 5 business day period after any 5 consecutive trading day period in which the Notes’ trading price is less than 98% of the product of the common stock price times the conversion rate; or

•
the occurrence of certain corporate events, such as a change of control, merger or liquidation.

At any time on or after December 15, 2022, a holder may convert its Notes in multiples of $1,000 principal amount. Holders of the Notes who convert their Notes in connection with a make-whole fundamental change (as defined in the Indenture pursuant to which the Notes were issued) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change or event of default prior to the Maturity Date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date.

As of June 30, 2018, the outstanding principal amount on the Notes was $171.5 million, the unamortized debt discount was $52.7 million, the unamortized debt issuance cost was $3.3 million and the net carrying amount of the liability component was $115.5 million, which was recorded as convertible notes within the condensed consolidated balance sheet. The Company recorded interest expense of $1.1 million for contractual coupon interest for the six months ended months ended June 30, 2018, which is also recorded as accrued interest expense as of June 30, 2018. The Company also recorded $126,000 and $132,000 for amortization of debt issuance costs for the three and six months ended June 30, 2018, respectively, and $2.0 million and $2.1 million for amortization of the debt discount for the three and six months ended June 30, 2018, respectively. As of June 30, 2018, no Notes were convertible pursuant to their terms.

In connection with the debt issuance, the Company entered into a prepaid forward stock repurchase transaction (“Prepaid Forward”) with a financial institution (“Forward Counterparty”). Pursuant to the Prepaid Forward, the Company used approximately $45.1 million of the net proceeds from its issuance of the Notes to fund the Prepaid Forward. The aggregate number of shares of the Company’s common stock underlying the Prepaid Forward was approximately 1,858,500. The expiration date for the Prepaid Forward is March 15, 2023, although it may be settled earlier in whole or in part. Upon settlement of the Prepaid Forward, at expiration or upon any early settlement, the Forward Counterparty will deliver to the Company the number of shares of common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward are treated as treasury stock and not outstanding for purposes of the calculation of basic and diluted earnings per share, but will remain outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company. The Company’s Prepaid Forward hedge transaction exposes the Company to credit risk to the extent that its counterparty may be unable to meet the terms of the transaction. The Company mitigates this risk by limiting its counterparty to a major financial institution.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share
 6 Months Ended
Jun. 30, 2018
Earnings Per Share [Abstract]  
Earnings Per Share
NOTE 12. EARNINGS PER SHARE

Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share are the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive due to the Company’s losses.
The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses at June 30, 2018 and December 31, 2017 (in thousands):
 
June 30,
December 31,
 
2018
2017
Shares issuable upon the release of restricted stock awards
16

24

Shares issuable upon exercise of stock options
8,093

7,328

 
8,109

7,352
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Equity-Based Compensation
 6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Employee Equity-Based Compensation
NOTE 13. EMPLOYEE EQUITY-BASED COMPENSATION

The following table summarizes option activity under all plans during the six-month period ended June 30, 2018:

 
Number of Shares
Weighted Average Exercise Price per Share
Options Outstanding January 1, 2018
7,328,131

$
10.16

Granted
1,115,371

25.45

Forfeited
(91,043
)
20.97

Exercised
(253,621
)
10.87

Expired
(5,495
)
23.43

Options Outstanding June 30, 2018
8,093,343

12.11



The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:

 
Three Months Ended
 
June 30,
June 30,
 
2018
2017
Expected term (in years)
6.06

6.12

Volatility
64
%
75
%
Expected dividends
—

—

Risk free interest rates
2.82
%
2.02
%
Weighted average fair value
$
13.53

$
16.80



The following table shows summary information for outstanding options and options that are exercisable (vested) as of June 30, 2018:

 
Options
Outstanding
Options
Exercisable
Number of options
8,093,343

5,689,985

Weighted average remaining contractual term (in years)
6.18

5.13

Weighted average exercise price
$
12.11

$
8.00

Weighted average fair value
$
8.52

$
5.68

Aggregate intrinsic value (in thousands)
$
88,348

$
83,067



The following table summarizes restricted stock unit and restricted stock award activity during the six-month period ending June 30, 2018:

 
Number of Shares
Weighted Average Grant Date Fair Value per Share
Outstanding January 1, 2018
24,150

$
26.45

Granted
—

—

Forfeited
—

—

Vested/released
(8,050
)
26.45

Outstanding June 30, 2018
16,100

26.45



Equity-based compensation is summarized below (in thousands):

 
Three Months Ended
Six Months Ended
 
June 30,
June 30,
June 30,
June 30,
 
2018
2017
2018
2017
Cost of sales
$
58

$
22

$
104

$
22

Research and development
838

1,166

2,450

1,892

Sales, general and administrative
2,513

3,047

6,457

5,536

Equity-based compensation expense
$
3,409

$
4,235

$
9,011

$
7,450



As of June 30, 2018 and 2017, $420,000 and $183,000 of equity-based compensation expense was included as a component of capitalized inventory, respectively. As of June 30, 2018 and 2017, $77,000 and $27,000 of equity-based compensation expense was included as a component of capitalized property and equipment, respectively.

As of June 30, 2018, unrecognized equity-based compensation expense related to unvested stock options and unvested restricted stock units was $22.8 million and $111,000, respectively. This is expected to be recognized over the years 2018 through 2023.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes
 6 Months Ended
Jun. 30, 2018
Income Tax Disclosure [Abstract]  
Income Taxes
NOTE 14. INCOME TAXES

For the three and six months ended June 30, 2018, the Company recorded a provision for income taxes of approximately $101,000 and $285,000, respectively, which primarily relates to profitable foreign jurisdictions without any net operating loss carryforwards. The Company’s tax expense for the three and six months ended June 30, 2018 differs from the tax expense computed by applying the U.S. statutory tax rate to its year-to-date pre-tax loss of $23.1 million and $43.8 million, respectively, as no tax benefits were recorded for tax losses generated in the U.S. and other foreign jurisdictions. At June 30, 2018, the Company had deferred tax assets primarily related to U.S. federal and state tax loss carryforwards. The Company provided a full valuation allowance against its deferred tax assets as future realization of such assets is not more likely than not to occur.

We account for uncertain tax positions pursuant to the recognition and measurement criteria under ASC 740, Income Taxes. For the three and six months ended June 30, 2018, we did not note any significant changes to our uncertain tax positions. We do not anticipate significant changes to uncertain tax position within the next 12 months.

Tax Cuts and Jobs Act

On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act. The Tax Act reduced the corporate tax rate from the maximum federal statutory rate of 35% to 21%. The Tax Act states that the 21% corporate tax rate is effective for tax years beginning on or after January 1, 2018. The Company revalued its net deferred tax assets for U.S. federal purposes to 21% as of December 31, 2017, with a corresponding adjustment to the valuation allowance. Therefore, the reduction in the U.S. corporate tax rate had no impact on the Company's earnings.

In conjunction with the Tax Act, the SEC staff issued SAB 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. The Company has recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in its consolidated financial statements for the year ended December 31, 2017. The ultimate impact may differ from these provisional amounts, possibly materially, due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the Tax Act. Any subsequent determinations and adjustments will be recorded during the remainder of the year ended December 31, 2018, as they are identified. 

The Tax Act subjects a U.S. shareholder to tax on global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. The FASB Staff Q&A, Topic 740, No. 5, Accounting for GILTI, states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. Given the complexity of the GILTI provisions, we are still evaluating the effects of the GILTI provisions and have not yet determined our accounting policy. At June 30, 2018, because we are still evaluating the GILTI provisions and our analysis of future taxable income subject to GILTI, we have included GILTI related to current-year operations only in our estimated annual effective tax rate, with a corresponding adjustment to the valuation allowance, and have not provided additional GILTI on deferred items.

At June 30, 2018, the Company has not completed its accounting for all of the tax effects of the Tax Act and has not made any adjustments to the provisional amounts recorded at December 31, 2017. The Company will continue to make and refine its calculations as additional analysis is completed. The Company’s estimates may also be affected as additional guidance is issued with regards to the Tax Act. These changes are not expected to be material to the Company’s financial statements since the effective tax rate impact will be offset by the corresponding adjustment in the valuation allowance.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments
 6 Months Ended
Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments
NOTE 15. COMMITMENTS

Leases

The Company has entered into lease agreements, lease amendments, and lease extensions (“Lease Agreements”) for office, laboratory and manufacturing space located in Tucson, Arizona and Europe, the last of which expires in 2022. Total rent expense, including common area charges was $346,000 and $309,000 for the three months ended June 30, 2018 and 2017, respectively, and for the six months ended June 30, 2018 and 2017 was $688,000 and $625,000, respectively. Future minimum lease payments under these agreements are as follows (in thousands):

Year ending December 31:
 
2018
$
557

2019
206

2020
85

2021
44

2022
4

Thereafter
—

 
$
896



Clinical Trial Agreements

The Company has entered into master agreements with clinical trial sites in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the clinical trial sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation. The expense incurred as part of the clinical trial is included in research and development on the Company's condensed consolidated statements of operations and comprehensive loss.

Marketing Study and Contracted Research

The Company has entered into marketing study agreements and contracted research agreements with research institutions and hospitals in which we typically pay a set amount for start-up costs and then pay for work performed. These agreements typically indemnify the sites from any and all losses arising from third party claims as a result of the Company's negligence, willful misconduct or misrepresentation.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Industry and Geographic Information
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Industry and Geographic Information
NOTE 16. INDUSTRY, GEOGRAPHIC AND REVENUE DISAGGREGATION

The Company operates as one operating segment. Sales to customers outside the U.S. represented 28% and 22% for the three months ended June 30, 2018 and 2017, respectively, and 27% and 14% for the six months ended June 30, 2018 and 2017, respectively.

As of June 30, 2018 and December 31, 2017, balances due from foreign customers, in U.S. dollars, were $864,000 and $1.0 million, respectively.

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
 
2018
2017
Primary Geographic Markets:
 
 
 
 
 
Domestic
$
1,220

$
544

 
$
1,815

$
1,063

Foreign
472

155

 
678

167

Net sales
$
1,692

$
699

 
$
2,493

$
1,230

 
 
 
 
 
 
Line of Business:
 
 
 
 
 
Accelerate Pheno™ revenue
$
1,665

$
675

 
$
2,435

$
1,180

Other revenue
27

24

 
58

50

Net sales
$
1,692

$
699

 
$
2,493

$
1,230

 
 
 
 
 
 
Products and Services:
 
 
 
 
 
Products
$
1,671

$
695

 
$
2,467

$
1,224

Services
21

4

 
26

6

Net sales
$
1,692

$
699

 
$
2,493

$
1,230



Lease income included in net sales for the three months ended June 30, 2018 and 2017 was $172,000 and $11,000, respectively, and $181,000 and $12,000 for the six months ended June 30, 2018 and 2017, respectively, which does not represent revenues recognized from contracts with customers.

The following presents long-lived assets (excluding intangible assets) by geographic territory (in thousands):
 
June 30,
December 31,
 
2018
2017
Domestic
$
4,210

$
3,779

Foreign
1,233

1,111

Property and equipment, net
$
5,443

$
4,890
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions
 6 Months Ended
Jun. 30, 2018
Related Party Transactions [Abstract]  
Related Party Transactions
NOTE 17. RELATED PARTY TRANSACTIONS

As part of the transaction discussed in Note 11, Convertible Notes, an affiliate of one member of the Company's board of directors purchased an aggregate of $30 million of the Notes. The affiliated entity is a Qualified Institutional Buyer which purchased and holds the Notes at June 30, 2018.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, as filed with the SEC on March 1, 2018.

The condensed consolidated balance sheet as of December 31, 2017 included herein was derived from the audited financial statements as of that date, but does not include all disclosures such as notes required by U.S. GAAP.

The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the entire year ending December 31, 2018, or any future period.

All amounts are rounded to the nearest thousand dollars unless otherwise indicated.
Principles of Consolidation
Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries after elimination of intercompany transactions and balances.
Use of Estimates
Use of Estimates

The Company’s consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of the Company’s consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventories, property and equipment, intangible assets, accruals, warranty liabilities, tax valuation accounts and stock-based compensation. Actual results could differ materially from those estimates.
Estimated Fair Value of Financial Instruments
Estimated Fair Value of Financial Instruments

The Company follows ASC Topic 820, Fair Value Measurements and Disclosures which has defined fair value and requires the Company to establish a framework for measuring fair value and disclose fair value measurements. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories:

•
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

•
Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability;

•
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

The carrying amounts of financial instruments such as cash and cash equivalents, trade accounts receivable, prepaid expenses, accounts payable, accrued liabilities, and other liabilities approximate the related fair values due to the short-term maturities of these instruments.
Cash and Cash Equivalents
Cash and Cash Equivalents

All highly liquid investments with an original maturity of three months or less at time of purchase are considered to be cash equivalents. Cash and cash equivalents include overnight repurchase agreement accounts and other investments. As part of our cash management process, excess operating cash is invested in overnight repurchase agreements with our bank. Repurchase agreements and other investments classified as cash and cash equivalents are not deposits and are not insured by the U.S. Government, the FDIC or any other government agency and involve investment risk including possible loss of principal. We believe however, that the market risk arising from holding these financial instruments is minimal.
Investments
Investments

The Company invests excess funds in various investments which are primarily held in the custody of major financial institutions. Investments consist of certificate of deposits, debt securities in U.S. government and agency securities, commercial paper, asset-backed securities and corporate notes and bonds. Management classifies its investments as available-for-sale investments and records these investments in the condensed consolidated balance sheet at fair value. The Company considers all available-for-sale securities, including those with maturity dates beyond 12 months, as available to support current operational liquidity needs. Unrealized gains or losses for available-for-sale securities are included in accumulated other comprehensive income (loss), a component of stockholders’ equity. The Company classifies its investments as current based on the nature of the investments and their availability for use in current operations.

The Company assesses whether an other-than-temporary impairment loss has occurred due to declines in fair value or other market conditions when an investment’s fair value remains less than its cost for more than twelve months. This assessment includes a determination of whether the investment is expected to recover in value and whether the Company has the intent and ability to hold the investment until the anticipated recovery in value occurs. When an investment is identified as having an other-than-temporary impairment loss, we adjust the cost basis of the investment down to fair value resulting in a realized loss. The new cost basis is not changed for subsequent recoveries in fair value and temporary future increases or decreases in fair value are included in other comprehensive income (loss).
Inventory
Inventory

The Company writes down its inventory for estimated obsolescence or in an amount equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, market conditions and, where applicable, product expiration.
Accounts Receivable
Accounts Receivable

Accounts receivable consist of amounts due to the Company for sales to customers and are recorded net of an allowance for doubtful accounts. Allowances on accounts receivable are recorded when circumstances indicate collection is doubtful for a particular accounts receivable. Receivables are written off if reasonable collection efforts prove unsuccessful. The Company provides for allowances on a specific account basis.

Property and Equipment
Property and Equipment

Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized. Gains and losses from retirement or replacement are included in costs and expenses. Depreciation of property and equipment is computed using the straight-line method over the estimated useful life of the assets, ranging from one to seven years. Leasehold improvements are depreciated over the remaining life of the lease or the life of the asset, whichever is less. Property and equipment includes diagnostic instruments used for sales demonstrations and instruments under rental agreements. The Company retains title to the instruments under these arrangements.
Long-lived Assets
Long-lived Assets

Long-lived assets and certain identifiable intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows from and the estimated fair value of such long-lived assets, and provides for impairment if such undiscounted cash flows or the estimated fair value are insufficient to recover the carrying amount of the long-lived asset.
Warranty Reserve
Warranty Reserve

Instruments are typically sold with a one year limited warranty, while kits and accessories are typically sold with a 60 days limited warranty. Accordingly, a provision for the estimated cost of the limited warranty repair is recorded at the time revenue is recognized. Our estimated warranty provision is based on our estimate of future repair events and the related estimated cost of repairs. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. The expense incurred for these provisions is included in cost of sales on the condensed consolidated statements of operations and comprehensive loss.
Convertible Notes
Convertible Notes

The Company issued convertible notes that had conversion prices which resulted in an embedded beneficial conversion feature. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with the corresponding amount recorded to contributed capital. The debt discount is amortized to interest expense over the life of the convertible notes using the effective interest method.
Revenue
Revenue Recognition

Effective January 1, 2018, the Company adopted the requirements of ASC 606, Revenue from Contracts with Customers, ("Topic 606") and recognizes revenue when control of the promised good or service is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenues.

We determine revenue recognition through the following steps:

•
Identification of the contract with a customer

•
Identification of the performance obligations in the contract

•
Determination of the transaction price

•
Allocation of the transaction price to the performance obligations

•
Recognition of revenue as we satisfy a performance obligation

Product revenue is derived from the sale or rental of our instruments and sales of related consumable products. When an instrument is sold, revenue is generally recognized upon installation of the unit consistent with contract terms, which do not include a right of return. When a consumable product is sold, revenue is generally recognized upon shipment. Invoices are generally issued when revenue is recognized.

Service revenue is derived from the sale of extended service agreements which are generally non-cancelable. This revenue is recognized on a straight-line basis over the contract term beginning on the effective date of the contract because the Company is standing ready to provide services. Invoices are generally issued annually and coincide with the beginning of individual service terms.

Our contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the price charged to customers for each individual performance obligation.

We also provide instruments to customers under bundled rental agreements. Under these agreements, we install the instrument in the customer’s facility and provide service. The customer agrees to purchase consumable products at a stated price over the term of the agreement, which is typically five years or less. Contracts sometimes have renewal clauses but such clauses do not provide for a bargain renewal option or penalize the customer if they do not renew. The instrument remains the Company’s property throughout the term of the agreement and there is no transfer of title upon expiration.

Our payment terms vary by the type and location of our customers and the product or services offered and typically range between 30 and 60 days.

Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The Company has determined these costs would have an amortization period of less than one year and has elected to recognize them as an expense when incurred. Contract asset opening and closing balances were immaterial for the quarter ended June 30, 2018.

The Company adopted Topic 606 using the modified retrospective method applied to those contracts that were not fully performed by the Company as of January 1, 2018. We recorded a decrease to opening retained earnings and an increase in deferred revenue of $49,000 as of January 1, 2018 due to the cumulative impact of adopting Topic 606. The impact to revenues for the three and six months ended June 30, 2018 was not material as a result of applying Topic 606.
Cost of Sales
Cost of Sales

Cost of sales consists of raw materials, depreciation, direct labor and stock-based compensation expense, manufacturing overhead, facility costs and warranty costs.
Shipping and Handling
Shipping and Handling

Shipping and handling costs billed to customers are included as a component of revenue. The corresponding expense incurred with third party carriers is included as a component of sales, general and administrative costs on the consolidated statements of operations and comprehensive loss.
Leases
Leases

The Company accounts for leases in accordance with ASC 840, Leases, which requires leases to be classified as either operating or capital leases. In general, the Company classifies leases as capital leases when there is either a transfer of ownership at the end of the lease term, the lease contains a bargain purchase option, the lease term is seventy-five percent or more of the estimated economic life of the leased property or the minimum lease payments are ninety percent or more of the fair value of the leased property at lease inception. Other leases are classified as operating leases.

Operating lease rent is recorded as an operating expense on a monthly basis. For capital leases, both an asset and liability are recorded at the inception of the lease based on the present value of lease payments. The asset is included with property and equipment on the condensed consolidated balance sheet and amortization is recorded on a straight-line basis over the term of the lease with the amortization expense included with depreciation on the statements of operations and comprehensive loss. For the liability, the amount due within the next year is recorded as a current liability and the amount due in more than a year is recorded as a long-term liability on the condensed consolidated balance sheet. Interest expense is recorded based on the implicit or explicit interest rate used in the lease and is included as non-operating interest expense on the statements of operations and comprehensive loss. As of June 30, 2018 and December 31, 2017, the Company did not carry any capital leases.
Equity-Based Compensation
Equity-Based Compensation

The Company awards stock options and other equity-based instruments to its employees, directors and consultants. Compensation cost related to equity-based instruments is based on the fair value of the instrument on the grant date, and is recognized over the requisite service period on a straight-line basis over the vesting period for each tranche (an accelerated attribution method). We account for forfeitures as they occur rather than on an estimated basis.

The Company estimates the fair value of stock option awards, including modifications of stock option awards, using the Black-Scholes option pricing model. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield.

The Company records the fair value of restricted stock units or stock grants based on published closing market price on the day before the grant date.
Income Taxes and Deferred Tax Assets
Income Taxes and Deferred Tax Assets

Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying condensed consolidated balance sheets. The change in deferred tax assets and liabilities for the period represents the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws in deferred tax assets and liabilities are reflected as an adjustment to the tax provision or benefit in the period of enactment.

The Company follows the provisions of ASC 740, Income Taxes, to account for any uncertainty in income taxes with respect to the accounting for all tax positions taken (or expected to be taken) on any income tax return. This guidance applies to all open tax periods in all tax jurisdictions in which the Company is required to file an income tax return. Under U.S. GAAP, in order to recognize an uncertain tax benefit the taxpayer must determine it is more likely than not certain that its tax position will be sustained, and the measurement of the benefit is calculated as the largest amount that is more likely than not to be realized upon resolution of the position. Interest and penalties, if any, would be recorded within tax expense.
Foreign Currency Translation and Foreign Currency Transactions
Foreign Currency Translation and Foreign Currency Transactions

The Company follows ASC 830 Foreign Currency Matters, which provides guidance on foreign currency transactions and translation of financial statements. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in the consolidated statements of stockholders’ equity.

The Company has assets and liabilities, including receivables and payables, which are denominated in currencies other than their functional currency. These balance sheet items are subject to re-measurement, the impact of which is recorded in foreign currency exchange gain and loss, within the condensed consolidated statement of operations and comprehensive loss.
Earnings Per Share
Earnings Per Share

Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share are computed similarly to basic earnings (loss) per share except the denominator includes additional common shares that would have been outstanding if notes convertible at the balance sheet date were converted and share-based payments had been issued. Diluted earnings are not presented when the effect of adding such additional common shares is antidilutive.
Recently Issued Accounting Pronouncements
In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-07, Compensation-Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments made to nonemployees so the accounting for such payments is substantially the same as those made to employees. Under this ASU, share-based awards to nonemployees will be measured at fair value on the grant date of the awards, entities will need to assess the probability of satisfying performance conditions if any are present, and awards will continue to be classified according to Accounting Standards Codification (“ASC”) 718 upon vesting, which eliminates the need to reassess classification upon vesting, consistent with awards granted to employees. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We do not anticipate this update will have an effect on our condensed consolidated financial statements because all share-based awards granted to nonemployees are fully vested.
In March 2018, issued ASU 2018-05, Amendments Pursuant to SEC Staff Accounting Bulletin (“SAB”) No. 118 (SEC Update), Income Taxes (Topic 740). ASU 2018-05 provides guidance regarding the recording of tax impacts where uncertainty exists, in the period of adoption of the 2017 U.S. Tax Cuts and Jobs Act (the “Tax Act”). In accordance with this guidance, the Company’s financial results reflect provisional amounts for those specific income tax effects of the Tax Act for which the accounting under ASC Topic 740 is incomplete but a reasonable estimate could be determined. During the six months ended June 30, 2018, the Company did not recognize any changes to the provisional amounts recorded in its 2017 Annual Report on Form 10-K in connection with the Tax Act, as the Company continues to collect the information necessary to complete those calculations. The accounting for the tax effects of the Tax Act will be completed in the second half of 2018.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220) Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI), which allows a reclassification from accumulated other comprehensive income to retained earnings for tax effects resulting from the Tax Act that the FASB refers to as having been stranded in AOCI. This ASU is effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2018, with early adoption permitted. The Company is evaluating the impact of the adoption of ASU 2018-02 on our condensed consolidated financial statements, though its effects are not expected to be material.

In March 2017, the FASB issued ASU 2017-08, Receivable-Nonrefundable Fees and Other Costs (Topic 310-20) Premium Amortization on Purchased Callable Debt Securities. This amendment shortens the amortization period for certain callable debt securities held at a premium. Specifically, the amendment requires premiums to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. This ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. If an entity early adopts in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments should be applied on a modified retrospective basis, with a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently assessing the impact this will have on our condensed consolidated financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740) Intra-Entity Transfers of Assets Other Than Inventory. This ASU is effective for periods after December 15, 2017 and eliminates the requirement that the Company recognize the income tax consequences of an intra-entity transfer of an asset upon transfer other than inventory, eliminating the current recognition requirement. This ASU is effective for the 2018 annual reporting period including the interim periods ended March 31, 2018 and June 30, 2018. In adopting this ASU, the Company recorded no cumulative-effect adjustment to retained earnings at January 1, 2018. As the U.S. and the consolidated group are in a net operating loss position, no prepaid tax has been recorded.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments, which amends the guidance on measuring credit losses on financial assets (including trade accounts receivable and available for sale debt securities) held at amortized cost. Currently, an “incurred loss” methodology is used for recognizing credit losses which delays recognition until it is probable a loss has been incurred. The amendment requires assets valued at amortized cost to be presented at the net amount expected to be collected using an allowance for credit losses. Reversal of credit losses on available for sale debt securities will be recorded in the current period net income. This ASU is effective for us on January 1, 2020, with early adoption permitted. We do not anticipate this guidance will have a significant impact on our condensed consolidated financial statements and plan to adopt on the effective date.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This replaces the existing standards relating to leases for both lessees and lessors. For lessees, the new standard requires most leases to be recorded on the condensed consolidated balance sheet with expenses recognized much like the existing standard. For lessors, the new standard modifies the classification criteria and accounting for sales-type and direct financing leases and eliminates leveraged leases. For both lessees and lessors, the standard eliminates real estate-specific provisions, changes some of the presentation and disclosure requirements, and changes sale and leaseback criteria. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is permitted. We are currently assessing the impact this will have on our condensed consolidated financial statements.

In January, 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Topic 825). This standard requires equity investments, with some exceptions, be measured at fair value with valuation changes recognized in net income, simplifies the impairment assessment of some equity investments, eliminates the requirement to disclose the methods and significant assumptions used to estimate the fair value for financial instruments measured at amortized cost, requires the use of the exit price notion when measuring the fair value of financial instruments, requires separate presentation of some changes in other comprehensive income, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial assets, and clarifies the need for a valuation allowance on some deferred tax assets. The Company adopted this ASU on January 1, 2018, and the adoption did not have a material impact on the Company’s consolidated financial statements.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of Product Warranty Reserve Activity
Warranty reserve activity for the three and six months ended June 30, 2018 and 2017 is as follows (in thousands):
 
Three Months Ended
Six Months Ended
 
June 30,
June 30,
June 30,
June 30,
 
2018
2017
2018
2017
Beginning balance
$
176

$
31

$
192

$
1

Provisions
145

50

266

80

Warranty expenses incurred
(122
)
(20
)
(259
)
(20
)
Ending balance
$
199

$
61

$
199

$
61
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments (Tables)
 6 Months Ended
Jun. 30, 2018
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Measurement
The following tables represent the financial instruments measured at fair value on a recurring basis on the financial statements of the Company and the valuation approach applied to each class of financial instruments at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
37,824

$
—

$
—

$
37,824

Commercial paper
—

5,982

—

5,982

Corporate notes and bonds
—

9,087

—

9,087

Total cash and cash equivalents
$
37,824

$
15,069

$
—

$
52,893

Investments:
 
 
 
 
Certificates of deposit
—

13,682

—

13,682

U.S. Treasury securities
31,744

—

—

31,744

U.S. Agency securities
—

6,944

—

6,944

Commercial paper
—

35,917

—

35,917

Asset-backed securities
—

8,993

—

8,993

Corporate notes and bonds
—

33,314

—

33,314

Total investments
31,744

98,850

—

130,594

Total assets measured at fair value
$
69,568

$
113,919

$
—

$
183,487


 
December 31, 2017
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
7,832

$
—

$
—

$
7,832

Investments:
 
 
 
 
Certificates of deposit
—

13,441

—

13,441

U.S. Treasury securities
14,716

—

—

14,716

U.S. Agency securities
—

8,459

—

8,459

Commercial paper
—

9,171

—

9,171

Asset-backed securities
—

3,025

—

3,025

Corporate notes and bonds
—

31,836

—

31,836

Total investments
14,716

65,932

—

80,648

Total assets measured at fair value
$
22,548

$
65,932

$
—

$
88,480
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Concentration of Credit Risk (Tables)
 6 Months Ended
Jun. 30, 2018
Risks and Uncertainties [Abstract]  
Schedule of Customer Concentration
ustomers who represented 10% or more of the Company’s net accounts receivable balance as of June 30, 2018 and December 31, 2017. The Company had two customers that accounted for 11% and 10% of the Company’s net accounts receivable balance as of June 30, 2018, and one Customer that accounted for 24% of the Company's net accounts receivable balance as of December 31, 2017.

Customers who represented 10% or more of the Company’s total revenue for the three and six months ended June 30, 2018 and 2017 were as follows:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2018
2017
 
2018
2017
Company A
13%
*
 
*
*
Company B
12%
*
 
*
*
Company C
11%
*
 
*
*
Company D
*
22%
 
*
13%
Company E
*
21%
 
*
12%
Company F
*
19%
 
*
11%
Company G
*
15%
 
*
*
Company H
*
*
 
*
31%
Company I
*
*
 
*
15%

* Less than 10% for the period indicated
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments (Tables)
 6 Months Ended
Jun. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Schedule of Available-for-Sale Investments
The following tables summarize the Company’s available-for-sale investments at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
13,682

$
—

$
—

$
13,682

U.S. Treasury securities
31,850

1

(107
)
31,744

U.S. Agency securities
7,013

—

(69
)
6,944

Commercial paper
35,917

—

—

35,917

Asset-backed securities
8,992

2

(1
)
8,993

Corporate notes and bonds
33,388

1

(75
)
33,314

Total
$
130,842

$
4

$
(252
)
$
130,594


 
December 31, 2017
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
13,441

$
—

$
—

$
13,441

U.S. Treasury securities
14,787

—

(71
)
14,716

U.S. Agency securities
8,510

—

(51
)
8,459

Commercial paper
9,171

—

—

9,171

Asset-backed securities
3,026

—

(1
)
3,025

Corporate notes and bonds
31,906

—

(70
)
31,836

Total
$
80,841

$
—

$
(193
)
$
80,648
Schedule of Available-For-Sale Investment Maturities
The following table summarizes the maturities of the Company’s available-for-sale securities at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
December 31, 2017
 
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due in less than 1 year
$
95,448

$
95,312

$
55,801

$
55,735

Due in 1-5 years
35,394

35,282

25,040

24,913

Total
$
130,842

$
130,594

$
80,841

$
80,648
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventory (Tables)
 6 Months Ended
Jun. 30, 2018
Inventory Disclosure [Abstract]  
Components of Inventories
Inventories consisted of the following at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30,
December 31,
 
2018
2017
Raw materials
$
5,101

$
4,220

Work in process
842

377

Finished goods
5,374

3,466

Inventory, net
$
11,317

$
8,063
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment (Tables)
 6 Months Ended
Jun. 30, 2018
Property, Plant and Equipment [Abstract]  
Property and Equipment
Property and equipment consisted of the following at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30,
December 31,
 
2018
2017
Computer equipment
$
2,801

$
2,756

Technical equipment
3,550

3,348

Facilities
3,620

3,621

Instruments
2,283

1,400

Capital projects in progress
720

349

Total property and equipment
$
12,974

$
11,474

Accumulated depreciation
(7,531
)
(6,584
)
Property and equipment, net
$
5,443

$
4,890
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Deferred Revenue, Income and Remaining Performance Obligations (Tables)
 6 Months Ended
Jun. 30, 2018
Deferred Revenue Disclosure [Abstract]  
Deferred Revenue and Income Summary
A summary of the balances as of June 30, 2018 and December 31, 2017 follows (in thousands):
 
June 30,
December 31,
 
2018
2017
Products and services not yet delivered
$
185

$
71

Arizona Commerce Authority grant
—

1,000

Deferred revenue and income
$
185

$
1,071
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share - (Tables)
 6 Months Ended
Jun. 30, 2018
Earnings Per Share [Abstract]  
Schedule of Potentially Issuable Common Shares not Included in Computation of Diluted Net Loss Per Share
The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses at June 30, 2018 and December 31, 2017 (in thousands):
 
June 30,
December 31,
 
2018
2017
Shares issuable upon the release of restricted stock awards
16

24

Shares issuable upon exercise of stock options
8,093

7,328

 
8,109

7,352
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Equity-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Option Activity
The following table summarizes option activity under all plans during the six-month period ended June 30, 2018:

 
Number of Shares
Weighted Average Exercise Price per Share
Options Outstanding January 1, 2018
7,328,131

$
10.16

Granted
1,115,371

25.45

Forfeited
(91,043
)
20.97

Exercised
(253,621
)
10.87

Expired
(5,495
)
23.43

Options Outstanding June 30, 2018
8,093,343

12.11
Inputs to Calculate Estimated Fair Value of Options Awarded
The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:

 
Three Months Ended
 
June 30,
June 30,
 
2018
2017
Expected term (in years)
6.06

6.12

Volatility
64
%
75
%
Expected dividends
—

—

Risk free interest rates
2.82
%
2.02
%
Weighted average fair value
$
13.53

$
16.80
Stock Option Supplemental Information
The following table shows summary information for outstanding options and options that are exercisable (vested) as of June 30, 2018:

 
Options
Outstanding
Options
Exercisable
Number of options
8,093,343

5,689,985

Weighted average remaining contractual term (in years)
6.18

5.13

Weighted average exercise price
$
12.11

$
8.00

Weighted average fair value
$
8.52

$
5.68

Aggregate intrinsic value (in thousands)
$
88,348

$
83,067
Restricted Stock Unit (RSU) Activity
The following table summarizes restricted stock unit and restricted stock award activity during the six-month period ending June 30, 2018:

 
Number of Shares
Weighted Average Grant Date Fair Value per Share
Outstanding January 1, 2018
24,150

$
26.45

Granted
—

—

Forfeited
—

—

Vested/released
(8,050
)
26.45

Outstanding June 30, 2018
16,100

26.45
Equity-Based Compensation Expenses
Equity-based compensation is summarized below (in thousands):

 
Three Months Ended
Six Months Ended
 
June 30,
June 30,
June 30,
June 30,
 
2018
2017
2018
2017
Cost of sales
$
58

$
22

$
104

$
22

Research and development
838

1,166

2,450

1,892

Sales, general and administrative
2,513

3,047

6,457

5,536

Equity-based compensation expense
$
3,409

$
4,235

$
9,011

$
7,450
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments (Tables)
 6 Months Ended
Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Operating Leases Obligations
Future minimum lease payments under these agreements are as follows (in thousands):

Year ending December 31:
 
2018
$
557

2019
206

2020
85

2021
44

2022
4

Thereafter
—

 
$
896
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Industry and Geographic Information (Tables)
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Disaggregation of Revenue
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
(in thousands)
 
(in thousands)
 
2018
2017
 
2018
2017
Primary Geographic Markets:
 
 
 
 
 
Domestic
$
1,220

$
544

 
$
1,815

$
1,063

Foreign
472

155

 
678

167

Net sales
$
1,692

$
699

 
$
2,493

$
1,230

 
 
 
 
 
 
Line of Business:
 
 
 
 
 
Accelerate Pheno™ revenue
$
1,665

$
675

 
$
2,435

$
1,180

Other revenue
27

24

 
58

50

Net sales
$
1,692

$
699

 
$
2,493

$
1,230

 
 
 
 
 
 
Products and Services:
 
 
 
 
 
Products
$
1,671

$
695

 
$
2,467

$
1,224

Services
21

4

 
26

6

Net sales
$
1,692

$
699

 
$
2,493

$
1,230
Long-lived Assets by Geographic Territory
The following presents long-lived assets (excluding intangible assets) by geographic territory (in thousands):
 
June 30,
December 31,
 
2018
2017
Domestic
$
4,210

$
3,779

Foreign
1,233

1,111

Property and equipment, net
$
5,443

$
4,890
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
- Narrative (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jan. 01, 2018
Dec. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Instrument warranty term 1 year    
Kits and accessories warranty term 60 days    
Decrease to opening retained earnings $ 286,058   $ 241,972
Cumulative impact of adopting Topic 606 | Topic 606      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Decrease to opening retained earnings   $ 49  
Minimum      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Estimated useful life of assets 1 year    
Payment terms 30 days    
Maximum      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Estimated useful life of assets 7 years    
Payment terms 60 days    
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Movement in Standard Product Warranty Accrual [Roll Forward]        
Beginning balance $ 176 $ 31 $ 192 $ 1
Provisions 145 50 266 80
Warranty expenses incurred (122) (20) (259) (20)
Ending balance $ 199 $ 61 $ 199 $ 61
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments $ 130,594 $ 80,648
Fair value on a recurring basis    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 52,893  
Investments 130,594 80,648
Total assets measured at fair value 183,487 88,480
Fair value on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 37,824  
Investments 31,744 14,716
Total assets measured at fair value 69,568 22,548
Fair value on a recurring basis | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 15,069  
Investments 98,850 65,932
Total assets measured at fair value 113,919 65,932
Fair value on a recurring basis | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 0  
Investments 0 0
Total assets measured at fair value 0 0
Fair value on a recurring basis | Certificates of deposit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 13,682 13,441
Fair value on a recurring basis | Certificates of deposit | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | Certificates of deposit | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 13,682 13,441
Fair value on a recurring basis | Certificates of deposit | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | U.S. Treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 31,744 14,716
Fair value on a recurring basis | U.S. Treasury securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 31,744 14,716
Fair value on a recurring basis | U.S. Treasury securities | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | U.S. Treasury securities | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | U.S. Agency securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 6,944 8,459
Fair value on a recurring basis | U.S. Agency securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | U.S. Agency securities | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 6,944 8,459
Fair value on a recurring basis | U.S. Agency securities | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 35,917 9,171
Fair value on a recurring basis | Commercial paper | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | Commercial paper | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 35,917 9,171
Fair value on a recurring basis | Commercial paper | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 8,993 3,025
Fair value on a recurring basis | Asset-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | Asset-backed securities | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 8,993 3,025
Fair value on a recurring basis | Asset-backed securities | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | Corporate notes and bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 33,314 31,836
Fair value on a recurring basis | Corporate notes and bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | Corporate notes and bonds | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 33,314 31,836
Fair value on a recurring basis | Corporate notes and bonds | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments 0 0
Fair value on a recurring basis | Total cash and cash equivalents    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 37,824 7,832
Fair value on a recurring basis | Total cash and cash equivalents | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 37,824 7,832
Fair value on a recurring basis | Total cash and cash equivalents | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 0 0
Fair value on a recurring basis | Total cash and cash equivalents | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 0 $ 0
Fair value on a recurring basis | Commercial Paper [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 5,982  
Fair value on a recurring basis | Commercial Paper [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 0  
Fair value on a recurring basis | Commercial Paper [Member] | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 5,982  
Fair value on a recurring basis | Commercial Paper [Member] | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 0  
Fair value on a recurring basis | Corporate notes and bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 9,087  
Fair value on a recurring basis | Corporate notes and bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 0  
Fair value on a recurring basis | Corporate notes and bonds | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: 9,087  
Fair value on a recurring basis | Corporate notes and bonds | Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents: $ 0  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
Apr. 06, 2018
Mar. 27, 2018
Jun. 30, 2018
Debt Instrument [Line Items]      
Over-allotment option, percent   15.00%  
Over-allotment option   $ 22,500,000  
Additional proceeds $ 21,500,000    
Unsecured obligations | 2.50% Convertible notes due 2023      
Debt Instrument [Line Items]      
Aggregate principal amount 171,500,000.0 $ 150,000,000  
Interest rate   2.50%  
Proceeds received $ 171,500,000    
Fair value     $ 159,000,000
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Concentration of Credit Risk (Details)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Net accounts receivable | Customer concentration | Company A          
Concentration Risk [Line Items]          
Risk concentration     11.00%    
Net accounts receivable | Customer concentration | Company B          
Concentration Risk [Line Items]          
Risk concentration     10.00%    
Net accounts receivable | Customer concentration | Company C          
Concentration Risk [Line Items]          
Risk concentration         24.00%
Total revenue | Customer concentration | Company A          
Concentration Risk [Line Items]          
Risk concentration 13.00%        
Total revenue | Customer concentration | Company B          
Concentration Risk [Line Items]          
Risk concentration 12.00%        
Total revenue | Customer concentration | Company C          
Concentration Risk [Line Items]          
Risk concentration 11.00%        
Total revenue | Customer concentration | Company D          
Concentration Risk [Line Items]          
Risk concentration   22.00%   13.00%  
Total revenue | Customer concentration | Company E          
Concentration Risk [Line Items]          
Risk concentration   21.00%   12.00%  
Total revenue | Customer concentration | Company F          
Concentration Risk [Line Items]          
Risk concentration   19.00%   11.00%  
Total revenue | Customer concentration | Company G          
Concentration Risk [Line Items]          
Risk concentration   15.00%      
Total revenue | Customer concentration | Company H          
Concentration Risk [Line Items]          
Risk concentration       31.00%  
Total revenue | Customer concentration | Company I          
Concentration Risk [Line Items]          
Risk concentration       15.00%  
Financial institution A | Cash and cash equivalents | Concentration of credit risk          
Concentration Risk [Line Items]          
Risk concentration     58.00%   82.00%
Financial institution B | Cash and cash equivalents | Concentration of credit risk          
Concentration Risk [Line Items]          
Risk concentration     28.00%   12.00%
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments - Schedule of Available-for-sale Securities (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Investment [Line Items]    
Amortized Cost $ 130,842 $ 80,841
Gross Unrealized Gains 4 0
Gross Unrealized Losses (252) (193)
Fair Value 130,594 80,648
Certificates of deposit    
Investment [Line Items]    
Amortized Cost 13,682 13,441
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 13,682 13,441
U.S. Treasury securities    
Investment [Line Items]    
Amortized Cost 31,850 14,787
Gross Unrealized Gains 1 0
Gross Unrealized Losses (107) (71)
Fair Value 31,744 14,716
U.S. Agency securities    
Investment [Line Items]    
Amortized Cost 7,013 8,510
Gross Unrealized Gains 0 0
Gross Unrealized Losses (69) (51)
Fair Value 6,944 8,459
Commercial paper    
Investment [Line Items]    
Amortized Cost 35,917 9,171
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 35,917 9,171
Asset-backed securities    
Investment [Line Items]    
Amortized Cost 8,992 3,026
Gross Unrealized Gains 2 0
Gross Unrealized Losses (1) (1)
Fair Value 8,993 3,025
Corporate notes and bonds    
Investment [Line Items]    
Amortized Cost 33,388 31,906
Gross Unrealized Gains 1 0
Gross Unrealized Losses (75) (70)
Fair Value $ 33,314 $ 31,836
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments - Schedule of Available-for-Sale Investment Maturities (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Amortized Cost    
Due in less than 1 year $ 95,448 $ 55,801
Due in 1-5 years 35,394 25,040
Total 130,842 80,841
Fair Value    
Due in less than 1 year 95,312 55,735
Due in 1-5 years 35,282 24,913
Total $ 130,594 $ 80,648
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments - Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Investments, Debt and Equity Securities [Abstract]        
Proceeds from sales of marketable securities $ 0 $ 6,500,000 $ 3,000,000 $ 6,522,000
Gross realized gains or losses from sales of marketable securities $ 0 $ 0 $ 0 $ 0
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventory (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Inventory Disclosure [Abstract]    
Raw materials $ 5,101 $ 4,220
Work in process 842 377
Finished goods 5,374 3,466
Inventory, net $ 11,317 $ 8,063
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Property, Plant and Equipment [Line Items]          
Total property and equipment $ 12,974   $ 12,974   $ 11,474
Accumulated depreciation (7,531)   (7,531)   (6,584)
Property and equipment, net 5,443   5,443   4,890
Depreciation 533 $ 540 1,100 $ 1,000  
Computer equipment          
Property, Plant and Equipment [Line Items]          
Total property and equipment 2,801   2,801   2,756
Technical equipment          
Property, Plant and Equipment [Line Items]          
Total property and equipment 3,550   3,550   3,348
Facilities          
Property, Plant and Equipment [Line Items]          
Total property and equipment 3,620   3,620   3,621
Instruments          
Property, Plant and Equipment [Line Items]          
Total property and equipment 2,283   2,283   1,400
Capital projects in progress          
Property, Plant and Equipment [Line Items]          
Total property and equipment $ 720   $ 720   $ 349
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
License Agreements and Grants - National Institute of Health Grant (Details) - National Institute of Health Grant - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 41 Months Ended
Feb. 28, 2015
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and Development Arrangement, Contract to Perform for Others, Proposed Period 5 years          
Total grant funding $ 5,000,000 $ 38,000 $ 0 $ 98,000 $ 3,000  
Cumulative amount awarded           $ 1,100,000
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
License Agreements and Grants - Arizona Commerce Authority and R&D Refundable Tax Credit Program (Details)
 1 Months Ended
Jan. 31, 2018
USD ($)
Aug. 31, 2012
USD ($)
job
milestone
Research and Development [Abstract]    
Arizona Commerce Authority grant | $   $ 1,000,000.0
Number of installments | milestone   4
Qualified jobs created, milestone 1 | job   15
Qualified jobs created, milestone 2 | job   30
Qualified jobs created, milestone 3 | job   40
Qualified jobs created, milestone 4 | job   65
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Revenue recognized | $ $ 1,000,000  
Minimum    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Capital investment milestone | $   $ 4,500,000.0
Grant related minimum annual wages | $   $ 63,000
Percent of company paid premiums   65.00%
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Deferred Revenue, Income and Remaining Performance Obligations (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2018
Dec. 31, 2017
Deferred Revenue Disclosure [Abstract]      
Products and services not yet delivered $ 185 $ 185 $ 71
Arizona Commerce Authority grant 0 0 1,000
Deferred revenue and income 185 185 $ 1,071
Revenues recognized included in contract liabilities balances 14 35  
Revenue expected to be recognized from remaining performance obligations $ 1,000 $ 1,000  
Contact period   4 years  
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Convertible Notes (Details)
 3 Months Ended 6 Months Ended
Apr. 06, 2018
USD ($)
day
shares
Mar. 27, 2018
USD ($)
$ / shares
Jun. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Debt Instrument [Line Items]        
Over-allotment option, percent   15.00%    
Over-allotment option   $ 22,500,000    
Additional proceeds $ 21,500,000      
Conversion ratio   0.032343    
Stock price conversion threshold, percentage 130.00%      
Consecutive trading days | day 20      
Threshold trading days 30      
Trading price threshold, percentage 98.00%      
Repurchase principal balance, percent 100.00%      
Unamortized debt discount     $ 52,700,000 $ 52,700,000
Debt issuance costs, net     3,300,000 3,300,000
Interest expense     1,100,000 1,100,000
Accrued interest expense     1,100,000 1,100,000
Amortization of debt issuance costs     126,000 132,000
Amortization of the debt discount     2,000,000 2,100,000
Net proceeds from notes to fund Prepaid Forward $ 45,100,000      
Aggregate number of shares | shares 1,858,500      
Unsecured obligations | 2.50% Convertible notes due 2023        
Debt Instrument [Line Items]        
Aggregate principal amount $ 171,500,000.0 $ 150,000,000    
Interest rate   2.50%    
Proceeds received 171,500,000      
Conversion multiple 1,000      
Initial conversion price (usd per share) | $ / shares   $ 30.92    
Long-term debt 116,600,000   171,500,000 171,500,000
Equity component 54,900,000      
Debt issuance costs $ 5,000,000      
Contractual term 5 years      
Effective interest rate 11.52%      
Net carrying amount     $ 115,500,000 $ 115,500,000
Unsecured obligations | 2.50% Convertible notes due 2023 | Long-term debt        
Debt Instrument [Line Items]        
Debt issuance costs $ 3,400,000      
Unsecured obligations | 2.50% Convertible notes due 2023 | Additional paid-in capital        
Debt Instrument [Line Items]        
Debt issuance costs $ 1,600,000      
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share (Details) - shares
shares in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive common stock instruments outstanding (shares) 8,109 7,352
Shares issuable upon the release of restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive common stock instruments outstanding (shares) 16 24
Shares issuable upon exercise of stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive common stock instruments outstanding (shares) 8,093 7,328
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Equity-Based Compensation - Stock Option Activity (Details)
 6 Months Ended
Jun. 30, 2018
$ / shares
shares
Number of Shares  
Granted (shares) | shares 1,115,371
Forfeited (shares) | shares (91,043)
Exercised (shares) | shares (253,621)
Expired (shares) | shares (5,495)
Outstanding, ending balance (shares) | shares 8,093,343
Weighted Average Exercise Price per Share  
Outstanding, beginning balance (dollars per share) $ 10.16
Granted (dollars per share) 25.45
Forfeited (dollars per share) 20.97
Exercised (dollars per share) 10.87
Expired (dollars per share) 23.43
Outstanding, ending balance (dollars per share) $ 12.11
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details) - $ / shares
 3 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Expected term (in years) 6 years 22 days 6 years 1 month 13 days
Volatility 64.00% 75.00%
Expected dividends 0.00% 0.00%
Risk free interest rates 2.82% 2.02%
Weighted average fair value (dollars per share) $ 13.53 $ 16.80
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Equity-Based Compensation - Stock Option Supplemental Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Options Outstanding    
Number of options (shares) 8,093,343  
Weighted average remaining contractual term (in years) 6 years 2 months 5 days  
Weighted average exercise price (dollars per share) $ 12.11 $ 10.16
Weighted average fair value (dollars per share) $ 8.52  
Aggregate intrinsic value (in thousands) $ 88,348  
Options Exercisable    
Number of options (shares) 5,689,985  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 5 years 1 month 17 days  
Weighted average exercise price (dollars per share) $ 8.00  
Weighted average fair value (dollars per share) $ 5.68  
Aggregate intrinsic value (in thousands) $ 83,067  
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Equity-Based Compensation - Restricted Stock Activity (Details)
 6 Months Ended
Jun. 30, 2018
$ / shares
shares
Number of Shares  
Beginning balance (shares) 7,328,000
Ending balance (shares) 8,093,000
RSUs and RSAs  
Number of Shares  
Beginning balance (shares) 24,000
Granted (shares) 0
Forfeited (shares) 0
Vested/Released (shares) (8,050)
Ending balance (shares) 16,000
Weighted Average Grant Date Fair Value per Share  
Beginning balance (dollars per share) | $ / shares $ 26.45
Granted (dollars per share) | $ / shares 0.00
Forfeited (dollars per share) | $ / shares 0.00
Vested/Released (dollars per share) | $ / shares 26.45
Ending balance (dollars per share) | $ / shares $ 26.45
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Equity-based compensation expense $ 3,409 $ 4,235    
Unrecognized equity-based compensation cost 22,800   $ 22,800  
Shares issuable upon the release of restricted stock awards        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Unrecognized equity-based compensation cost, restricted stock units 111   111  
Cost of sales        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Equity-based compensation expense 58 22    
Research and development        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Equity-based compensation expense 838 1,166    
Sales, general and administrative        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Equity-based compensation expense $ 2,513 $ 3,047    
Capitalized inventory        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Equity-based compensation expense     420 $ 183
Property and equipment        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Equity-based compensation expense     $ 77 $ 27
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Tax Disclosure [Abstract]        
Provision for income taxes $ 101 $ 175 $ 285 $ 175
Pre-tax loss $ 23,124 $ 16,282 $ 43,752 $ 30,482
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]        
Rent expense $ 346 $ 309 $ 688 $ 625
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments - Operating Lease Obligations (Details)
$ in Thousands
Jun. 30, 2018
USD ($)
Year ending December 31:  
2018 $ 557
2019 206
2020 85
2021 44
2022 4
Thereafter 0
Total operating lease obligations $ 896
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.10.0.1
Industry and Geographic Information - Narrative (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2018
USD ($)
segment
Jun. 30, 2017
USD ($)
Dec. 31, 2017
USD ($)
Segment Reporting [Abstract]          
Number of operating segments | segment     1    
Segment Reporting Information [Line Items]          
Trade accounts receivable $ 1,823   $ 1,823   $ 1,946
Lease Income $ 172 $ 11 $ 181 $ 12  
Total revenue | Geographic concentration | Foreign          
Segment Reporting Information [Line Items]          
Risk concentration 28.00% 22.00% 27.00% 14.00%  
Net accounts receivable | Geographic concentration | Foreign          
Segment Reporting Information [Line Items]          
Trade accounts receivable $ 864   $ 864   $ 1,000
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.10.0.1
Industry and Geographic Information - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers $ 1,692 $ 699 $ 2,493 $ 1,230
Products 1,671 695 2,467 1,224
Services 21 4 26 6
Net sales 1,692 699 2,493 1,230
Accelerate Pheno™ revenue        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 1,665 675 2,435 1,180
Other revenue        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 27 24 58 50
Domestic        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 1,220 544 1,815 1,063
Foreign        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers $ 472 $ 155 $ 678 $ 167
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.10.0.1
Industry and Geographic Information - Long-lived Assets by Geographic Territory (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]    
Long-lived assets (excluding intangible assets) $ 5,443 $ 4,890
Property and equipment | Geographic concentration    
Segment Reporting Information [Line Items]    
Long-lived assets (excluding intangible assets) 5,443 4,890
Property and equipment | Geographic concentration | Domestic    
Segment Reporting Information [Line Items]    
Long-lived assets (excluding intangible assets) 4,210 3,779
Property and equipment | Geographic concentration | Foreign    
Segment Reporting Information [Line Items]    
Long-lived assets (excluding intangible assets) $ 1,233 $ 1,111
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transaction (Details)
Jun. 30, 2018
USD ($)
Director | Note holder  
Related Party Transaction [Line Items]  
Aggregate principal amount $ 30,000,000
XML 72 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; EXCEL 73 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 76 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 194 272 1 false 66 0 false 8 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://acceleratediagnostics.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheet CONDENSED CONSOLIDATED BALANCE SHEET Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedBalanceSheetParenthetical CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATEDSTATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedstatementsOfOperationsAndComprehensiveLoss CONDENSED CONSOLIDATEDSTATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://acceleratediagnostics.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 2101100 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPolicies Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies Notes 6 false false R7.htm 2102100 - Disclosure - Recently Issued Accounting Pronouncements Sheet http://acceleratediagnostics.com/role/RecentlyIssuedAccountingPronouncements Recently Issued Accounting Pronouncements Notes 7 false false R8.htm 2103100 - Disclosure - FDA Clearance Sheet http://acceleratediagnostics.com/role/FdaClearance FDA Clearance Notes 8 false false R9.htm 2104100 - Disclosure - Fair Value of Financial Instruments Sheet http://acceleratediagnostics.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 9 false false R10.htm 2105100 - Disclosure - Concentration of Credit Risk Sheet http://acceleratediagnostics.com/role/ConcentrationOfCreditRisk Concentration of Credit Risk Notes 10 false false R11.htm 2106100 - Disclosure - Investments Sheet http://acceleratediagnostics.com/role/Investments Investments Notes 11 false false R12.htm 2107100 - Disclosure - Inventory Sheet http://acceleratediagnostics.com/role/Inventory Inventory Notes 12 false false R13.htm 2108100 - Disclosure - Property and Equipment Sheet http://acceleratediagnostics.com/role/PropertyAndEquipment Property and Equipment Notes 13 false false R14.htm 2109100 - Disclosure - License Agreements and Grants Sheet http://acceleratediagnostics.com/role/LicenseAgreementsAndGrants License Agreements and Grants Notes 14 false false R15.htm 2110100 - Disclosure - Deferred Revenue, Income and Remaining Performance Obligations Sheet http://acceleratediagnostics.com/role/DeferredRevenueIncomeAndRemainingPerformanceObligations Deferred Revenue, Income and Remaining Performance Obligations Notes 15 false false R16.htm 2112100 - Disclosure - Convertible Notes Notes http://acceleratediagnostics.com/role/ConvertibleNotes Convertible Notes Notes 16 false false R17.htm 2113100 - Disclosure - Earnings Per Share Sheet http://acceleratediagnostics.com/role/EarningsPerShare Earnings Per Share Notes 17 false false R18.htm 2114100 - Disclosure - Employee Equity-Based Compensation Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensation Employee Equity-Based Compensation Notes 18 false false R19.htm 2115100 - Disclosure - Income Taxes Sheet http://acceleratediagnostics.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 2116100 - Disclosure - Commitments Sheet http://acceleratediagnostics.com/role/Commitments Commitments Notes 20 false false R21.htm 2117100 - Disclosure - Industry and Geographic Information Sheet http://acceleratediagnostics.com/role/IndustryAndGeographicInformation Industry and Geographic Information Notes 21 false false R22.htm 2118100 - Disclosure - Related Party Transactions Sheet http://acceleratediagnostics.com/role/RelatedPartyTransactions Related Party Transactions Notes 22 false false R23.htm 2201201 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies) Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesPolicies Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Policies) Policies http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPolicies 23 false false R24.htm 2301302 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables) Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesTables Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies (Tables) Tables http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPolicies 24 false false R25.htm 2304301 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://acceleratediagnostics.com/role/FairValueOfFinancialInstruments 25 false false R26.htm 2305301 - Disclosure - Concentration of Credit Risk (Tables) Sheet http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskTables Concentration of Credit Risk (Tables) Tables http://acceleratediagnostics.com/role/ConcentrationOfCreditRisk 26 false false R27.htm 2306301 - Disclosure - Investments (Tables) Sheet http://acceleratediagnostics.com/role/InvestmentsTables Investments (Tables) Tables http://acceleratediagnostics.com/role/Investments 27 false false R28.htm 2307301 - Disclosure - Inventory (Tables) Sheet http://acceleratediagnostics.com/role/InventoryTables Inventory (Tables) Tables http://acceleratediagnostics.com/role/Inventory 28 false false R29.htm 2308301 - Disclosure - Property and Equipment (Tables) Sheet http://acceleratediagnostics.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://acceleratediagnostics.com/role/PropertyAndEquipment 29 false false R30.htm 2310301 - Disclosure - Deferred Revenue, Income and Remaining Performance Obligations (Tables) Sheet http://acceleratediagnostics.com/role/DeferredRevenueIncomeAndRemainingPerformanceObligationsTables Deferred Revenue, Income and Remaining Performance Obligations (Tables) Tables http://acceleratediagnostics.com/role/DeferredRevenueIncomeAndRemainingPerformanceObligations 30 false false R31.htm 2313301 - Disclosure - Earnings Per Share - (Tables) Sheet http://acceleratediagnostics.com/role/EarningsPerShareTables Earnings Per Share - (Tables) Tables http://acceleratediagnostics.com/role/EarningsPerShare 31 false false R32.htm 2314301 - Disclosure - Employee Equity-Based Compensation (Tables) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationTables Employee Equity-Based Compensation (Tables) Tables http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensation 32 false false R33.htm 2316301 - Disclosure - Commitments (Tables) Sheet http://acceleratediagnostics.com/role/CommitmentsTables Commitments (Tables) Tables http://acceleratediagnostics.com/role/Commitments 33 false false R34.htm 2317301 - Disclosure - Industry and Geographic Information (Tables) Sheet http://acceleratediagnostics.com/role/IndustryAndGeographicInformationTables Industry and Geographic Information (Tables) Tables http://acceleratediagnostics.com/role/IndustryAndGeographicInformation 34 false false R35.htm 2401403 - Disclosure - - Narrative (Details) Sheet http://acceleratediagnostics.com/role/NarrativeDetails - Narrative (Details) Details 35 false false R36.htm 2401404 - Disclosure - Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details) Sheet http://acceleratediagnostics.com/role/OrganizationAndNatureOfBusinessBasisOfPresentationPrinciplesOfConsolidationSignificantAccountingPoliciesScheduleOfProductWarrantyReserveActivityDetails Organization and Nature of Business; Basis of Presentation; Principles of Consolidation; Significant Accounting Policies - Schedule of Product Warranty Reserve Activity (Details) Details 36 false false R37.htm 2404402 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details) Sheet http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueMeasurementDetails Fair Value of Financial Instruments - Schedule of Fair Value Measurement (Details) Details 37 false false R38.htm 2404403 - Disclosure - Fair Value of Financial Instruments - Narrative (Details) Sheet http://acceleratediagnostics.com/role/FairValueOfFinancialInstrumentsNarrativeDetails Fair Value of Financial Instruments - Narrative (Details) Details 38 false false R39.htm 2405402 - Disclosure - Concentration of Credit Risk (Details) Sheet http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskDetails Concentration of Credit Risk (Details) Details http://acceleratediagnostics.com/role/ConcentrationOfCreditRiskTables 39 false false R40.htm 2406402 - Disclosure - Investments - Schedule of Available-for-sale Securities (Details) Sheet http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleSecuritiesDetails Investments - Schedule of Available-for-sale Securities (Details) Details 40 false false R41.htm 2406403 - Disclosure - Investments - Schedule of Available-for-Sale Investment Maturities (Details) Sheet http://acceleratediagnostics.com/role/InvestmentsScheduleOfAvailableForSaleInvestmentMaturitiesDetails Investments - Schedule of Available-for-Sale Investment Maturities (Details) Details 41 false false R42.htm 2406404 - Disclosure - Investments - Narrative (Details) Sheet http://acceleratediagnostics.com/role/InvestmentsNarrativeDetails Investments - Narrative (Details) Details 42 false false R43.htm 2407402 - Disclosure - Inventory (Details) Sheet http://acceleratediagnostics.com/role/InventoryDetails Inventory (Details) Details http://acceleratediagnostics.com/role/InventoryTables 43 false false R44.htm 2408402 - Disclosure - Property and Equipment (Details) Sheet http://acceleratediagnostics.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://acceleratediagnostics.com/role/PropertyAndEquipmentTables 44 false false R45.htm 2409401 - Disclosure - License Agreements and Grants - National Institute of Health Grant (Details) Sheet http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsNationalInstituteOfHealthGrantDetails License Agreements and Grants - National Institute of Health Grant (Details) Details 45 false false R46.htm 2409402 - Disclosure - License Agreements and Grants - Arizona Commerce Authority and R&D Refundable Tax Credit Program (Details) Sheet http://acceleratediagnostics.com/role/LicenseAgreementsAndGrantsArizonaCommerceAuthorityAndRdRefundableTaxCreditProgramDetails License Agreements and Grants - Arizona Commerce Authority and R&D Refundable Tax Credit Program (Details) Details 46 false false R47.htm 2410402 - Disclosure - Deferred Revenue, Income and Remaining Performance Obligations (Details) Sheet http://acceleratediagnostics.com/role/DeferredRevenueIncomeAndRemainingPerformanceObligationsDetails Deferred Revenue, Income and Remaining Performance Obligations (Details) Details http://acceleratediagnostics.com/role/DeferredRevenueIncomeAndRemainingPerformanceObligationsTables 47 false false R48.htm 2412401 - Disclosure - Convertible Notes (Details) Notes http://acceleratediagnostics.com/role/ConvertibleNotesDetails Convertible Notes (Details) Details http://acceleratediagnostics.com/role/ConvertibleNotes 48 false false R49.htm 2413402 - Disclosure - Earnings Per Share (Details) Sheet http://acceleratediagnostics.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://acceleratediagnostics.com/role/EarningsPerShareTables 49 false false R50.htm 2414402 - Disclosure - Employee Equity-Based Compensation - Stock Option Activity (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionActivityDetails Employee Equity-Based Compensation - Stock Option Activity (Details) Details 50 false false R51.htm 2414403 - Disclosure - Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationInputsToCalculateEstimatedFairValueOfOptionsAwardedDetails Employee Equity-Based Compensation - Inputs to Calculate Estimated Fair Value of Options Awarded (Details) Details 51 false false R52.htm 2414404 - Disclosure - Employee Equity-Based Compensation - Stock Option Supplemental Information (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationStockOptionSupplementalInformationDetails Employee Equity-Based Compensation - Stock Option Supplemental Information (Details) Details 52 false false R53.htm 2414405 - Disclosure - Employee Equity-Based Compensation - Restricted Stock Activity (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationRestrictedStockActivityDetails Employee Equity-Based Compensation - Restricted Stock Activity (Details) Details 53 false false R54.htm 2414406 - Disclosure - Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details) Sheet http://acceleratediagnostics.com/role/EmployeeEquityBasedCompensationEquityBasedCompensationExpenseAndTaxBenefitDetails Employee Equity-Based Compensation - Equity-Based Compensation Expense and Tax Benefit (Details) Details 54 false false R55.htm 2415401 - Disclosure - Income Taxes (Details) Sheet http://acceleratediagnostics.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://acceleratediagnostics.com/role/IncomeTaxes 55 false false R56.htm 2416402 - Disclosure - Commitments - Narrative (Details) Sheet http://acceleratediagnostics.com/role/CommitmentsNarrativeDetails Commitments - Narrative (Details) Details 56 false false R57.htm 2416403 - Disclosure - Commitments - Operating Lease Obligations (Details) Sheet http://acceleratediagnostics.com/role/CommitmentsOperatingLeaseObligationsDetails Commitments - Operating Lease Obligations (Details) Details 57 false false R58.htm 2417402 - Disclosure - Industry and Geographic Information - Narrative (Details) Sheet http://acceleratediagnostics.com/role/IndustryAndGeographicInformationNarrativeDetails Industry and Geographic Information - Narrative (Details) Details 58 false false R59.htm 2417403 - Disclosure - Industry and Geographic Information - Disaggregation of Revenue (Details) Sheet http://acceleratediagnostics.com/role/IndustryAndGeographicInformationDisaggregationOfRevenueDetails Industry and Geographic Information - Disaggregation of Revenue (Details) Details 59 false false R60.htm 2417404 - Disclosure - Industry and Geographic Information - Long-lived Assets by Geographic Territory (Details) Sheet http://acceleratediagnostics.com/role/IndustryAndGeographicInformationLongLivedAssetsByGeographicTerritoryDetails Industry and Geographic Information - Long-lived Assets by Geographic Territory (Details) Details 60 false false R61.htm 2418401 - Disclosure - Related Party Transaction (Details) Sheet http://acceleratediagnostics.com/role/RelatedPartyTransactionDetails Related Party Transaction (Details) Details http://acceleratediagnostics.com/role/RelatedPartyTransactions 61 false false All Reports Book All Reports axdx-20180710.xml axdx-20180710.xsd axdx-20180710_cal.xml axdx-20180710_def.xml axdx-20180710_lab.xml axdx-20180710_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2017-01-31 true true ZIP 78 0001628280-18-010708-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-18-010708-xbrl.zip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end